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Abstract
The thesis describes the performance of the HepG2 cell line, a proliferating liver 
cell line, potentially to be used as the cellular component of a bioartificial liver 
(BAL). HepG2 cells in 3-Dimensional (3-D) spheroidal culture demonstrate 
dramatically improved function, compared to monolayer culture. The main aims 
of the thesis were to investigate the phenomenon in this culture system, whereby 
function in 3-D culture is optimal between Days 8-10, and thereafter there is a 
decline in function in spite of continued proliferation and viability. For optimal 
use in a BAL, it is necessary to increase function per cell either at later time points 
of 3-D HepG2 culture when cell numbers are greater, and/or increase cell number 
at times of peak function i.e. Days 8-10 of 3-D culture.
The initial hypothesis was that the downregulation of activity observed from 
Day 11 occurred at the transcriptional level. Approaches to determine expression 
of liver-enriched transcription factors at times of peak and diminished function in 
3-D culture and in monolayer culture were not conclusive.
To understand the mechanisms underlying the temporal change in function in 3-D 
culture, the hypothesis that hypoxia and/or other forms of stress were responsible 
for the drop in function observed was explored. Microarray data and Western blot 
analysis highlighted the expression of genes and proteins known to be upregulated 
by hypoxia at Day 15. Ambient oxygen concentration was increased to attempt to 
increase cell performance but was ineffective. Genes and proteins implicated in 
oxidative stress were expressed. Results from assays to measure oxidative stress 
in HepG2 culture demonstrated an increase at Day 15 compared with Day 8 
spheroidal cultures. Attempts to alleviate this stress by supplementing the culture 
medium with additional anti-oxidants at later times of 3-D culture did not enhance 
cell performance.
Some stress-related proteins and genes were more strongly expressed in Day 8 
cultures, as an adaptive response to increased metabolic activity during peak 
function, while others in Day 15 were turned off. These genes were investigated 
further at a functional level and results reflected the pattern observed.
3-D culture was manipulated with the addition of extracellular matrix (ECM) in
order to enhance cell performance. Cell proliferation was measured by total nuclei 
quantification, incorporation of BrdU as a measure of DNA synthesis and Ki-67 
labelling, as a measure of the total growth fraction. Positively labelled cells were 
seen throughout the spheroid indicating that even at the centre of the spheroids; 
there was maintenance not only of viability, but also the capacity to proliferate, 
indicating other microenvironmental changes may be responsible for the 
diminished function observed at Day 15.
The thesis has highlighted the possible causes for the downregulation of function 
observed and modulation of the 3-D environment to overcome this, and 
emphasised the complex relationship between cell performance and the stress 
response, in order to improve a system which could provide the basis for the 
biological component of a BAL.
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Synopsis
Chapter 1 is a general introduction to the thesis, outlining the background to the 
research undertaken. The long term aim is to develop an extracorporeal liver 
support system temporarily replacing liver function, which would be a major 
advance for the treatment of liver failure. In particular, the thesis highlights the 
performance of the HepG2 ceil line, a proliferating human liver cell line, 
potentially to be used as the cellular component of a bioartificial liver (BAL). 
HepG2 cells in 3-D spheroidal culture demonstrate dramatically improved 
function, compared to monolayer culture. Previous work carried out to 
investigate these effects is described, and the time course of performance vs. 
proliferation defined, which is especially important regarding potential use in a 
BAL.
Chapter 2 describes the general methods used throughout the thesis. More specific 
methods are described in their relevant chapters.
Chapter 3 and 4 attempt to understand the mechanisms underlying the temporal 
change in function in 3-D culture. Chapter 3 investigates the phenomenon with 
an initial hypothesis that the downregulation of activity observed from Day 11 
onward despite uninterrupted cell proliferation, was at the transcriptional level. 
RNA protection analysis was performed to investigate expression of liver- 
enriched transcription factors at times of peak and diminished function in 3-D 
culture and in monolayer culture. Results of this were inconclusive, and a 
Microarray analysis of RNA expression was performed.
Chapter 4 explores the hypothesis that hypoxia and/or other forms of stress within 
the alginate beads might lead to downregulation of function after 10 days. The 
Microarray data was interrogated and analysis of the data highlighted the 
expression of genes known to be upregulated in the presence of hypoxia via 
Hypoxia Inducible Factor 1 (HIF-1), at a time of diminished function (Day 15) 
compared with optimal performance (Day 8). Western analysis was carried out
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for HIF-1, as well as for a number of proteins also upregulated during hypoxia 
and a similar pattern of expression observed.
Further analysis of the Microarray database and Western blots were carried out to 
look for changes in genes and proteins, implicated in other stress responses such 
as oxidative stress, and assays to measure oxidative stress in HepG2 culture were 
carried out; results demonstrated an increase in lipid peroxidation and 
carbonylated proteins, as a measure of oxidative stress at Day 15 compared with 
Day 8 spheroid cultures.
Attempts to alleviate these stresses included increasing ambient oxygen 
concentration to increase cell performance, but was ineffective, and then 
supplementing the culture medium with additional anti-oxidants at later times of 
3-D culture, which did not improve cell number or enhance protein synthesis per 
cell at Day 11 or Day 15 of 3-D culture.
However, some stress-related proteins and genes were more strongly expressed in 
optimally performing Day 8 cultures, and turned on as an adaptive response, as a 
consequence of increased metabolic activity. Some of these genes were 
investigated further at the protein and functional levels; catalase and GSH 
transferase showed parallel changes in specific activities and mRNA levels. 
Others are more strongly expressed in Day 15 cultures as performance diminishes. 
Thus the relationship between cell performance and the stress response is complex 
in this system.
Chapter 5 investigates further previous work aimed at increasing proliferation and 
improving cell function in 3-D HepG2 culture. This chapter manipulates 3-D 
culture with the addition of a biological differentiating agent, extracellular matrix 
(ECM) derived from human placenta and/or mouse sarcoma to increase cell 
proliferation at later times of 3-D culture. Cell proliferation was measured in 
three ways: nuclei quantification using crystal violet and haemocytometer 
counting, incorporation of a thymidine analogue BrdU into nuclei followed by 
immunocytochemical detection and quantification, and analysis of Ki-67 a 
proliferation associated antigen as a measure of the total growth fraction. BrdU 
and Ki-67 staining gave us an indication of the localisation and pattern of
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proliferation in spheroidal culture. Similar percentage increases in cell number 
were observed, with all manipulations of ECM. Nevertheless, BrdU and Ki-67 
labelled cells were seen throughout the spheroid indicating that even at the centre 
of the spheroids, there was maintenance not only of viability but also the capacity 
to proliferate. Therefore, the diminished function observed is not as a result of 
loss of viability, indicating other microenvironmental changes may be 
responsible.
Chapter 6 summarises the research undertaken with an overall discussion, and 
suggestions for future work.
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Chapter 1
Introduction
Introduction
1.1 General Overview of the Liver
The liver is the largest solid organ in the body. Two blood vessels enter the liver, 
namely the hepatic portal vein with dissolved food substances from the small 
intestine, and the hepatic artery, with oxygenated blood from the lungs. Sinusoidal 
cells form a functional unit together with the parenchymal cells (hepatocytes) and 
hepatocytes are separated from each other by large capillary spaces called 
sinusoids. The plate structure of the liver and high permeability of the sinusoids 
allows each hepatocyte to be in close contact with the blood. The hepatic plates 
are arranged into functional units called liver lobules. The basal faces of 
adjoining hepatocytes are joined together by junctional complexes to form 
canaliculi, the first channel in the biliary system. Hepatocytes secrete bile into the 
canaliculi and at the ends of the canaliculi, bile flows into bile ducts. The liver is 
covered with a connective tissue capsule that branches and extends throughout the 
substance of the liver as septae and provides a scaffolding of support, and the 
highway along which afferent blood vessels, lymphatic vessels and bile ducts 
traverse the liver. Additionally, the sheets of connective tissue divide the 
parenchyma of the liver into lobules. The functions of the liver are varied and 
remarkable in that it maintains several biochemical pathways that permit the 
detoxification, or breakdown, of toxic products that accumulate because of the 
body’s normal chemical functions and exposure to environmental poisons. The 
liver works intimately with nearly every fundamental process in the body, 
including homeostasis and the regulation of blood sugar levels. Metabolic 
functions of the liver are multiple and include synthesis of bile and certain 
proteins for blood plasma such as albumin, production of cholesterol and 
processing of haemoglobin (MacSween et al. 2002). It also has a remarkable 
capacity for regeneration, after damage (Rozga 2002).
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1.11 Cell types in the liver
The parenchymal cells (hepatocytes) comprise approximately 60-70% of the liver 
volume. The other 30-40% is made up of non-parenchymal cells (NPC)s; the 
biliary epithelial cells lining the hepatic bile ducts and the hepatic sinusoid which 
harbours four different cells: endothelial cells, Kupffer cells, stellate cells (or also 
known as fat-storing cells, Ito cells or lipocytes) (Bouwens et al. 1992), and pit 
cells. Each cell type has its own specific morphology and functions, and no 
transitional stages exist between the cells. These cells have the potential to 
proliferate locally. Endothelial cells filter the fluids, exchanged between the 
sinusoid and the space of Disse through fenestrae that measure 175 nm in 
diameter and are grouped in sieve plates. Fenestrae occupy 6-8% of the cell 
surface. No intact basal lamina is present under these cells (Wisse et a l 1996). 
These changes mainly affect the passage of lipoproteins, which contain 
cholesterol and vitamin A among other components (Wilson et al. 1983).
The sinusoidal endothelial cells demonstrate endocytic capacity for ligands, 
including glycoproteins and components of the ECM such as collagen or 
fibronectin. They may also function as antigen-presenting cells and secrete 
eicosanoids, endothelin-1, nitric oxide and ECM components (Kmiec 2001).
Hepatic stellate cells (HSC) are pericytes, located in the space of Disse, with long, 
contractile processes, which probably influence liver (sinusoidal) blood flow. 
HSCs possess characteristic fat droplets and contain 80% of the body’s vitamin A 
which is stored as long-chain fatty acid esters, and is the main source of retinoids, 
utilised by tissues throughout the body (Senoo 2004). Vitamin A deficiency 
transforms fat-storing cells into myofibroblast-like cells with enhanced ECM 
production. Activation of HSC is promoted by cytokines from Kupffer cells and 
platelets, of which transforming growth factor-beta (TGF-P) is of great 
importance. TGF-P stimulates the expression of ECM components, inhibits 
collagenase components, and also promotes the activation of fat-storing HSCs 
towards a myofibroblast phenotype (Nakamura et al. 2000).
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Kupffer cells accumulate in periportal areas. They specifically endocytose 
endotoxin, which activates these macrophages (Xie et a l 2002). 
Lipopolysaccharide, together with interferon gamma, are very potent activators of 
Kupffer cells. Upon activation, these cells secrete oxygen radicals, tumor 
necrosis factor, interleukin (IL)-l, IL-6 that may damage hepatocytes, are active 
in the remodelling of ECM, and become cytotoxic against tumour cells (e.g., 
colon carcinoma cells). They play a major role in the response to inflammatory 
stimuli (Everett et a l 2003).
The biliary epithelial cells form the bile ducts and secrete bicarbonate rich 
solutions. The composition of bile is modified by these cells (Buanes et al 
1988;Tavoloni 1985). Bile acids are the most abundant biliary components, and 
play a major role in the maintenance of bile flow and are natural detergents that 
allow lipids to be digested in the intestinal lumen. They also secrete cytokines 
such as monocyte chemotactic protein-1 (MCP-1) which allows inflammatory 
cells to be recruited and promotes stellate cell proliferation and collagen synthesis 
(Lamireau et a l 2003).
Pit cells represent a population of large granular lymphocytes, and display a high 
level of spontaneous cytolytic activity against various tumour cells, identifying 
them as natural killer cells. The number and cytotoxicity of pit cells can be 
considerably enhanced with biological response modifiers, such as IL-12 (Wisse 
e ta l 1996).
1.1.1.2 Parenchymal cells- Hepatocytes
Hepatocytes are the basic functional cell of the liver and constitute approximately 
70% of the cellular content of the liver. They are the most important cell of the 
liver for metabolism. The liver has the unique ability to regulate its growth and 
size, and is under autocrine regulation releasing growth factors and cytokines. 
This regenerative property displayed by hepatocytes has been demonstrated 
following partial hepatectomy in response to decreased hepatic mass (Higgins and 
Anderson 1931).
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1,1.1.2,1 Physiological functions
Hepatocytes are the most metabolically diverse cells in the body. They play 
critical roles in synthesizing molecules that are utilized to support homeostasis, 
such as maintaining blood glucose homeostasis. Hepatocytes also store many 
nutrients, carry out secretory and excretory functions, and play a role in the 
production and release of plasma proteins, as well as regulating energy balances.
1.1.1.2.2 Protein Metabolism
Hepatic protein synthesis accounts for approximately 15% of total body protein 
production including most of the plasma proteins. Albumin, the major plasma 
protein, is synthesized almost exclusively by the liver, with a normal plasma 
concentration of 40-50g/l. Its principal functions are to regulate plasma colloidal 
pressure and act as a major transport protein. Also, the liver synthesizes many of 
the clotting factors necessary for blood coagulation; prothrombin, fibrinogen, and 
ai-Antitrypsin (MacSween et al. 2002).
Urea is synthesized by hepatocytes from ammonia generated by catabolism of 
amino acids derived either from digestion of proteins in the intestines or from 
endogenous tissue proteins, for excretion into urine, and deamination and 
transamination of amino acids, followed by conversion of the non-nitrogenous 
part of those molecules to glucose or lipids. Ammonia is very toxic and if not 
rapidly and efficiently removed from the circulation, will result in central nervous 
system disease (Mian and Lee 2002).
1.1.1.2.3 Carbohydrate metabolism
Glucose absorbed from the gut after a meal or glucose directly entering the blood 
stream as an intravenous infusion, reaches the liver and enters the hepatocytes by 
an active carrier-mediated process. Immediately it is converted to 
glucose-6-phosphate which is utilised by the liver for its various metabolic 
functions and for lipid synthesis (glycolysis). Hepatocytes contain dozens of 
enzymes that are alternatively turned on or off depending on whether blood levels
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of glucose are rising or falling out of the normal range. Two important examples 
of these abilities are: excess glucose entering the blood after a meal is rapidly 
taken up by the liver, and glucose-6-phosphate which is converted to glycogen 
and stored in the liver (glycogenesis). Later, when blood concentrations of 
glucose begin to decline, the liver activates other pathways which lead to 
depolymerization of glycogen (glycogenolysis) and export of glucose back into 
the blood for transport to all other tissues. When hepatic glycogen reserves 
become exhausted, i.e. during fasting, hepatocytes synthesise glucose from amino 
acids (alanine and glutamine) and non-hexose carbohydrates (gluconeogenesis) 
(Banhegyi and Mandl 2001;Ferrer et a l 2003).
1.1.1.2.4 Lipid metabolism
Few aspects of lipid metabolism are unique to the liver, but many are carried out 
predominantly by the hepatocyte. Major examples of the role of the liver in fat 
metabolism include oxidizing triglycerides to produce energy. This is carried out 
in the smooth endoplasmic reticulum of the hepatocyte, which also synthesises 
triglycerides, cholesterol, phospholipids and bile acids. The liver breaks down 
more fatty acids than the hepatocytes need at any one time, and therefore exports 
large quantities of acetoacetate into blood where it can be readily metabolized by 
other tissues and used for ATP generation (Guidoux 1991). Some of this is 
packaged with lipoproteins and made available to the rest of the body. The 
remainder is excreted in bile as cholesterol or bile acids. The hepatocytes are the 
site of synthesis and secretion of serum lipoproteins (Bouma et a l 1988). They 
also play major roles in cholesterol and steroid metabolism and in the metabolism 
of the fat-soluble vitamins (vitamins A and D).
1.1.1.2.5 Detoxification
Hepatocytes are important in the detoxification of lipid-based drugs. The 
microsomes are responsible for the "conjugation" process involved in the 
inactivation of drugs (Chen et al 2002). The major pathways for excretion of 
xenobiotics are via bile or urine, after they have been made hydrophilic. The
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cytochrome P450 monooxygenases oxidise endogenous substrates, and drugs and 
carcinogens. P450 3A4 is of major importance, as it is the most abundant P450 in 
the human liver and is known to metabolize the majority of drugs whose 
biotransformation is known (Anzenbacher and Anzenbacherova 2001). P450 
enzymes are located in the smooth endoplasmic reticulum and perform the Phase 
1 reactions. Many compounds need to be conjugated in a Phase II reaction. The 
major conjugation reactions are glucuronidation of drugs such as morphine and 
acetaminophen (paracetamol), glutathione conjugation, amino acid conjugation, 
sulfation, acetylation and methylation (de Wildt et a l 1999). The Phase I 
intermediates can be highly reactive and are often more toxic than the parent 
compound.
1.2 Hepatic failure
Acute liver failure (ALF), also known as fulminant hepatic failure (FHF) is 
serious, often life threatening, and occurs when the whole liver begins to fail. It 
may be a complication of acute hepatitis due to viruses (hepatitis A, B), overdose 
or reaction to drugs (e.g. acetaminophen). It usually develops rapidly and 
demands immediate care (Gill and Sterling 2001).
1.2.1 Definitions and causes
FHF can be divided into hyperacute, acute, or subacute liver failure. In all types, 
liver failure is characterized by hepatic encephalopathy, jaundice, coagulopathy, 
and high mortality rates. Viral hepatitis, drugs, or toxins can precipitate ALF in 
patients without chronic liver disease. Metabolic stress such as bleeding or 
infections can precipitate acute-on-chronic liver failure in patients with chronic 
liver disease. The term, “acute liver failure” is, however, usually defined as 
patients developing hepatic encephalopathy, in the absence of pre-existing liver 
disease (MacSween et a l 2002). While the etiologies of FHF are multiple and 
varied, the prognosis is dependent on several factors, including the underlying 
cause of liver failure (Farmer et a l 2003). Cerebral oedema is the main cause of 
death in patients (Plevris et a l 1998).
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Hepatitis viruses can be grouped together (hepatitis A-E) (Chen 2003). 
Biochemical changes associated with liver hepatitis include raised serum 
aminotransferase and alkaline phosphatase activity. Acute viral hepatitis is 
characterised morphologically by a combination of inflammatory cell infiltration, 
macrophage activity, hepatocellular damage i.e. hepatocyte swelling and 
regeneration, and necrosis of the liver. The most severely affected patients with 
ALF due to viral causes will survive only with liver transplantation (Plevris et al 
1998;Panteva et al. 2003). Paracetamol overdose remains the major cause of 
acute of liver failure in the UK (Plevris et a l 1998). The overall mortality rate is 
approximately 40% but is much higher in those with profound coagulopathy and 
renal failure.
1.3 Treatments for Hepatic Failure
Advances in intensive care and medical management have led to some 
improvements which treat the clinical manifestations of ALF, such as hepatic 
encephalopathy which is treated with withdrawal of dietary protein, lactulose and 
neomycin, but they are not wholly effective. Neomycin has the potential to 
increase the risk of renal failure (Plevris et al 1998). Other complications include 
bacterial/fungal infections but the use of a wide spectrum of antibiotics such as 
aztrenam with vanomycin or piperaciliin with gentamycin have proved to be 
ineffective (Rolando et a l 1992).
1.3.1 Liver Transplantation
Unfortunately, without liver transplantation, the survival rate for patients with 
ALF is poor but the one year survival rate following liver transplantation has 
improved from ~ 30% in the 1960s and 1970s to more than 80% in the 1990s 
from cadaveric donors (Bramhall et al 2001). Recent programmes have 
introduced living related liver transplantation as an alternative treatment due to 
the relative shortage of cadaveric donors, with subsequent increased survival rates 
(Karliova et a l 2002;Miwa et a l 1999). However, this potentially large group of 
donors is limited due to blood group mismatch, size incompatibilities, age or 
pre-existing disease, so providing a donor organ in only 30% of cases (Stockmann
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and IJzermans 2002). Due to this overall shortage, an extracorporeal approach to 
the treatment of ALF is being investigated.
1.3.2 Extracorporeal/Artificial and Bioartificial Devices 
A form of liver support that could aid patients with liver failure, either until they 
recover spontaneously or an organ becomes available, could be a major benefit. 
Essentially, there are two types of extracorporeal supportive therapy under 
development: bio-artificial devices, which use hepatocytes to perform the 
functions of the failing liver; and artificial devices which are described below. 
Many devices have been developed which focus on detoxification alone as several 
substances such as bilirubin, bile acids, ammonia and lactate accumulate rapidly 
and cause multiple organ dysfunction and encephalopathy. Some of these 
endogenous toxins are water soluble, but most of them have a high binding 
affinity to albumin, a molecule overloaded with toxins in hepatic failure due to the 
reduced detoxification capacity of the liver. These devices do not possess the 
negative side effects of bioincompatibilty and lack of selectivity, but to date they 
have not improved the clinical status of these patients (Stange et al 
1999;Stockmann and IJzermans 2002). Earlier attempts to provide liver support 
included the use of detoxification procedures such as haemofiltration and 
haemoperfusion which (Ponting et a l 1992) will be discussed in detail later, and 
plasma exchange. However, these techniques were not significant in effectively 
removing albumin bound toxic molecules due to their affinity for albumin and 
their inability to permeate dialysis membranes (Ponting et al 1992).
1.3.2.1 Haemodialysis
Haemodialysis requires a semi-permeable dialysis membrane through which 
fluids and small solutes may pass via diffusion, but may have an adverse effect on 
cardiac output and can lead to increased cerebral oedema.
Albumin dialysis is a new method that combines the efficacy of sorbents to 
remove albumin-bound molecules with the bioincompatibility of the modem 
dialysis membrane. The albumin acts as a specific molecular adsorbent and 
recirculates in a recycling system (i.e., molecular adsorbents recycling sytem, or
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MARS). However, there is considerably little data regarding the use of MARS in 
ALF. One study described four such patients treated with MARS, where 
improvement of bilirubin and ammonia was observed but only one survived (Sen 
et a l 2002). A further recent study showed that a patient population with severe 
acute alcoholic hepatitis demonstrated improved bilirubin, renal function and 
encephalopathy. There was an improvement of a 3-month predicted mortality 
(pre-MARS: 76%, post MARS: 27%); and a 50% 3-month survival (Sen et al 
2003).
Although MARS is an exciting tool for the treatment of liver failure, most studies 
to date have been small, and the majority uncontrolled.
1.3.2.2 Haemojiltration
Haemofiltration and continuous haemodiafiltration are blood purification 
methods, as forms of renal replacement therapies, following liver failure. In this 
system, water and solutes are removed continuously and gradually, and in contrast 
to conventional haemodialysis, this allows for gradual correction of fluid balance 
and osmotic pressure. The membrane pore size of the haemofilter used is larger 
than that of the dialyzer used for conventional haemodialysis, allowing movement 
of substances with higher molecular weights (Oda et al 2002).
13.2.3 Haemoperfusion
Haemoperfusion removes toxins and low-to-middle weight molecules i.e. bile 
acids, phenols, ammonia by using different adsorbents for a range of water 
soluble molecules, e.g. charcoal. Although charcoal is an effective adsorbent for 
a range of water-soluble molecules, it is not for ammonia or protein bound 
compounds. A randomised clinical trial has shown that charcoal haemoperfusion 
has little influence on survival (Liu et a l 2002).
1.3.3 Alternative treatments fo r  hepatic failure- Bioartificial liver devices
Such is the complexity of liver function that it is generally agreed that such an 
artificial support would require a cellular component. Therefore the proposal to 
design a BAL is to aid patients until they either recover or receive a liver
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transplant (Strain and Neuberger 2002). A BAL needs to accomplish a number of 
liver specific functions. The underlying principle is that a BAL device would 
circulate patients’ plasma extracorporeally through a cartridge containing 
optimally functional hepatocytes.
Source of cells for a BAL
133.1  Animal cells
To use primary hepatocytes from other species, particularly porcine hepatocytes, 
would overcome the problem of obtaining normal human liver tissue. Primary 
porcine hepatocytes are indeed used in current BAL devices. It has been 
estimated that approximately 15 billion hepatocytes (10% of a normal liver) are 
required to sustain a patient in liver failure (Allen and Bhatia 2002).
Nevertheless, there would be the risk of xenozoonosis and immunological 
rejection. Porcine endogenous retrovirus (PERV) is regarded as a potential 
pathogen, as it can infect human cell lines in vitro, and human plasma can be 
detrimental to animal hepatocytes, due to activation of complement (Hoekstra and 
Chamuleau 2002). Until progress has been made on preventing animal proteins 
from being transmitted to the patient, animal cells are probably unsuitable for 
application in a BAL in the current climate.
13,3,2 Human cells
1.33.2.1 Primary hepatocytes
The primary human hepatocyte is the ideal candidate for the biological component 
of the BAL. However, primary hepatocytes need to be isolated from donor organs 
of which there is already a shortage. Primary hepatocytes rapidly de-differentiate 
and proliferate poorly in vitro, lose liver specific gene expression and become 
unstable (Bhandari et a l 2001). The large scale isolation, culture and sufficient 
numbers of cryopreservation of adult human hepatocytes, with long term stable 
highly differentiated function is not yet a reality.
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1.3.3.2.2 Stem cells
An alternative source of human hepatocytes for a liver support system is stem 
cells (Selden and Hodgson 2004). In vitro cell transplantation or extracorporeal 
liver support therapies would benefir from utilizing stem cells if they provide a 
proliferating but readily differentiatable cell supply. Stem cells could therefore 
offer a potentially unlimited source of cells for hepatocyte replacement, and 
overcome the limitations imposed by existing techniques for immortalizing 
functional human hepatocytes and the risk of transmission of xeno-derived viruses 
and disease.
Stem cells, by definition, retain the ability for unlimited self-renewal while giving 
rise to progeny that differentiate along the lineage (Faris et al. 2001). It is now 
generally accepted that the liver contains cells with stem-like properties and that 
these cells can be activated to proliferate and differentiate into mature hepatic 
epithelial cells under certain pathophysiological circumstances in humans and 
animals (Zhang et al. 2003). For example, evidence from in vitro studies in 
rodents and humans suggested that stem cells give rise to liver cells, particularly 
in the presence of severe liver damage (Petersen et al. 1999; Alison et a l 2000). 
There are a number of putative hepatocyte progenitors from a variety of sources. 
These are briefly described below.
Embryonic stem cells are derived from blastocysts and are multipotential for 
every cell type and therefore described as totipotent. Adult stem cells are mostly 
tissue specific and are located either in the bone marrow or in the liver itself. 
These are considered to be multipotent. Haemapoietic stem cells and 
mesenchymal stem cells are bone marrow derived. The foetal liver is also a 
source of haemapoietic stem cells in rodents and demonstrate proliferative 
capacity and differentiation (Cantz et al. 2003) even after transplantation, unlike 
the generally quiescent adult hepatocytes.
The oval cell population contains stem-like cells which can differentiate along 
hepatocytic, biliary, intestinal and pancreatic lineages in various rodent systems 
(Faris et al. 2001). These are known as hepatocyte progenitors and somewhat 
more committed than true stem cells.
Plasticity of stem cells has been demonstrated in the liver. For example when
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liver stem/progenitor cells engraft in the portal space, they differentiate into bile 
duct cells, when engrafted into the parenchyma, they differentiate into 
hepatocytes (Alison et a l 1993). Recently, probably distinct stem cell 
populations potentially capable of developing into hepatocytes have been 
demonstrated in rodents (Alison et al 1997) and humans, derived from the adult 
liver, where CD34+ and c-kit+ were cultured from human liver up to 8 days 
(Crosby et al. 2001). Selden et al. 2003 identified colonies from the 
non parenchymal cell population from a diseased liver which expressed stem cell 
markers OCT-4 and secreted albumin and AAT into the medium for several 
months. In peripheral blood of both mice and humans with treatment of growth 
colony stimulating factor (GCSF), mRNA expression was detected for markers 
AFP and CK19, indicating that they have the potential to develop into hepatocytes 
and/or biliary epithelial cells. In the adult liver, Evarts et al. 1996 demonstrated 
through pulse-chase experiments, the differentiation of oval cells (liver cell 
progenitors) into hepatocytes. However, identifying and particularly culturing 
liver cell progenitors in and from normal human liver has proved very difficult 
and it is easier to identify oval cells generated experimentally or in vivo 
pathophysiologically.
The mechanisms underlying the apparent conversion of stem cells into 
hepatocytes has been debated (Dahlke et al. 2004). Various reports suggested that 
stem cells could fuse with liver cells, which initially contain 2 or more additional 
sets of chromosomes. In some cases, this was followed by a reduction-division, 
which led to a normal chromosome set in the resulting cells (Wang et al. 
2003;Vassilopoulos et al. 2003). Transdifferentiation is also a possible 
mechanism, but appears to be a rare event but analysis on a clonal level could 
provide further support for this hypothesis (Theise and Wilmut 2003). Currently 
research is ongoing to investigate the factors controlling the differentiation of 
stem cells into the desired cell type. Stable differentiation and/or commitment is 
necessary in order to repetitively culture the cell type of interest but so far 
approaches to manipulate stem cells from adult tissues have had only partial 
success, and so cell lines still remain the source for the biological component of 
the BAL.
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1.3.3.2.3 Cell lines
Cultured hepatic cell lines, hepatoma/hepatoblastoma cell lines could eliminate 
the problem of human hepatocyte shortage, however there maybe a risk of 
tumourogenicity. Cultured as monolayers, none of these cell types retain 
sufficient functional capacity for use in BAL devices. Immortalisation of human 
cells in vitro requires that malignant transformation and de-differentiation 
associated with progressive tumorogenesis be excluded. The HH25 cell line for 
example was developed by co-culturing with rat liver epithelial cells and retains 
some differentiated functions such as albumin synthesis and cytochrome P450 
function. Immortalised cell lines have been engineered to maintain differentiated 
function and proliferate in vitro (Roberts et al 1994;Smalley et al. 1999). 
However, continuous replication and an increased rate of cell division and 
therefore metabolic activity, can render them genetically unstable, and can lead to 
the production of subclones with different metabolic capabilities. One example is 
the C3A hepatocyte cell line, a sub-clone of the HepG2 hepatoblastoma cell line. 
Human hepatocytes that have been immortalised have been derived from foetal or 
mature liver tissue. Generally most human hepatocytes have been immortalised 
by introduction of a single Ml (non-dividing state or senescence) or M2 (second 
growth arrest) factor where cells enter a non-dividing senescence state.
The NKNT-3 cell line, created by introduction of Simian virus 40 (SV40)-T 
causing it to block the action of p53, allows cells to escape Ml and divide 
continually until the second growth arrest, M2 where the telomere ends become 
short, create chromosomal instabilities and rearrangements and eventually 
apoptosis (Hoekstra and Chamuleau 2002). SV40T Ag induced immortalisation 
of cells in general is often accompanied by de-differentiation and karyotypic 
instability, whereas hTERT-immortalised cells retain more differentiated 
functions and have less chromosomal damage. Our laboratory has designed 
human hepatic cell lines using a temperature-sensitive SV40T Ag. However, 
these cell lines only partially resemble in vivo normal human hepatocytes, due to 
progressive loss of cytochrome P450 activity, and lack of albumin secretion
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(Smalley et a l 2001).
A final safety measure in immortalised cell lines is the addition of suicide genes, 
such as HSV thymidine kinase that provide negative selection with gangcyclovir . 
Immortalisation of human hepatocytes, which are metabolically active and 
expressing a full repertoire of liver specific functions have still not been achieved. 
The availability of in vitro expandable human hepatocytes would greatly advance 
liver directed cell therapies.
1.3.3.2.4 Foetal hepatocytes
Foetal hepatocytes have a higher proliferative capacity than mature hepatocytes, 
but depending on the age of the donor, they may not carry out all differentiated 
functions. There are also practical and ethical difficulties in utilising this system. 
However, considering the large quantities required for hepatocyte based therapies, 
using cells from the foetal human liver is an intriguing possibility, as these cells 
display a higher proliferative capacity then mature hepatocytes. It was established 
that hepatocytes from the foetal human liver are amenable to hTERT-mediated 
telomerase reconstitution without disrupting the ability to differentiate in vivo and 
in future potentially play a role in liver-directed cell therapies, but also relies on 
the availability of human tissue (Wege et al. 2003). Foetal hepatocytes have been 
harvested from the liver obtained from mid-trimester abortions, but the yield and 
the availability of hepatocytes were adversely affected by the condition of the 
foetus. Although, it was feasible to maintain these hepatocyte cultures for over 8 
days, when hepatocytes were innoculated into a hollow fibre module to formulate 
a BAL support device, the cultures developed either cellular disintegration or 
bacterial infections (Anand et a l 2000).
The use of some of these sources of cell types as the cellular component of BAL 
devices and in clinical trials will be described further.
1.3,4. Extracorporeal BAL devices in clinical trials
The basic BAL bioreactor consists of a column containing a collection of hollow- 
fibre capillaries through which patient plasma is pumped. Hepatocytes are
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innoculated into the capillary space, alone or attached to microcarrier beads. In 
the secondary circuit, plasma is separated, warmed, oxygenated, and then 
perfused through the lumen of the bioreactor capillaries, to allow free exchange of 
molecules between plasma and hepatocytes. The design must provide optimal ex 
vivo maintenance of hepatocytes, and given that conventional monolayer cultures 
are unable to maintain optimal function, hepatocytes would have to be induced to 
form cellular aggregates.
One example is the C3A hepatocyte cell line, a sub-clone of the HepG2 
hepatoblastoma cell line, which is currently being tested in a BAL device, the 
ELAD system. ALF induced dogs with C3A cells in this system resulted in an 
80% survival rate of treated animals compared with none of the control animals. 
A pilot controlled trial on humans with ALF showed no significant improved 
survival rate and no ammonia reducing activity (Sussman and Kelly 1993), and in 
addition, these cells attached as monolayers instead of 3-D culture on 
microcarriers. In a pilot controlled study in 1996, there was no significant 
difference observed between the survival rates of the extracorporeal liver assisted 
device (ELAD)-treated and the control groups (Ellis et a l 1996). Recent models 
of ELAD are modified versions with an oxygenator supplied to ensure adequate 
oxygen supply to the cells (Millis et al 2002). Although 4 out of 5 patients 
survived in these trials, there was an increase in ammonia in the secondary circuit, 
and none of the patients who were treated experienced any neurological 
improvement. Strain et al 2002 suggested that more clinical trials need to be 
carried out, as the first clinical trial with this system consisted of 24 ALF patients. 
Currently, a larger multicenter trial of the ELAD is underway in the USA and UK 
under the direction of Vitagen (Moussy 2003;Sen et a l 2002). Vitagen 
announced their enrolment of a phase II trial of ELAD. The trial was to evaluate 
the safety and effectiveness of the ELAD system in bridging patients to either 
transplantation or recovery. Despite the severity of the patients disease 
progression, when controlled in this trial, initial outcomes comparing ELAD 
treated patients, showed 80% of ELAD treated patients, successfully bridged to 
transplantation or recovery, compared to 56% in the control group.
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Demetriou and coworkers used porcine hepatocytes which were attached to 
microcarriers which are coated with collagen and innoculated into the extra fibre 
compartment of hollow fibre modules, and a charcoal perfusion column through 
which plasma passed, prior to entering the bioreactor (Rozga et a l 1993). 
However, there still remains the risk of zoonoses. Treatment of liver failure in 
pigs with the BAL utilising charcoal, but no cells, delayed the onset of intracranial 
hypertension to a significantly lesser degree, but survival time in those animals 
was similar to that seen in pigs subjected to a sham BAL containing neither cells 
nor charcoal (Khalili et a l 2001). This indicates that removal of small molecular 
weight toxins by means of high flux charcoal plasma perfusion is far less effective 
in treating experimental liver failure in pigs than the complete BAL, agreeing with 
their earlier results from studies in dogs (Rozga et a l 1993). Human patients with 
ALF were treated with a hybrid BAL consisting of an extracorporeal perfusion 
system containing porcine hepatocytes. The patient's blood was separated by 
plasmapheresis and the plasma was perfused through a charcoal sorbent column 
and a cartridge containing the porcine hepatocytes. The cartridge contains hollow 
fibers through which the patient's plasma circulates and 5xl09 porcine hepatocytes 
attached to beads were innoculated into the extra-fibre compartment. The 
membrane separating the plasma from hepatocytes has 0.2-pm pores that allow 
the passage of molecules, such as immunoglobulins. However, ALF patients 
exposed to pig hepatocytes after repetitive treatments with a BAL device, 
developed strong IgG and IgM anti-pig Abs, mostly directed against the alpha Gal 
epitope (Baquerizo et a l 1999).
Gerlach and his colleagues designed a bioreactor system which essentially 
provides an optimised compartment for porcine hepatocytes to encourage them to 
reorganise into functional cellular aggregates by creating a three dimensional 
capillary space, to provide an efficient oxygen supply and allow the flow of 
plasma (Baquerizo et a l 1999;Gerlach et a l 1995). However, the Gerlach 
bioreactor is difficult to run outside the setting of the laboratory (Strain and 
Neuberger 2002).
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The AMC BAL of Amsterdam requires at least 10 billion porcine hepatocytes and 
uses hollow oxygenation fibres. The bioreactor consists of a spirally wound, 
nonwoven polyester matrix in a cartridge, in which the hepatocytes are attached to 
the polyester matrix, and the design of this BAL is similar to one our laboratory 
would utilise. The unique feature of this BAL is that the plasma of the patient has 
direct contact with the hepatocytes, thereby reducing the diffusion distance and 
allowing mass exchange similar to the situation in the sinusoids of the intact liver 
parenchyma. A phase I study in Italy, showed that 6 of their first 7 patients were 
successfully bridged to orthotopic liver transplantation (Sosef et a l 2002). The 
function of this BAL was evaluated using anhepatic pigs, in other trials, but did 
not result in an improved coagulation state, i.e. prothrombin time, due to 
extensive consumption of clotting factors (Sosef et a l 2003).
The Sussman, Demetriou and Gerlach BAL devices are on clinical trial, but there 
are other BAL reactors which have not reached clinical trials, and although 
hepatocytes can function in BAL devices, detailed analysis of these studies are 
still awaiting reviews and appraisals. Progress has been made in this field, but it 
has been limited.
The successful development of the BAL depends on the hepatocyte component, 
the matrix support, and the bioreactor design. The bioreactor compartment must 
allow optimum cell culture, storage prior to use and cell integrity for use in the 
artificial support system. As well as the ability to culture hepatocytes within 
capillary membranes, allowing efficient gas exchange, substrate supply and waste 
removal to be carried out efficiently and practically. The cells may be seeded, 
cultured and grown within capillary membranes and perfused in the extra­
capillary space, providing both mechanical and physiological protection from 
toxic blood or plasma.
In summary, none of the systems investigated have convincingly proved effective 
in replacing impaired liver function. Another important aspect is whether liver 
cells cultured in bioreactors can remain stable for a sufficient period of treatment. 
Selected metabolic or detoxifying functions of the bioreactor are difficult to
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assess. Furthermore, since some applications combine biological units with other 
components, such as active charcoal, it is difficult to assess the role of hepatocytes 
in these settings.
Understanding the conditions necessary for a normal hepatocyte to express its full 
functional repertoire is important to establish fully functional cultures of liver 
cells, whether for experimental studies, work in drug development, or with the 
aim of creating a BAL. One major requirement is to maintain expression of 
normal differentiated function. To achieve this, a three-dimensional (3-D) 
environment for hepatocyte growth would resemble better the in vivo architecture 
of the liver to optimise the performance of liver cells growing in vitro.
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1.4 A Three-Dimensional Environment for Hepatocytes
Hepatocytes require cell-cell and cell substrate interactions to survive and 
function. Furthermore, cell proliferation and differentiated function are often 
inversely dependent on one another and highly regulated in the micro­
environment. All organs are organised three-dimensionally, so two-dimensional 
models, i.e. those based on monolayer cultures, cannot imitate their structures. 
Three-dimensional models can potentially mimic the in vivo physiology of the 
liver as cell shape and environment determines gene expression and the biological 
behaviour of the cells. If cultured cells remain cuboidal, differentiated function is 
maintained better than in monolayer culture (Berthiaume et al. 1996) which 
would be ideal to maintain optimal function for use in a BAL. There have been 
many approaches pursued to minimise this loss of differentiated function 
observed in monolayer culture, by co-culture with NPCs and various matrices. 
These will now be discussed with respect to their ability to induce 3-dimensional 
growth.
1.4.1 Collagen sandwich
Rat hepatocytes cultured in a collagen sandwich maintained normal morphology 
and a physiological rate of albumin secretion for at least 42 days, whereas 
hepatocytes cultured on a single layer of collagen gel ceased albumin secretion 
within a week (Dunn et al. 1989). The addition of ECM induces both cellular 
polarity and cell-ECM interactions (Hamilton et al. 2001). However, 
microcarriers such as collagen can also induce plasma clotting (Cunningham and 
Hodgson 1992).
1.4.2 Engelbreth Holm Swarm (EHS) mouse sarcoma-derived matrix 
Engelbreth Holm Swarm (EHS) mouse sarcoma-derived matrix contains laminin 
and type IV collagen, growth factors etc. that can affect differentiated function. In 
hepatocytes cultured on thick EHS gel, production of plasma proteins and 
expression of cytochrome P450 was maintained (Lindblad et al. 1991). For cells 
cultured on plastic substratum and thin layer collagen, the ratio of albumin/beta-
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actin mRNA was low and declined compared to cells cultured on EHS gel, where 
the ratio was high and serially increased during the culture period (Berthiaume et 
al 1996;Gomez-Lechon et a l 1998;Nagaki et a l 1995). However, EHS matrix is 
of animal tumour origin and therefore inappropriate for a human BAL, but useful 
as proof of principle studies in the absence of human ECM which is difficult to 
obtain.
1,4.3 Alginate
Alginate is commercially available as alginic acid as a sodium salt, which is a 
linear polysaccharide. Alginate, isolated mainly from marine brown seaweed, 
was discovered by the British chemist Stanford in 1815. Alginic acid polymers 
are present in three types, depending on the part of the seaweed they are extracted 
from: 1) consisting entirely of D-mannuronic acid, 2) consisting entirely of 
L-guluronic acid, 3) alternating L-guluronic acid and mannuronic acid. Alginate 
being the skeletal component of the seaweed is both strong and flexible. The 
chain arrangement provides strength for the molecule and is responsible for fibre 
forming properties. Only sodium and potassium alginate salts are soluble in 
water. By pouring the sodium salt of alginic acid into calcium ions, the calcium 
salt of alginate is formed and the solution changes into a semi-solid state with an 
exchange of calcium ions for sodium ions. The gel formed is 99-99.5% water and 
0.5-1.0% calcium alginate, if a 1% gel is prepared. The "hydrogel" is 
thermostable over 0-100°C. Maintaining sodiumxalcium <=25:1 avoids gel 
destabilisation. The higher the guluronic content, the more rigid the gel.
1.4.3.1 Advantages o f using alginate encapsulation
Microencapsulated cells or tissue in alginate, as artificial organs, are under study 
for treatment of a variety of other diseases, including Parkinson's disease, 
hypocalcaemia and diabetes (Xue et al 2001;Picariello et al 2001;Darquy and 
Reach 1985;Clayton et al 1993). Industrial applications include encapsulating 
yeast in ethanol production (Navratil et al 2002;Najafpour et al 2004). The use of 
an encapsulation system protects the cells or tissue within. Compared to other 
possible encapsulation techniques such as macrocapsules and intravascular
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devices, microcapsules have several advantages. The large surface area of small 
beads results in enhanced survival of tissue due to better nutrition and oxygen 
supply, and in addition microcapsules can be implanted with minimal invasive 
surgery. It is, however, important to recognize the need for working with 
wellcharacterized alginate in order to obtain gel beads with reproducible 
properties. For medical applications it is also of crucial importance that the 
alginates are documented according to regulatory requirements and contain low 
levels of impurities.
Use of other different three-dimensional support systems, have included porous 
glass and silicon. When comparing alginate to porous glass and silicon, cells 
encapsulated in alginate performed better. Protein secretion was higher in cells 
encapsulated in alginate, although silicon supported greater protein secretion than 
did porous glass (Selden et al 1998). Cultured hepatocytes can be induced to 
form spheroids by microgravity and elliptical shaking (Berger et al 
1995;Khaoustov et a l 1999;Khaoustov et a l 2001). However, once out of these 
inductive conditions, the spheroids disaggregate, contrary to that seen with 
spheroids cultured in alginate.
L4,3.2 Cell choice fo r encapsulation in 3-D culture by alginate
The sources of potential cells for a BAL have been previously described. Two 
human hepatocyte cell lines were previously assessed for function, morphology 
and proliferation: HepG2 cells and HHY41 cells in monolayer and in 3-D culture 
(Khalil et al 2001). HepG2 cells in 3-D culture were chosen for further 
investigation. In this thesis the HepG2 cell line derived from a human 
hepatoblastoma free of known hepatropic viral agents is investigated. Minces of 
liver biopsies were initially overlaid on feeder cultures of irradiated mouse cell 
layers. After several months of passage of individual colonies, with restricted 
growth, a proliferating cell line that became feeder independent was obtained 
(Javitt 1990). HepG2 cells are a mature cell line, capable of carrying out many 
differentiated liver functions e.g. protein synthesis of albumin and cytochrome 
P450 function. In general, protein synthesis is better preserved than cytochrome 
P450 detoxificatory pathways. HepG2 cells in monolayer express normal low-
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density lipoprotein (LDL) receptors and internalise very low density lipoproteins 
(VLDL), synthesise bile acids and secrete them into the medium. Electron 
microscopic appearance of the monolayer also supports the idea of HepG2 being a 
mature cell line, as there are, for example, tight junctions bordering on bile 
canaliculi with microvilli indicating a capacity for active secretory processes, 
which suggests HepG2 cells may be an appropriate cell line for use in a BAL 
(Kono et a l 1995;Kono and Roberts 1996). Roberts et al 1994 developed the 
HHY41 cell line by culturing human hepatocytes derived from normal liver tissue 
between collagen gel layers in medium enriched with growth factors for four 
weeks. The cells were not treated with carcinogens or virus transfection. The 
cells retained the characteristics of differentiated hepatocytes for example 
cytochrome P450 function and protein secretion and they proliferated freely in 
vitro (Roberts et al 1994). Of the two cell lines described above, cytochrome 
P450 assessed by 7-Ethoxyresorfin-O-deethylase (EROD) and 
7-Methoxyresorufin-O-dealkylase (MROD) activity was greater in HepG2 cells 
than HHY41 cells, although the same pattern of enzyme activities were observed 
in both cell lines. HHY41 cells in alginate expressed all five urea cycle enzymes 
and synthesized urea. Monolayer HepG2 cells do not demonstrate the five 
enzymes of the urea cycle. However, in 3-D spheroids, they expressed 4 urea 
cycle enzymes at a rate comparable to that of rat liver, but ornithine 
transcarbamylase (OTC) was undetectable. Since OTC is the rate-limiting 
enzyme in the urea cycle, its lack in HepG2 results in no overall urea synthesis. 
Currently others in the group are working on overexpressing OTC in HepG2 cells 
by transfection and cloning. HepG2 cells were considered the cell line of choice, 
as a subclone of HepG2 had previously been approved for clinical usage in a 
BAL.
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1.4.4 Improved liver-specific function demonstrated by HepG2 cells in 3-D 
culture - Data from previous work in the laboratory as a basis for the aims o f 
this thesis
HepG2 cells in monolayer (seeded at 0.5 x 106/ml) reaching 
70-80% confluency at Day 8 of culture
DayO Day 8 Day 15
3-D culture in alginate 
Fig.l Phase contrast microscopy using an inverted microscope (Eclipse TE200, 
Nikon, Maidstone, UK) allowed HepG2 cells to be visualised throughout culture 
(xlO)
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In HepG2 cells, peak function was observed at Day 8. At Day 8, a 2.5-9.0 fold 
increase in protein secretion per cell was observed for albumin, fibrinogen, 
prothrombin, alpha-1-antitrypsin (AAT) and alpha-1-acid glycoprotein (AGP) as 
compared to secretion from monolayer cultures. Khalil et al 2001 showed a 
slower rate of proliferation of HHY41 cells than HepG2 cells.
However, HepG2 cells in 3-D culture demonstrate better function per cell in terms 
of protein secretion for albumin, fibrinogen and AAT.
Morphologically, HepG2 cells encapsulated in alginate, compared to monolayer 
culture, form a 3-D configuration and this is demonstrated in Fig. 1.
The same pattern of secretion was seen in both cell lines, in which peak function 
was achieved between Days 8 and 10, with subsequent decreases in protein 
secretion, inspite of continued viability and proliferation (Fig 2a and 2b). This 
has been demonstrated in this thesis and by Khalil et al 2001.
In order to use a feasible amount of cells in a BAL to replace liver function, it is 
necessary to maintain or improve cell function at later time points when cell 
numbers increase. In this thesis, function will primarily be defined as albumin 
secretion per HepG2 cell.
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HepG2 cell proliferation in spheroids is initially slow and after a lag phase up to 
Day 8, double at a rate of every 4.5 days (Fig.2b). Therefore, for example to 
replace one-third of the liver with our cells working optimally at Day 8 (Fig.2a 
and 2b) it would require approximately 17.5 litres of cells. This volume would 
be required to replace albumin production and is calculated on the basis of -2  x 
1011 cells in the liver, (-7 x 1010 = 1/3 of cells in the liver) producing -12 g 
albumin/24h. At Day 8 (peak function) in our culture system, we have achieved 
a cell density of 4 x 106 /ml. Therefore to replace one-third of the function of the 
liver: 7 x 1010/4 x 106 = 1.75 x 104 mis = 17.5 litres. Using cells which had been 
cultured longer, e.g. Day 15 spheroids where cell numbers are much greater, a 
much smaller volume of cells to replace liver function would be required e.g. 1-2 
litres, which would be more practical for therapeutic purposes (Roberts et al 
1994) provided per cell function could be maintained at the Day 8 peak function. 
Part of the aim of this thesis is to explore ways of improving function. Whilst it 
is known that albumin could be administered exogenously, it serves here simply 
as an example of measurable liver specific function.
1.5 Causes for downregulation of function
Various hypotheses were investigated previously as possible causes for this down 
regulation of function, including measuring protein content within different 
compartments of the spheroids and the alginate matrix, to see if protein diffusion 
was impeded. Alginate was crosslinked with stronger divalent cations than 
calcium chloride i.e. barium and strontium to see if function could be maintained. 
Other alginate sources were also used. However, no significant differences, with 
regard to proliferation and function were observed.
Having ruled out simple physical explanations, the first part of this thesis serves 
to explore changes in transcriptional levels within the different cultures to see 
whether key genes are being switched on and off during periods of peak and 
diminished function.
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1.6 OVERALL AIMS
The overall aim of the thesis was to:
To characterise and improve the methods to enhance the performance of HepG2 
cells in alginate spheroidal culture:
1) By determining both gene and protein expression during enhanced performance 
at Day 8 of spheroidal culture compared to monolayer culture, and diminished 
function at Day 15 of spheroidal culture with peak function, Day 8 spheroidal 
culture.
2) Manipulating the 3-D culture system in the light of these results.
1.7 INITIAL HYPOTHESES
My initial hypothesis was that A) different transcription factors are present at 
times of peak function, 3-D culture (at Day 8) compared to monolayer culture and 
times of diminished function in 3-D culture (at Day 15) compared to peak 
function (Day 8).
and B) decreased levels of liver-enriched transcription factors in Day 15 3-D 
cultures are contributing to the diminished amount of liver specific proteins such 
as albumin and AAT compared to peak function at Day 8.
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Chapter 2
General Methods
Chapter 2- General Methods
2.1 General Cell culture- Culture and maintenance of HepG2 cells
2.1.1 Materials
HepG2 cells were cultured in alpha Minimal Essential Medium 
(a-MEM) with ribonucleosides and deoxyribonucleosides (Invitrogen) 
supplemented with the following ingredients:
Table 1 Culture medium components for HepG2 cells
Component Stock concentration Final concentration Store
Foetal Calf Serum 100% 10% - 20°C
(FCS)
Penicillin/Streptomycin 5000U/ml 50U/ml - 20°C
Glutamine 200mM 2 mM - 20°C
Fungizone 270.6mM 1.35mM - 20°C
All the above are supplied by Invitrogen
(Scotland)
Linoleic acid albumin 258.6mM 0.14mM + 4°C
Hydrocortisone 2.8mM 0.12pM -20°C
Thyroid releasing 2.8 mM 0.12 pM -20°C
Hormone (TRH)
All the above are supplied by Sigma (Dorset, UK)
Insulin
(Novo Nordisk, UK) 0.6mM 0.18pM + 4°C
Sodium selenite 0.58mM 0.12pM + 4°C
(Merck Ltd, UK)
*D -Glucose Solution 2.50M 22mM + 4°C
(Sigma)
! ixtra Glucose is only adc ed to medium for 3-Dimensional culture of cells, not
when cells are in conventional monolayer
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HepG2 cell line from ECACC (Wiltshire UK)
Tissue culture flasks and medium from Nunc (Life Technologies, 
Invitrogen, Scotland)
Hanks Buffered Salt Solution (HBSS), without calcium or 
magnesium (Life Technologies, Invitrogen, Scotland)
Trypsin Ethylenediaminetetra-acetic acid (EDTA) (in citrate 
saline/glucose) (Life Technologies, Invitrogen, Scotland)
0.2% Trypan Blue in IX phosphate buffered saline (PBS).
2.1.2 HepG2 culture
HepG2 cells were seeded in monolayer in 175cm flasks at a density of 
0.5 million/ml to reach a confluency of 70-80% a week later and a final yield of 
35-40 million cells. Cells were cultured in supplemented oc-MEM (without high 
glucose (HG)) and medium changed every 48 hours. The cells were maintained 
in incubators at 37°C in a humidified atmosphere of 95% air: 5% CO2.
2.1.2.1 Trypsinising
The cells were passaged/trypsinised when they reached 70-80% confluency and 
were a single sheet of rounded uniform cells.
After removal of the medium, the cells as monolayers were washed three times 
with warm HBSS (Ca2+/Mg2+ free). Warm (37°C) trypsin (lOmls for 175cm2 and 
5mls for 80cm2 flasks) was added through a 0.2pm filter (Minisart, Sartorius) and 
incubated at 37°C for 30-90 seconds. After firmly tapping the sides of the flasks, 
the cells detached as a monolayer sheet from the surface and were poured rapidly 
into a Nunc tube with warm complete oc- MEM (25mls for 175cm flask, 12mls for 
80cm flask) to neutralise the trypsin. The cells were centrifuged at 300g at room 
temperature for 4 minutes (Heraeus, UK). The supernatant was discarded and the 
pellet was resuspended in warm oc-MEM complete (5mls for 175cm2 and 2mls for 
80cm ) with gentle pipetting. Cells were gently syringed with a sterile 21G 
needle 4-5 times to disaggregate cell clumps and form a single cell suspension.
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2.1.2.2 Cell yield and viability
Cell density and viability was determined by trypan blue exclusion. Trypan blue 
stains dead or injured cells due to breakdown of the cell membrane; intact 
membranes will exclude trypan blue. In the following order 160pl of HBSS, 20pl 
of Trypan Blue and 20pl of the cell suspension were added. Yield and viability 
were estimated after 2 minutes in a haemocytometer. The cells were reseeded at 
an appropriate cell density into fresh flasks or frozen in 5% Dimethyl Sulphoxide 
(DMSO) in 50% FCS in liquid nitrogen for future use.
2.1.3 Preparation fo r alginate encapsulated HepG2 cells
2.1.3.1 Materials
Alginic acid sodium salt from Macrocystis pyrifera, kelp. Cat No. A2033 
(medium viscosity, Sigma Chemical Co).
0.15M NaCl pH 7.4
0.102M CaCl2 in 0.15M NaCl pH 7.4
Dulbeccos Minimal Essential Medium (DMEM) with glutamax, 
sodium pyruvate and 10% FCS and Penicillin/Streptomycin 
(Invitrogen 31966-021) 
a- MEM complete with HG 
60-70% confluent flask of HepG2 cells.
2.1.3.2 Apparatus
23G co-axial cannula (constructed at the Medical Engineering
Unit, Hammersmith Hospital)
Electronic syringe pump and syringe piston (Harvard Apparatus 
Co.)
Medical air gas cylinder.
2.1.3.3 Alginate preparation
The 2% w/v alginate preparation was made with alginic sodium salt (light 
sensitive) added very gradually to 0.15M NaCl pH 7.4, and left to stir overnight 
and autoclaved on the day of use at 121 °C for 10 minutes.
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2.1.3.4 Encapsulation o f HepG2 cells 
Electronic syringe pump and syringe piston
"► 20mi syringe
alginate/medium 
cell suspension
23 G
co-axial
cannula
-> air flow 
meter
filtered 
air supply
-  o
o
o o  <
magnetic stirrer
H i n 4-
air flow control 
valve
HepG2 cells and promote 3-Dimensional culture
The 2% w/v alginate preparation was mixed with HepG2 cells at a required cell 
density of 0.5 x 106/ml and a-MEM with HG to achieve a final 1% alginate 
concentration. The suspension was mixed very gently and loaded onto a syringe 
of appropriate volume, fitted with a specifically designed 23G co-axial cannula. 
The cannula system was connected to an air supply, with the syringe piston 
controlled by an adjustable valve (units + cc/min). The solution was pumped 
through at 1.5ml/minute. The syringe diameter was also set on the pump 
depending on the syringe used. The system was set up under sterile conditions in 
a tissue culture laminar flow hood.
Micro droplets of alginate-encapsulated cells were formed by a concentric air
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flow created around the cannula. The alginate beads solidify on contact with 
calcium chloride cationic divalent solution (0.102M in 0.15M NaCl). Beads were 
collected for a timed period into a container with a 200pm nylon mesh bottom 
immersed in the calcium chloride solution.
After polymerisation in the calcium chloride solution for 15 minutes the beads 
were washed in DMEM solution and transferred into a T175cm tissue culture 
flask.
The beads were resuspended in the flask and aliquotted into 6 well culture plates 
with 100pm mesh filters in each well on which the beads were supported. Each 
well contained a volume of 0.25mls of beads in 8mls of a-MEM medium with 
HG. The culture medium was replenished every 48 hours. In this way beads 
received medium from above and below.
2.1.4 Harvesting o f Alginate-Encapsulated cells
2.1.4.1 Materials
4mM EDTA (disodium salt) (Merck Ltd) in 0.15 M NaCl pH 7.4 
0.15MNaCl pH 7.4
2.1.4.2 Method
The day before harvesting, cell strainers containing 0.25ml of beads were placed 
into a fresh well of a 6 well plate with 5mls of a-MEM HG medium. Exactly 24 
hours later, the conditioned medium was removed from the wells and frozen at - 
20°C for further analysis. The beads were transferred from the cell strainers into a 
6 well plate. Warm EDTA solution (chelating agent) was added to each well (1.9 
mis per 0.25mls of beads in each well) and incubated for 30 minutes at 37°C. 
EDTA chelates calcium cations depolymerising the alginate allowing the cell 
spheroids to break out of the alginate beads. Cell spheroids were broken up with 
multiple, vigorous syringing, using a 23G needle, avoiding foaming and the cell 
suspension was spun at lOOOOg for 5 minutes at room temperature (Eppendorf 
5402, Germany). Any excess EDTA/alginate was removed by washing with 
0.15M NaCl, followed by centrifugation. The pellet containing nuclei was 
resuspended in the appropriate volume of crystal violet solution (1%) depending
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on the harvesting time point.
Harvesting Time Point (Day) Volume of crystal violet solution (ml)
4 0.4
8 0.8
11 1.0
15 1.5
Table 2 Typical volumes of crystal violet solution added at harvesting time points
2.1,4.3 Determining cell yield
2.1.4.3.1 Materials
0.1M citric acid containing 1 % w/v crystal violet and 0.2 % 
Triton X-100 pH 3-4.
2.1.4.3.2 Method
After the addition of crystal violet solution, the samples were incubated at 37°C 
for 1 hour and then left overnight at 4°C. Nuclei were counted using a 
haemocytometer; each sample was counted in triplicate.
2.1.5 For cell viability
2.1.5.1 Materials
Propidium iodide (PI) -lmg/ml-(store in dark at 4°C)
Fluorescein diacetate (FDA) 1 mg/ml made up in DMSO 
(kept at room temperature)
IX PBS warm
Simultaneous staining with FDA and PI is used for the identification of living and 
dead cells. PI passes through dead cell membranes and intercalates with DNA to 
form a bright red fluorescent complex. FDA passes though living cell membranes 
and is hydrolysed by intracellular esterase to convert non-fluorescent FDA to 
fluorescein. Fluorescein accummulates inside the cell and fluoresces green; FDA 
stains the cytoplasm and fluoresces green showing viable cells (Clarke et al. 
2001).
65
2.1.5.2 Method
Approximately 1 ml medium containing beads were placed in a microfuge tube, 
beads were washed twice with PBS and resuspended in 1ml of PBS. lOpl of PI 
and 20pi of FDA was added, mixed gently and allowed to stand for a few 
minutes. The beads were washed again twice with PBS and finally resuspended 
in 0.5ml of PBS. The beads were viewed under a fluorescent microscope using a 
filter with an excitation filter of 510-560nm and an emission filter of 590nm for 
PI stained cells, and for FDA stained cells, using an excitation filter of 465-495nm 
and an emission filter of 515-555nm.
2.2 Measuring presence of liver specific secreted proteins
The enzyme linked immunosorbent assay (ELISA) uses a colorimetric detection 
system to quantify specific protein content. Antigen is captured by an unlabelled 
antibody and detected with a secondary antibody conjugated to an enzyme to give 
a visual signal, which can be quantified. Examples of detection systems include 
horseradish peroxidase (HRP) and alkaline phosphatase which are the most 
widely employed enzyme conjugates in enzyme immunoassay. The substrate for 
peroxidase is hydrogen peroxide. In HRP assays, cleavage of H2O2 is coupled to 
the oxidation of a hydrogen donor which changes colour during the reaction.
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InDirect Sandwich ELISA
ANTIBODY SAMPLE CONJUGATE COLOUR
SUBSTRATE
EVERY STEP IS FOLLOWED BY INCUBATIONS AND WASHINGS 
The indirect sandwich ELISA was used to determine amounts of secreted liver- 
specific proteins, albumin, AGP, fibrinogen, prothrombin, AAT and alpha 
fetoprotein (AFP). Medium was conditioned for 24 hours and kept at -20°C until 
further analysis.
2.2.1 Materials
Nunc immuno 96-well plates (Maxisorp) (Invitrogen, Scotland) 
Wash Buffer- IX PBS containing 0.05% Tween 20 
Coating Buffer
Sodium carbonate (NazCOs) 0.318g In 200ml 
Sodium hydrogen (NaHC(>3) 0.586g K at 4°C 
carbonate *
Working OPD solution
OPD 4mg (1,2- phenylenediamine dihydrochloride, 
DAKO) dissolved in 12mls dH20. 6pl of hydrogen 
peroxide (30% solution) were added immediately 
before use. The solution was protected from light 
Sulphuric acid (2M) - Stop solution
Primary antibodies and secondary horse-radish peroxidase (HRP) 
conjugated antibodies ( DAKO Ltd, High Wycombe).
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Protein
Primary Antibody Secondary Antibody
Standards
Albumin Rabbit polyclonal anti­
human albumin (lOmg/L) 
Cat No. A0001 
(1/1400)
(HRP) conjugated 
rabbit polyclonal anti­
human albumin 
(1/8000) Cat No. P356
Human serum 
albumin (Sigma 
Ltd) Range: 
25-200ng/ml
A1GP Rabbit polyclonal anti­
human A1GP (lOmg/L) 
Cat No. A0011 (1/1900)
HRP conjugated rabbit 
polyclonal anti-human 
A1GP (1/1000)
Cat No. PE324
Human A1GP 
(Sigma Ltd) 
Range: 6.25- 
200ng/ml
Al-AT Rabbit polyclonal anti­
human A1AT (lOmg/L) 
Cat No. A0012 
1/900
HRP conjugated rabbit 
polyclonal anti-human 
Al AT (1/1000)
Cat No. PE876
Citrated human 
plasma 
Range: 12.5- 
200ng/ml
Fibrinogen Rabbit polyclonal anti­
human fibrinogen 
(lOmg/L) Cat No. A0080 
1:400
HRP conjugated rabbit 
polyclonal anti-human 
fibrinogen (1/4000) 
Cat No. P445
Citrated human 
plasma 
Range 6.25- 
200ng/ml
Prothrombin Rabbit polyclonal anti­
human prothrombin 
(lOmg/L) Cat No. A325 
(1/1000)
HRP conjugated rabbit 
polyclonal anti-human 
prothrombin (1/1000) 
Cat No. P445
Citrated human 
plasma 
Range 12.5- 
200ng/ml
Al-FP Rabbit polyclonal anti­
human Al FP (lOmg/L) 
Cat No. A008 (1/200)
HRP conjugated rabbit 
polyclonal anti-human 
A1FP (1/7500)
Cat No. P445
Human AFP 
(DAKO) 
Range 12.5- 
200ng/ml
Table 3 Antibodies and standard curve ranges used to measure liver specific 
proteins
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2,2,2 Method
For each ELISA, the appropriate primary antibody was diluted in coating buffer; 
wells were coated with lOOpl. The plate was wrapped in cling film to prevent 
evaporation and left overnight at 4°C or at 37°C for 2 hours.
Plates were washed 3 times with wash buffer PBS/ 0.05% Tween 20. Appropriate 
standards in lOOpl were added in triplicate to the plate, the plate was sealed and 
incubated for 1 hour at 37°C. The plate was then washed 3 times with wash 
buffer.
An appropriate dilution of the secondary HRP conjugated antibody in PBS/Tween 
20 (wash buffer) was made (Table 3); lOOpl was added and incubated for 1 hour 
at 37° C. The plate was washed 5 times with PBS/0.05% Tween 20.
To the plate lOOpl of OPD solution was added at timed intervals and left covered 
in foil until a sufficient colour change (orange) had taken place (usually between 1 
to 4 minutes depending on the protein being assayed). The reaction was stopped 
by addition of 50pl of 2M sulphuric acid at the same time intervals. Within 1 
hour, absorbances were read at 492nm using a micro-plate reader (Anthos HTII, 
Anthos Labtec Instruments, Salzburg, Austria) and analysed by Biolise Software. 
Results were expressed as ng protein per ml.
2.3 Preparation of total RNA from HepG2 cells in monolayers and cultured 
in alginate at Day 8 and Day 15 of culture and human liver.
High purity and integrity of RNA isolated from cultured cells or tissue is essential 
for effective use in applications such as nuclease protection assays, Northern 
blotting, cDNA synthesis for microarray and reverse transcription PCR. The 
RNAgents Total RNA Isolation System from Promega (Cat No. Z5110) was used 
and subsequently the Qiagen RNeasy mini kit (Cat No. 74104) to rapidly extract 
pure and intact RNA. These commercially available kits avoid the need to utilise 
time-consuming and tedious methods such as CsCl step-gradient 
ultracentrifugation, ethanol or LiCl precipitations, or methods involving the 
repeated use of toxic substances such as phenol and/or chloroform. These
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methods are able to recover smaller RNAs which do not sediment efficiently 
during centrifugation through CsCl. The use of LiCl can result in the loss of RNA 
smaller than 5.8S and the carryover of lithium salts can inhibit cDNA synthesis 
reactions.
The essential steps required for the successful isolation of intact RNA includes 
efficient disruption of cells or tissue, denaturation of nucleoprotein complexes, 
inactivation of endogenous ribonuclease (RNase) activity and elimination of 
contaminating DNA and protein.
The RNAgents Total RNA Isolation System from Promega includes a denaturing 
solution which contains two potent inhibitors of RNase activity, guanidine 
thiocynate with N-lauryl sarcosine and P-mercaptoethanol which act to disrupt the 
nucleoprotein complexes allowing RNA to be released free of protein. 
Contaminants are then separated by acid extraction using phenol: chloroform: 
isoamyl alcohol.
The RNeasy mini kit was used to clean up RNA previously isolated by the Total 
RNAgents method. This method was not utilised for total RNA prepared for the 
Ribonuclease protection assay but was included as a step for the preparation of 
total RNA for cDNA synthesis in microarray analysis.
Before this purification step, samples were treated with DNase digestion to 
denature any contaminating genomic DNA in the samples.
Lysis buffer (containing p-mercaptoethanol) and ethanol are added to the samples 
to provide conditions that promote selective binding of RNA to the RNeasy 
membrane. The kit combines the selective binding properties of a silica-gel-based 
membrane with the speed of microspin technology. The sample is applied to an 
RNeasy spin column where the total RNA binds to the membrane, and 
contaminants are washed away. High quality RNA is eluted in RNase free water. 
Total RNA was extracted from samples of monolayer HepG2 cells, and 3-D 
HepG2 spheroids cultured in alginate (n=3).
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All steps were carried out in an RNase free environment, surfaces were clean, 
solutions were treated with DEPC, glassware was baked at 200°C overnight and 
sterile tips with filters were used.
2.3.1 Materials
- RNAgents Total RNA Isolation System from Promega (Cat No. 
Z5110)
- DEPC (Diethyl Pyrocarbonate, Sigma, UK)
- RNase Away (Molecular BioProducts Cat no. 7003)
- HBSS on ice
- 4mM EDTA in 0.15M NaCl pH 7.4
- IX PBS (treated with 0.1% DEPC)
- Ethanol
- 0.1% DEPC treated water 
Baked apparatus at 200°C
- Pestle and Mortar
- Homogenisers
- Glassware.
2.3.2 Total RNA preparation from  monolayer HepG2 cells
A 70% confluent T175 flask of HepG2 cells in monolayer yields -2.5 x 107 cells. 
Two flasks were used. Briefly, the flask was washed twice with ice cold sterile 
PBS (treated with 0.1% DEPC previously). Denaturing solution (3mls) was 
added to each flask and the flasks were rocked by hand until the solution became 
viscous. The entire solution was transferred to Oakridge tubes on ice (also 
previously treated with 0.1% DEPC). To the tube 1/10 volume 3M Sodium 
acetate pH 5.2 was added and mixed by inversion 4-5 times to precipitate the 
RNA. An equal volume of phenol: chloroform: isoamyl alcohol was added, 
mixed by inversion 4-5 times and vortexed vigorously for 15 seconds. The 
solution chilled on ice for 15 minutes. The phenol mix separates the solution into 
phases. The top aqueous phase contains the pure RNA. DNA remains in the
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organic phase and protein at the interface. The tubes were centrifuged at lOOOOg 
for 20 minutes at 4°C (MSE Europa). The top aqueous layer was removed 
avoiding the interface and transferred to a clean tube. An equal volume of 
isopropanol was added and incubated at -20°C for 1-2 hours to precipitate the 
RNA. The solution was centrifuged at lOOOOg for 15 minutes at 4°C (MSE 
Europa). The pellet was resuspended in an appropriate amount of denaturing 
solution and vortexed until dissolved. An equal volume of isopropanol was 
added, mixed, vortexed well and cooled for a 1 hour at -20°C. The solution was 
centrifuged at lOOOOg for 15 minutes at 4°C (MSE Europa). The pellet was 
washed with 75% ethanol (diluted with 0.1% DEPC treated water) and broken up. 
The pellet was centrifuged at 6500g for 10 minutes at 4°C (MSE Europa). The 
pellet was left to air dry for 1-2 minutes and resuspended in RNase free water. 
The total RNA in solution was quantitated and analysed for purity by measuring 
its optical density at 260nm and 280nm. RNA was aliquotted and stored at -80°C.
2.3.3 Total RNA preparation from  3-D HepG2 cultures
Cell yield from spheroids was determined as described previously. Sufficient 
beads for ~5 x 107 cells were transferred into Nunc tubes. The beads were 
allowed to settle and medium removed. Beads were washed twice with cold 
HBSS on ice. For every 0.25ml of beads, 1.9ml of 4mM EDTA in 0.15M NaCl 
pH 7.4 (treated with 0.1% DEPC) and 1% v/v P-mercaptoethanol was added fresh 
immediately to the EDTA solution, just before incubation with the EDTA. The 
tubes were inverted until the alginate dissolved. The tubes were centrifuged at 
200g for 4 minutes at 4°C (Heraeus, UK) and the supernatant removed. Cold 
PBS (0.1 % DEPC treated-5ml) was added to the tubes and centrifuged at 200g 
for 4 minutes at 4°C (Heraeus, UK). The supernatant was removed and an 
appropriate amount of denaturing solution was added. The remainder of the RNA 
isolation was identical to that described for monolayer.
2.3.4 Total RNA preparation from  human liver tissue
Normal human liver tissue was obtained under the approval of the Royal Free 
Local Research Ethics Committee, Reference 38-200 entitled “Culture if human
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liver cells obtained at surgery” (See Appendix A for further details). Liver tissue 
was placed immediately in liquid nitrogen. The pestle and mortar was cooled 
with liquid nitrogen and the tissue was transferred to the cold pestle and mortar 
under nitrogen. The tissue was homogenised in liquid nitrogen and the fine 
powder transferred into Oakridge tubes. An appropriate amount of denaturing 
solution was added and the RNA isolation procedure was continued as described 
for cells in monolayer and 3-D culture.
2.4 Protein lysate preparation for Western blot analysis
2.4.1 Materials
Lvsis Buffer - lOmM Tris pH 7.4 
1% Glycerol
ImM Sodium orthovanadate
2X Electrophoresis buffer - 125mM Tris pH 6.8
4% sodium dodecyl sulphate (SDS)
10% Glycerol
0.006% Bromophenol blue
IX PBS (cold)
Cell scrapers 
HBSS on ice
4mM EDTA in 0.15M NaCl pH7.4 
2% P-mercaptoethanol.
Apparatus
Sonicator (Soniprep 150, Sanyo, Leicestershire, England)
2.4.2 Method
2.4.2.1 From 3-D cultures
For Day 8 and Day 15 3-D cultures, sufficient alginate-HepG2 beads were taken 
from each condition so that an equal number of cells were present. Typically, ~ 
50 x 106 cells from each culture condition.
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Beads were transferred to polypropylene conical tubes. The beads were allowed 
to settle and the medium carefully removed with a sterile pipette. The beads were 
washed with cold HBSS and IX PBS. PBS was removed and EDTA solution 
added (1.9mls/0.25ml beads). The tubes were mixed manually until the alginate 
dissolved and released the HepG2 spheroids. The samples were spun at 200g for 
10 minutes at 4°C (Heraeus, UK). While the samples were spinning, the lysis 
buffer was brought to boiling point. After the samples had been centrifuged, the 
supernatant was removed, and 3-4mls of boiling lysis buffer added to the 
remaining pellet. The samples are mixed and vortexed well to break up the pellet. 
The samples were briefly microwaved for 5-10 seconds uncapped. The cells were 
lysed by sonication, briefly for 30 seconds, avoiding foaming.
The samples were vortexed and a small amount -100pi was used to determine 
total protein using the Lowry method. The remaining samples were diluted in 2X 
electrophoresis buffer to obtain a final concentration of 1 mg/ml. Samples were 
stored at -80°C until further analysis.
2.4.2.2 From Monolayer Cultures
HepG2 cells cultured as monolayers in T175cm flasks (~50 x 10 ) were washed 
twice with cold IX PBS. To each flask 3mls of boiling lysis buffer was added. 
The flasks were rocked until the solution became viscous. The solution was 
pipetted into polypropylene conical tubes, centrifuged as for 3-D cultures and 
treated as described earlier.
2.4.3 Total protein determination
The mini Lowry method was carried out for the determination of total protein 
(Schacterle and Pollack 1973).
2.4.3.1 Materials
96 well plate
Copper sulphate reagent- 10% Na2C0 3 , 0.2% Potassium Sodium
Tartrate, 0.05% CuS04.5H20 , 2% NaOH
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25g ofNa2C 03> 5g of NaOH, 0.5g of potassium sodium tartrate were made up to 
approximately 200mls ddH20. 195mg of CuSO4.5H20 was dissolved in a few mis 
of ddH20. The copper sulphate solution was slowly added to the alkaline tartrate 
solution, and the final volume was adjusted to 250ml. This solution was stored in 
a polypropylene bottle, protected from light, at room temperature and was stable 
for a month.
Folin and Ciocalteau Phenol reagent (F/C Stock, Sigma Aldrich 
Cat No. F-9252) stored at 4°C and diluted 1:16 with water prior to 
use
Protein standard curve was constructed with known protein 
amounts of bovine serum albumin (BSA), prepared by doubling 
dilution (ranging from 0 - 32pg/well) in 0.3 M NaOH / 0.1% SDS 
or sample buffer
2,4.3,2 Method
50pl of sample or standard was added in triplicate to wells of a 96 well plate. 
50j l i 1 of copper sulphate solution was added to the wells in the same order at 10 
second intervals. The plate was incubated at room temperature for exactly 10 
minutes from first addition of the copper sulphate solution on an orbital mixer. 
Colour detection was started by the addition of 200pl of diluted F/C reagent at 10-  
second intervals. The plate was briefly mixed in an orbital shaker and incubated 
at 55°C for 5 minutes to complete the colour reaction. The plate was removed 
and left to cool in a tray of ice. The absorbance was measured at 620nm in a 
microplate reader (Anthos HTIII), connected to Biolise Software to plot a 
standard curve and calculate the amount of protein per well in pg for each sample.
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2.5 Western blotting for detection of specific proteins
This method is used to identify a specific protein in a complex mixture and
simultaneously determine its molecular weight. The procedure requires: -
1) Size separation of the denatured proteins in the mixture by SDS- 
Polyacrylamide Gel Electrophoresis (PAGE). The anionic detergent SDS was 
used with p-mercaptoethanol and heat to dissociate the proteins before they 
were loaded onto the gel. Denatured proteins bind SDS in a sequence 
independent manner which is proportional to the molecular weight. A 
negative charge is conferred to each protein, allowing separation under 
electrophoresis.
2) Transfer of the separated proteins to a membrane while retaining their relative 
position.
3) Detecting the protein under investigation by using antibodies raised against 
the target protein and confirmation of its size relative to standard proteins of 
known size. The proteins were visualised by an enzyme-linked 
chemiluminescent reaction onto autoradiographic film.
2.5.1 SDS-PAGE Electrophoresis
2.5.1.1 Materials
Pre-cast 4-20% Tris-Glycine Gradient gel (Invitrogen, Scotland) 
Novex Mini Gel Apparatus (Invitrogen, Scotland)
10X (Tris/Glycine/SDS) Running Buffer (National 
Diagnostics,UK)
Molecular weight standard -Rainbow coloured marker ranging 
from 250kDa-10kDa (Amersham Life Sciences, 
Buckinghamshire).
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2.5.1.2 Method
Samples (in electrophoresis buffer) were heated to 100°C for 4 minutes in a 
boiling water bath and loaded onto a pre-cast 4-20% Tris-Glycine with IX 
Tris/Glycine SDS Running buffer, with lOpl of the rainbow marker and the 
samples were run at 125V, 35mA for 2 hours until the bromophenol blue dye was 
within 1cm of the gel base.
2.5.2 Protein detection
2.5.2.1 Materials
- The following antibodies were obtained from Becton Dickinson (UK) 
except for actin (Autogen, Bioclear UK)
Protein Catalog
No
MW
(kDa)
Control Dilution Stock
Cone1
pg/pl
Final
Cone"
pg/pl
HIF-la H72320 120 HeLa+ 1:250 250 1
MEKK3 M79820 71 SW-13 1:250 250 1
MKK3b M85420 37 HeLa 1:250 250 1
JNKK1/MKK4 M66420 44 Rat
cerebrum
1:500 250 0.5
P385/ SAPK4 P72020 42 A431 1:500 250 0.5
MAPKp49/JNKl
SAPK1
M54920 49 PC12 1:250 250 1
JNK Phospho- 
Specific
S37220-
050
43/56 Hela + 
Anisomycin
1:250 250 1
STIl/Hop-p60 S65720 62 A431 1:250 250 1
HO-1 H59320 32 SW-13 1:250 250 1
HO-2 H77220 36 SW-13 1:250 250 1
Cox-2 C22420 70 Macrophage 1:250 250 1
Actin Sc-1616 43 - 1:500 0.2 0.0004
Table 4. Commonly used antibodies with working dilutions
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PVDF membrane, 3MM Whatman Filter Paper Sandwich 
(Invitrogen LC2002)
Transfer buffer- (200mD Tris Base (12mM)
Glycine (96mM)
Methanol (20%)
Wash buffer - (800ml) 1 OmM Tris pH 7.5
lOOmM NaCl 
0.1% Tween 20 
Goat Anti-Mouse IgG antibody (Becton Dickinson # Ml 5345) 
Rabbit Anti-Goat IgG antibody (Dako #P0449)
Enhanced Chemiluminescence plus (ECL+) detection kit 
(Amersham Pharmacia Cat No. RPN 2132)
Kodax BioMax MR film (Sigma Aldrich).
2.5.2.2 Eletrophoretic transfer o f proteins to membrane
During Western blotting, proteins separated by SDS-PAGE were transferred from 
a gel to a solid matrix support. This was probed with antibodies that were specific 
to a particular antigenic epitope displayed by the target protein, allowing for the 
identification of specific proteins in complex mixtures without the need for 
immunoprecipitation.
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2.5.2.27 Method
The filter paper was placed in transfer buffer, and the PVDF membrane was 
briefly soaked in 100% methanol, and rinsed twice for 5 minutes with distilled 
water, and equilibrated in transfer buffer.
The blotting pads were soaked in 700mls of transfer buffer to saturate. The gel 
was removed ffom its plastic cassette and placed in the apparatus for transferring 
as follows;
Blotting Pad 
Blotting Pad
Filter Paper 
PVDF membrane 
2nd gel
PVDF membrane 
Filter Paper 
Blotting Pad 
Blotting Pad
The module was closed and filled at the top with transfer buffer until covered. 
The outer buffer chamber was filled with deionised water, which ideally should be 
approximately 2cm ffom the top of the lower buffer chamber. The gels were 
transferred for 2 hours at 25 V.
The apparatus was disassembled. Gels were placed in coomassie blue solution for 
45 minutes at room temperature with gentle agitation and destained overnight to 
determine efficient transfer of proteins. The PVDF membranes with the 
transferred proteins were quickly placed in blocking buffer made up of 5% non­
fat dried milk in wash buffer for 1 hour at room temperature with gentle agitation. 
For detection of phosphorylated proteins, it is generally not recommended to use 
milk as a blocking agent in conjunction with anti phosphotyrosine antibodies, as
Filter Paper
1st gel
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milk contains an abundance of tyrosine phosphorylated proteins such as phospho- 
casein. However, there is more background if just milk alone was used, so a 
blocking buffer made of 1% non-fat dried milk, 1% BSA, 50mM sodium fluoride 
in IX TBS with 0.05% Tween 20 was used. The primary and secondary antibody 
for phosphorylated proteins was also made up at the appropriate dilutions in this 
blocking buffer. The primary antibody for all other proteins were made in 
solutions in the appropriate dilutions in 5% non-fat dried milk in wash buffer with 
0.05% Tween 20 and the membranes were incubated at 4°C overnight with gentle 
agitation. The membranes were washed with several changes every 5 to 10 
minutes with wash buffer (0.01% Tween 20) for 1 hour at room temperature. The 
membrane was incubated in goat anti-mouse Ig (HRP conjugated) or rabbit anti- 
Goat Ig (HRP conjugated) in 5% non-fat dried milk in wash buffer with 0.05% 
Tween 20 in a 1:2000 dilution for 1 hour with gentle agitation. The membranes 
were washed with changes every 5-10 minutes in wash buffer (0.01% Tween 20). 
The antibody reacts strongly and specifically to mouse IgG in a number of 
immunochemical and immunological assays. After washing, the membranes were 
transferred to a dark room, excess wash buffer was drained and the signal 
developed by immersion in active ECL+ reagent at 40:1 mix of component A and 
B. Typically for 2 membranes of ~8.5cm by 7.5cm each, 2ml solution A and 50p,l 
of Solution B were mixed together, protected from light and ~lml of this solution 
used for each membrane and incubated for 5 minutes at room temperature. The 
excess was drained, and the membranes were wrapped in Saran wrap and exposed 
to autoradiographic film.
The ECL+ detection kit (Amersham Pharmacia) is a very sensitive method for the 
detection of immobilised specific antigens conjugated to HRP labelled antibodies. 
Initial exposures were of 10 seconds and extended as necessary. Exposed films 
were developed in a bench top developer (Compact X4, X-ograph Imaging 
Systems, Malmesbury, Wiltshire).
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2.6 Powerblot-Protein Array
To complement the DNA Microarray, a protein array was carried out. 
Approximately 8mg of protein lysate was prepared from Day 8 3-D HepG2 cells, 
Day 15 3-D HepG2 cells and monolayer HepG2 cells as described in section 2.4. 
The samples were analysed by Western blot by Becton Dickinson (USA) (the 
Powerblot), using every antibody in their catalogue.
This technique on a larger scale can be described as proteomics, which is a 
complementary technology to DNA Microarrays to analyse patterns of gene 
expression at the protein level. Genes may be present but not necessarily 
transcribed. Proteins are usually the functional molecules. The PowerBlot data is 
provided as a file with all the proteins detected, in order of confidence, 1 through 
5, with 5 being the highest confidence. The confidence level is based on fold 
change, reproducibility, and signal intensity. Briefly, level 5 includes proteins 
with changes greater than 2-fold in triplicate from good quality signals, level 4, 
changes 1.50-1.99-fold in triplicate from good quality signals and so on. In the 
results I have summarised the proteins in functional groups in confidence level 4 
and 5, as these results are more rigorous.
2.7 Statistics
Statistical analysis was performed using the two-sample student’s t-test assuming 
unequal variances of the data ranges. Two-tailed tests were used to determine the 
significant differences between means and the levels of significance were 
assessed at the following probabilities:
Chapter 3
The Ribonuclease Protection Assay to 
investigate transcriptional levels in 3-D cultures 
as a cause for the diminishedfunction observed
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Chapter 3- The Ribonuclease Protection Assay to investigate transcriptional 
levels in 3-D cultures as a cause for the diminished function observed
3.1 Causes for downregulation of function
Various hypotheses were investigated previously as possible causes for this down 
regulation of function as described in the introduction.
Having ruled out simple physical explanations, the first part of this thesis serves 
to explore changes in transcriptional levels within the different cultures to see 
whether key genes are being switched on and off during periods of peak and 
diminished function.
The initial hypotheses as described in chapter 1, was that a) different transcription 
factors are present at times of peak function, 3-D culture (at Day 8) compared to 
monolayer culture and times of diminished function in 3-D culture (at Day 15) 
compared to peak function (Day 8) and b) decreased levels of liver-enriched 
transcription factors in Day 15 3-D cultures are contributing to the diminished 
amount of liver specific proteins such as albumin and AAT compared to peak 
function at Day 8.
3.2 Transcriptional control of liver specific function
Gene regulation is the basis for the phenomenon of differentiation by which 
different cells become structurally and biochemically specialised for different 
functions. Actions and properties of each cell are determined by the proteins they 
contain which is determined by its corresponding mRNA, frequency of mRNA 
translation and its stability. Although gene function is conducted via its protein 
product, there are several observations that the amount of protein produced is 
directly dependent on the amount of mRNA that encodes it (Cereghini 
1996;Edwards 2003;Keene 2003).
Performance per cell diminishes at Day 15 compared to Day 8, and is generalised 
rather than limited to specific function, therefore the level of control of expression 
is more likely to be at the transcriptional level.
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3.2.1 General overview o f gene control
In eukaryotes there are a number of stages between initial synthesis of primary 
RNA transcript and production of mRNA. The initial transcript is modified at its 
5’ end by addition of a cap structure containing a modified guanosine residue and 
the cap is an unusual 5’-5’ triphosphate linkage. The 5’ end is further modified 
by methylation of N7 of the terminal guanine. This “cap” serves several functions 
including protecting the 5’ end from phosphatases and nucleases, thus enhancing 
the efficiency of mRNA translation. RNA splicing can be used by cells to 
regulate gene expression to create different protein products from a single gene. 
Alternative splicing of the primary transcripts produced from complex 
transcription units is often regulated to yield different mRNAs (Cho and Campbell 
2000;Proudfoot 2000). An example of this method of gene control comes from 
the fibronectin gene. Fibronectin is an ECM glycoprotein involved in cell 
adhesion and migration (Yamada et a l 2003). The multiple exons in the 
fibronectin primary transcript are spliced to produce two isoforms of fibronectin, 
one secreted by hepatocytes and the other by fibroblasts and other cell types. 
Splicing of fibronectin pre-mRNA in fibroblasts yields an mRNA containing two 
exons, which encodes protein domains that interact with cell-surface receptors 
making fibroblast fibronectin adherent to cell surfaces. However, splicing of 
fibronectin pre-mRNA in hepatocytes excludes those two exons, which make the 
fibronectin protein adherent so that the fibronectin secreted by hepatocytes is not 
strongly adherent to cell surfaces, but is free to circulate in the serum (Misteli 
2000).
3.2.1.1 Transcription
Control of the transcription process occurs at DNA sequences usually upstream of 
the transcription start site. Two types of regulatory DNA sequences exist, 
promoters and enhancers (Cereghini 1996).
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3.2.1.2 RNA synthesis
The TATA box in the promoter of the gene, determines precisely where RNA 
synthesis begins (located 20-30 base pairs upstream of the start site). Promoters 
also contain a CAAT box and GC box usually -  40 and -110 bases respectively 
ffom the transcription start site. Enhancers increase the rate of transcription of 
specific genes and serve as recognition sites for transcription activator proteins 
(Zohar et a l 2001).
The basic transcriptional mechanism begins with synthesis of mRNA in the 
nucleus. Transcription factors (DNA binding proteins) and coactivators bind to 
enhancer sequences. They are joined by general transcription factors and RNA 
polymerase II to assemble a transcription initiation complex at the promoter.
RNA polymerase is positioned at a promoter by transcription factors and binds to 
double-stranded DNA. RNA polymerase can initiate transcription of DNA into 
RNA, unwinding the duplex, separating the base pairs of DNA. A second 
ribonucleotide pairs with the template and joins to the first base by a 
phosphodiester bond. Polymerase copies the DNA, separates the DNA base pairs 
ahead and forms base pairs behind. RNA is elongated as the polymerase 
transcribes the gene. Only one DNA strand is transcribed into RNA (Misteli 
2000). A general class of general initiation factors (TFIIB, TFIID, TFIIE, TFIIF 
and TFIIH) function intimately with RNA polymerase II and are required for 
selective binding of polymerase to its promoters, formation of the “open” 
complex, and synthesis of the first few phosphodiester bonds of nascent 
transcripts (Krumm et al 1995). In vitro studies have shown how additional 
constitutive factors such as DNA topoisomerase I and other adaptor proteins are 
important for transcription initiation and activation (Umehara and Horikoshi 
2003). Protein-protein interactions are important and many DNA binding proteins 
involved in transcriptional activation do not interact with the basic transcriptional 
machinery but provide the structural components necessary to bring distal 
activators in association with general factors (Vellanoweth et a l 1994).
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3,2.2 Liver-specific transcription
Present knowledge of molecular signals that govern liver development and 
differentiation has come from analysis of experimental systems including the 
developing embryo, cell and tissue culture, knockout mice and transplantation of 
hepatic precursor cells. Growth factors and families of transcription factors 
including hepatocyte nuclear factors (HNF) 1, 3 and 4 and CCAAT/enhancer 
binding protein (liver-enriched transcription factors), abundant in the liver but not 
exclusive to the liver, are important elements required for cell differentiation 
(Hayashi ef a/. 1999).
The tissue specific expression of genes is based on the presence of cis-acting 
sequences in the promoter and enhancer regions that interact with sequence 
specific DNA binding domains in nuclear transcription factors, which can 
enhance or depress transcription. The promoter sequence of each gene is unique 
and contains a number of recognisable motifs that allow regulation of expression 
of that gene by a group of transcription factor molecules. These DNA binding 
proteins bind to their complementary promoter sequences (Cereghini 1996). The 
determination of the tissue distribution of these factors and analysis of their 
relations has led to the hypothesis that the association of liver-enriched 
transcription factors and ubiquitous transcription factors such as AP-1 (Activator 
Protein), Oct-1 and CoupTFI (ovalbumin upstream promoter transcription factor) 
is important and perhaps even sufficient for the maintenance of liver-specific gene 
transcription and maintenance of a fully differentiated state (Darlington 
1999;Hayashi et al. 1999;Zaret 1996). There are two transcription factor 
complexes, nuclear factor NFkB and Stat3 that are activated as part of the initial 
response of the remnant liver following partial hepatectomy (Darlington 1999). 
Cultured cells can show a decrease or a complete loss of expression of tissue- 
specific function, however present knowledge has been gained from a 
combination of cultured primary cells, cell lines and studies during development. 
All of these have their limitations, but each has provided some insights. For 
example HNF-3p, a member of the hepatocyte nuclear 3 family is required for 
survival of the embryo so HNF-3P is not readily amenable to analysis by 
knockout strategies (Hayashi et a l 1999).
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3.2.3 Transcriptional regulation -  liver enriched transcription factors (LETFs)
3.2.3.1 The homeoproteins
The homeoproteins are a family of proteins that share a common domain of 60 
amino acid residues, the homeodomain, conserved throughout evolution from 
yeast to human. These homeodomains act as transcription factors.
Hepatocyte nuclear factor 1 (HNF-1) is a homeodomain containing a 
transcriptional regulator that is essential for the liver-specific expression of 
albumin, AFP, AAT and transthyretin and the hepatitis B virus large surface 
protein (Hayashi et a l 1999). The HNF-1 family includes HNF-la and HNF-lp 
(also called variant HNF-1). It recognises a pseudopalindromic sequence 
(consensus g/aGTTAATNATTAACc/a) that is present in the promoter regions of 
many liver specific genes (Jacob et a l 1997). The functions of different 
transactivation domains localised at their C-terminal regions show that HNF-la 
has a higher potency of transactivation than HNF-1 p. HNF-la is expressed in 
well differentiated hepatoma cell lines such as H4II, Fao and HepG2, but is absent 
in the de-differentiated variants H5 and C2 (Babajko et a l 1993;Bailly et a l 
1998). On the other hand HNF-lp retains its expression in some de-differentiated 
variants and somatic cell hybrids. An HNF-la binding site has been identified in 
the HNF-4 promoter (Kuo et a l 1992). In H5 cells, which lack liver specific 
expression, transfection of HNF-4 activates the HNF-1 gene. Although the H5 
variant cells lack HNF-4 and HNF-1, other transcription factors CAAT Enhancer 
Binding Protein (C/EBP)a and HNF-3 are present in cells lacking liver specific 
gene expression which suggests that liver specific genes are regulated by 
combinations of transcription factors rather than a single factor (Darlington 
1999;Hayashi et a l 1999). Studies have also shown that HNF-1 and HNF-4 
mRNA levels are influenced by ECM and that ECM could stimulate cell 
differentiation by activating HNF-4 gene expression. HNF-1 can also act 
synergistically with transcription factors of different functions e.g. C/EBP. One 
example is the activation of human albumin (Nagaki et a l 1995).
The HNF-3 family contains to date three proteins, HNF-3 a, HNF-3 p, HNF-3y 
which have been identified. These proteins share a high homology in the winged
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helix/fork head DNA binding domain and in two short similar regions in their C- 
terminal and N-terminal regions that show transactivity. The principal contact 
surface is provided by the a-helix, which is flanked by two long loops that contact 
the DNA backbone. The consensus recognition sequence is 
A(a/t)TRTT(g/t)RYTY (R:purines; Y:pyrimidines) (Darlington 1999;Vallet et al.
1995). In combination with other liver-enriched transcription factors such as 
HNF-1, HNF-3 binds and transactivates numerous liver specific genes such as 
transthyretin, albumin, and AAT. The HNF-3 factors have been implicated in the 
nucleosomal organisation of the albumin gene and also found to regulate the 
HNF-4 promoter (Hayashi et a l 1999). A study analysing the role of HNF-3 
transacting factors on the expression of liver specific genes in differentiated 
hepatocytic cells produced a truncated protein that inhibits the access of native 
HNF-3 factors to DNA. The data showed that overproduction of this truncated 
protein decreased the expression of albumin, transferrin and transthyretin, 
whereas a decrease in truncated protein production restored the expression of 
some of these genes in differentiated hepatoma cultured cells (Benvenga and 
Robbins 1998;Darlington 1999;Hayashi et al. 1999). The concentration of HNF- 
3a increases when hepatocyte derived cell lines are cultured on a thick ECM gel 
substratum as opposed to monolayer culture on plastic. This substratum induces 
differentiated cell morphology and liver specific gene transcription in primary 
cultures. HNF-3p is not often amenable to analysis by knockout strategies, as its 
function is required for the survival of the embryo (Darlington 1999).
HNF-4 is expressed in the liver, kidney and intestines in the adult and is 
constitutively transcribed at low levels. HNF-4, first identified by its interaction 
within the transthyretin and AAT promoters, is part of the nuclear hormone 
receptor family that is expressed in hepatic diverticulum at the onset of liver 
development. The consensus site for HNF-4 is GGGTCAAAGGTCA. It 
activates a diverse set of liver genes responsible for a variety of functions. For 
example, transthyretin whose normal function is to transport thyroid hormones 
and other hydrophobic substances in the blood (Boobis et al. 1996), and AAT, a 
serine protease inhibitor found in plasma, and are both regulated by HNF-4 (Hu 
and Perlmutter 2002). Genes also activated by HNF-4 include OTC, the rate-
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limiting enzyme in the urea cycle and the cytochrome P450s (Peterson and 
Renton 1986). These genes are activated by HNF-4 in early liver development 
(Bulla 1997). No specific ligand for HNF-4 has been identified. Its C-terminal 
ligand binding domain is involved in transactivation, ligand binding and protein 
dimerisation. In genetic analysis of hepatocyte differentiation, HNF-4 can 
transactivate endogenous HNF-la and liver genes such as AAT; it can also 
induce re-differentiation of a de-differentiated hepatoma cell line, H5, by stable 
transfection of exogenous HNF-4 (Bulla 1997). HNF-4 interacts with regulatory 
elements in promoters and enhancers of genes whose products are involved in 
cholesterol and amino acid metabolism, gluconeogenesis and blood coagulation. 
HNF-4 is phosphorylated at tyrosine, serine and threonine residues and various 
inhibitors and stimulators of protein kinase pathways modify the HNF-4 mediated 
transcriptional activation. Members of the CoupTF family can act as negative 
regulators of the transactivation exerted by HNF-4. The effects of HNF-4 are also 
important for the maintenance of differentiated hepatic epithelial cell morphology 
by inducing re-expression of E-cadherin (Zaret 1996).
HNF-6 has been described relatively recently. It contains two different DNA 
binding domains. One corresponds to a novel type of homeodomain and the other 
is homologous to the Drosophila cut domain. HNF-6 is expressed in tissues that 
originate from the endoderm. HNF-6 binding sites are found in the promoter 
regions of HNF-3 P, HNF-4, transthyretin, and AFP. HNF-6 expression 
disappears transiently from the liver between embryonic Days 12.5 and 15, but 
reappears in the liver after Day 15 and this parallels the expression of HNF-3 p 
transcripts (Liu et a l 1991;Zaret 1996).
3.2.3.2 CCAAT/Enhancer Binding Protein(C/EBP) Family 
C/EBP was originally isolated from rat as a protein binding to CCAAT and 
contains a basic leucine zipper domain involved in DNA recognition (Darlington 
1999;Zaret 1996). The consensus binding site for C/EBP is the sequence 
ATTGCGCAAT. C/EBPa mRNA transcripts have been identified in a wide 
range of cells but the protein itself is detected only in differentiated hepatocytes 
and adipocytes. C/EBP stimulates the transcription of genes such as albumin and
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transthyretin. This transcription factor is required for the conversion of 
preadipocytes into fully differentiated adipocytes (Gonzalez and Lee 1996;Zaret 
1996). Constitutive antisense C/EBPa mRNA impairs the expression of C/EBPa 
itself and adipocyte specific genes. Proliferating hepatocytes in the 
hepatectomised liver show a reduction of C/EBPa mRNA within the first three 
hours of surgery, corresponding to transition from GO to the G1 phase of the cell 
cycle, which returns to normality by 72 hours, through a gradual increase after the 
S phase. Induction of C/EBPa expression in HepG2 cells results in reversible 
arrest of proliferation and delays tumorigenesis in immunodeficient mice (Zaret
1996).
C/EBPp is critical for liver regeneration and positively regulates gluconeogenesis 
through activation of the phosphophenolpyruvate carboxykinase gene. Several 
signalling pathways can be stimulated post-translationally by C/EBPp. Calcium- 
dependent kinases can mediate phosphorylation and increase its transactivation 
potential (Darlington 1999). Among the isoforms of the C/EBPp gene is the liver 
enriched inhibitory protein (LIP) from which the amino-terminal transactivation 
domain is missing (Grimm and Rosen 2003). One mechanism by which LIP is 
generated is through use of alternate AUG start sites (Xiong et a l 2001). LIP 
dimerises with CEBPp to reduce its transcriptional activation.
Finally, in the C/EBP family is C/EBP5, which mediates that regulation of acute 
phase response; it has low activity until activated by inflammatory stimuli (Liu et 
al 1991;Patel etal. 1995).
In the liver, these families of transcription factors do not work in isolation but as a 
regulatory network in particular with respect to cytochrome P450 genes. Several 
different liver-enriched transcription factors including HNF-la, HNF-3, HNF-4 
and C/EBPp and more ubiquitous transcription factors, Spl, GABP a/p and 
NF2d9 are responsible for governing the transcription of cytochrome P450 genes 
(Celis et a l 2000;Rana et a l 1995).
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3.3 Techniques to measure gene regulation
Various experimental approaches could be taken to assess gene expression and 
investigate presence of and/or increases or decreases in levels of liver enriched 
transcription factors. These may contribute to the upregulation of function, and 
be achieved by comparing Day 8, 3-D spheroids (peak function) with monolayer 
HepG2 cells (less function). Investigation of the liver enriched transcription 
factors which may contribute to diminished function can be achieved by 
comparing Day 15 spheroids to Day 8 spheroids. These techniques include using 
the ribonuclease protection assay, which was used in this study.
3.3,1 Ribonuclease Protection Assay
The Ribonuclease Protection Assay (RPA) is an extremely sensitive method for 
the detection and quantitation of mRNA species in a complex mixture of total 
cellular RNA (Prediger 2001). A labelled probe is synthesized complementary to 
part of the target RNA to be analysed using a PCR primer that contains the T7 
promoter sequence. After hybridisation of the probe with target RNA, the 
mixture is treated with RNase to degrade single-stranded, unhybridised probe. 
Labelled probe hybridising to its complementary target RNA is protected from 
nuclease digestion and can then be separated on a polyacrylamide gel and 
visualised by autoradiography (for radioactively-labelled probes). The advantages 
of RPAs are that low abundance mRNAs can be detected and quantified. There is 
no loss of signal, which may occur by northern blotting, which require transfer to 
a solid support, and as the probes in the RPA are shorter than the RNA species 
being detected, the target RNA can be less intact, without affecting the RPA. The 
RPA also allows simultaneous detection of multiple targets in a single sample 
(Henttu2001;Tymms 1995).
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3.3.1.1 Methods
Total RNA was prepared from HepG2 cells in monolayer and cultured in alginate 
at Day 8 and Day 15 of culture and human liver as previously described in Section
3.3.2 Checking RNA integrity
3.3.2.1 Materials
- Agarose (Molecular Biology Grade)
- 0.1%DEPCH2O
10X 3- (N -morpholino)propanesulfonic acid (MOPS)
- Formaldehyde
- Form amide
- 0.24 - 9.5 kB RNA ladder (Invitrogen Cat No. 15620-016)
- Bromophenol Blue (0.25% /15% Ficoll)
- Ethidium Bromide (1 Omg / ml)
1 OX Running Buffer
17g MOPS 
1.64g NaAc
8ml 0.5M EDTApH 8.0 
5.7 ml 5M NaOH
Make up to 400ml with DEPC H20. Autoclave and protect 
from light. Straw-coloured buffer works well, but darker 
buffer doesn’t.
33.2.2 Method
Before running the samples, the sample buffer was checked to ensure that the 
formamide used was sufficiently deionised. To check the sample buffer, 5 pi of 
H20, 12.5pl of deionised formamide, 7pl of sample buffer and 5pl of 
Bromophenol blue/Ficoll mix was added together. The mixture should be a
2.3.
Sample buffer
1 OX Running Buffer 
Formaldehyde
- lOOpl
- 178pl
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denim/sky blue colour. If the mixture was green/blue it indicated that the 
formamide had become ionised.
For a 150ml gel, 1.1% agarose gel was prepared in 16.5ml of 10X Running 
Buffer, with 118.95ml of DEPC H2O. The agarose was dissolved by heating, and 
once cooled, (less than 60°C), 29.1ml of formaldehyde was added, and the gel 
poured.
For approximately 5pl of RNA solution, 12.5pl of formamide solution was added 
and mixed thoroughly. The solution was heated for 5 minutes at 50°C. 7pi of 
sample buffer (formaldehyde and 10X Running Buffer) was added and mixed 
thoroughly. The solution was heated for 8 minutes at 65°C and a further 5pi of 
bromophenol blue/Ficoll mix was added and stored on ice ready to load onto the 
agarose gel.
The samples were loaded with 4pl of the RNA ladder, and run in IX Running 
Buffer at 100V for 3 hours changing the running buffer every 30 minutes until the 
bromophenol blue dye had migrated two-thirds the length of the gel. The gel was 
removed and in the dark stained in 800mls of IX Running Buffer with lOOpl of 
lOmg/ml ethidium bromide for 20 minutes, and destained by washing in IX 
Running Buffer alone, changing the Running Buffer until the bands were visible. 
The gel was photographed by short-wave UV transillumination (300nm) on a gel 
documentation system and the densities of the 28S and 18S bands measured to 
obtain a ratio (Epi Chemi II Darkroom, Ultra Violet products, Cambridge).
3,3,3 Preparation o f template DNA
3,3,3,1 Methods
RNA probes were generated by in vitro transcription with T7 polymerase and 
DNA template. DNA templates were produced by polymerase chain reaction 
(PCR). PCR primers were designed with the 19 base T7 promoter region 
TAATACGACTCACTATAGG ffom the primer selection site on the ‘Human 
Genome Mapping Project Resource Centre’
(http://alces.med.umn.edu/rawprimer.html). Probes were designed such that the 
size of the protected fragment is at least 10% different from any other full-length
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probe or protected fragment.
Table § Design of primers for liver-enriched transcription factors
Transcription Factor Size
(bp)
Primer Sequence
HNF-1 424
5’- CAGCTCCTCTGTCTCGAGCG-3’ (F)
5’- TAATACGACTCACTATAGGTCCCAGGGT 
AGACGCGGTA-3’ ( R )
HNF-4 292
5 ’-ATCCAGGGAAGATCAAGCGG-3 ’ (F) 
5’-TAATACGACTCACTATAGGTTGTGTTGGC 
AACGATGACG-3 ’ (R)
C/EBPa 139 5’- AGGAACACGAAGCACGATCAGT-3* ( F)
5’-TAATACGACTCACTATAGGAATGGTGGTTT 
AGCAGAGACGGTA-3 ’ ( R )
C/EBPp 181
5’- GACAAGCACAGCGACGAGTACA-3’ (F)
5’-TAATACGACTCACTATAGGCAGCTGCTTG 
AACAAGTTCCG-3 ( R)
Human Albumin 368
5’- CCCTGTGCAGAAGACTATCTATCCG-3’ (F)
5’-TAATACGACTCACTATAGGGGCAAAGCAG 
GTCTCCTTATCG-3 ’ ( R )
3.3.3.2 First strand cDNA synthesis from  human liver mRNA
3.3.3.2.1 Materials
Oligo (dt), 500ug/ml (Sigma Genosys) 
Recombinant RNasin RNase Inhibitor (Promega) 
SUPERSCRIPT II RNase reverse transcriptase kit 
(Cat No. 18064-014) (Invitrogen, Scotland)
0.1M Dithioreitol (DTT)
0.1M dNTP mix.
3.3.3.2.2 Method
5 pi of Oligo (dT), 5pg of total RNA and nuclease free sterile water were made up 
to a volume of lOOpl. All components were mixed thoroughly and heated at 70°C
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for 10 minutes and immediately placed on ice. The contents of the tube were 
collected by pulse centrifugation (Eppendorf 5402, Germany). 20pl of 5X First 
Strand Buffer, lOpl of 0.1M DTT, 5pi of lOmM dNTP mix and 2pi of RNasin 
Inhibitor were added to the tube and mixed gently. The mixture was incubated at 
42°C for 2 minutes. 5pi (1000 units) of SUPERSCRIPT II was added, mixed 
gently with a pipette and incubated for 1 hour at 45°C. The reaction was 
inactivated by heating at 70°C for 15 minutes.
3,33,3 Polymerase Chain Reaction to generate DNA templates
3.3.3.3.1 Materials
PCR primer pairs (Sigma Genosys)
Advantage-GC cDNA Polymerase Mix (Cat No. 8433-1, Clontech
Labarotories)
lOmM dNTP mix.
3.3.3.3.2 Method
PCR Reaction XI X6
PCR-grade FfeO 14 84
5X GC cDNA PCR 10 60
Reaction Buffer GC-melt (5M) 10 60
dNTP mix (lOmM) 5 30
Advantage-GC cDNA Polymerase mix 1 6
Forward Primer (lOpmol / pi) 2.5
Reverse Primer (lOpmol /p i) 2.5
cDNA template 5
The reagents were made up to a final volume of 50pl with 2 negative controls 
replacing template DNA with water and using primers for human albumin which 
is abundant in the liver. The components were mixed thoroughly and centrifuged
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for 1 minute at lOOOOg (Eppendorf 5402, Germany) to collect the contents of the 
tube.
3,3,4 PCR cycling conditions
Reactions were carried out in a Perkin-Elmer DNA Thermal Cycler Model 480 
Initial denaturation
Denaturation 
Annealing 
Extension
Final extension 
Cooling
The samples were stored at 4°C until ready for further analysis by agarose gel 
electrophoresis.
3.3.4.1 Gel Electrophoresis
3.3.4.1.1 Materials
Agarose (Molecular Biology Grade, Invitrogen) 
lx Tris Acetic acid, EDTA (TAE)
Ethidium bromide (1 Omg/ml)
Hyperladder IV Cat no. 109F (Bioline Reseach)
Loading Buffer 
6XTAE 
30% glycerol
0.25% Bromophenol Blue.
3.3.4.1.2 Method
100ml, of a 2% agarose gel was prepared in IX TAE with 5pi of ethidium 
bromide and placed in a gel tank with IX TAE as running buffer with ethidium 
bromide (50j.il of ethidium bromide in 1 litre of TAE).
lpl of loading buffer was added to 5 pi of the PCR reaction, and loaded into the
94°C for 5 minutes
}
94°C for 20 seconds
55°C for 20 seconds \  For 30 cycles 
68°C for 50 seconds
68°C for 7 minutes 
4°C for 10 minutes.
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wells of the agarose gel, using 5 pi of Hyperladder DNA marker, ranging from 
lOO-lOOObp. The gel was electrophoresed at 100V and stopped when the bands 
had migrated two-thirds the length of the gel. The bands were visualised under a 
UV transilluminator (Ultraviolet Products, Cambridge).
3,3.5 Clean up o f double stranded DNA in PCR template
3.3.5.1 Materials
Wizard PCR Preps DNA Purification System (Promega, Madison, 
UK)
Low melting point agarose gel (Sigma Aldrich, UK).
3.3.5.2 Methods
Samples were separated on a 1% low melting point agarose gel (poured in a cold 
room) (5pi of lOmg/ml ethidium bromide in 100ml of lx TAE buffer), until they 
had migrated two-thirds of the gel. Bands were excised and cleaned up using a 
purification system.
Briefly, the agarose section with the desired fragment was transferred to a 
microfuge tube and heated in a waterbath at 70°C until it had dissolved. 1ml of 
resin, which binds DNA, was added to the melted agarose. The sample was 
mixed without vortexing. The resin/DNA mix was transferred to a syringe barrel 
of a column and pushed into the minicolumn with the plunger. The plunger was 
removed and 2mls of 80% isopropanol was added to the syringe to wash away 
salts. The column was removed from the syringe and transferred to a centrifuge 
tube. The tube was centrifuged for 2 minutes at lOOOOg at room temperature 
(Eppendorf 5402, Germany) to dry the resin. The column was transferred to 
another tube and 50pl of dH20 was added. After approximately 1 minute the tube 
was centrifuged for 1 minute at lOOOOg (Eppendorf 5402, Germany) to elute the 
DNA. A small sample was run out on a 1% agarose gel to ensure there was 
efficient recovery of the preparation.
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3,3.6 Radiolabelling o f cDNA probes
MAXIscript, in vitro transcription can be used to incorporate virtually any 
labelled nucleotide into RNA. Traditionally 32P labelled UTP is used. The high 
promoter specificity of the T7 RNA polymerases allows the transcription of one 
strand of the template with virtually no cross-talk ffom the promoter on the 
opposite strand. As a positive control pTRI RNA 18S antisense control template 
was used, containing an 80bp insert of a highly conserved region of the human 
ribosomal RNA gene and was used as an internal standard or reference. 18s 
rRNA makes up 20% of total cellular RNA.
3.3.6.1 Materials
Maxiscript In Vitro Transcription Kit, Cat No. 1312 (Ambion, UK) 
18S rRNA cat no 7339 (Ambion, UK)
32p  UTp (18 5 M B q j  Cat no PB20383 (Amersham,
Buckinghamshire).
3.3.6.2 Method
4 RNA probe samples and 2 internal controls rRNA (18S)
Transcription factor samples Control
Nuclease-free CIH2O 3.25pl 10.6pl
DNA template 2.0pl /
lOx Transcription Buffer l.Opl 2.0jal
lOmM GTP 0.5pl l.Opl
lOmMCTP 0.5pl l.Opl
lOmM ATP 0.5pl l.Opl
32P UTP (800 Ci /mmol, lOmCi/ml) 1.25pl 0.4pl
T7 RNA polymerase l.Opl 2.0pl
PTRI 18S (rRNA internal control) / 2.0pl
Total volume lOul 20ul
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All the contents above were mixed thoroughly by pipetting, and centrifuged for 1 
minute at lOOOOg (Eppendorf 5402, Germany), and were incubated at 37°C for 2 
hours. During this incubation period, the denaturing acrylamide gel was prepared 
for probe purification as follows:
Component Volume (ml)
20% acrylamide (in 7M Urea + lx tris boric acid EDTA (TBE) 17.5
in DEPC H20)
7M urea and TBE 52.5
25% ammonium persulphate 0.153
TEMED 0.066
After 2 hours incubation, lpl of sample was taken from each of the samples and 
put into corresponding tubes with 49pl of RNase free dt^O (1/50 dilution). 0.5pl 
of DNase was added to the transcription factor samples and l.Opl to the control 
samples. The samples were thoroughly mixed, vortexed and incubated at 37°C 
for 30 minutes. An equal volume of gel loading buffer was added to the samples 
(9.5pi to the test samples and 20pl to the control samples). The samples were 
mixed and heated for 5 minutes at 95°C. The wells of the gel were thoroughly 
washed with the running buffer made of IX TBE in DEPC treated water to rinse 
out any urea, prior to sample loading on a gel prepared for probe purification. 
The gel was run at 300V until the leading dye band (bromophenol blue) had just 
run off the bottom of the gel.
While the gel was running, 5 pi of the 1/50 diluted samples were pipetted onto 2 
glass microfibre filter papers. One of the filter papers with the sample represented 
total counts and was left to dry on the bench and the other was placed on a 
vacuum manifold, washed twice with cold 10% trichloroacetic acid (TCA), once 
with methanol, and once with acetone, and represented the precipitated RNA i.e. 
the proportion of the UTP incorporated into RNA. These samples were left to 
dry. Each sample on a filter was placed in a vial with scintillation fluid and 
counted in a p counter (Beckman Coulter, CA, USA); specific activity could be
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determined from % radioactivity incorporation, total cpm and mass of probe from 
the samples.
The gel was transferred to 3MM Whatman filter paper and covered with Saran 
wrap. Flourescent stickers were placed on 3 comers of the gel and the gel was 
exposed to photographic film (Kodax Biomax Cat No. 8294985) for 
approximately 2 minutes. The appropriate bands were cut out of the film and 
used as a template to cut the correct bands out of the gel; these were placed in 
corresponding sterile microfuge tubes to which 300pl of elution buffer was added. 
The samples were immersed in the buffer and incubated overnight at 37°C.
3.3.7 Hybridisation o f sample RNA and radiolabelled probe
After incubation of samples in elution buffer, 2 pi of each test sample and 5 pi of 
the control sample were spotted on filter paper to calculate cpm/pl. A total 
volume containing lx 104 cpm of each of the labelled probes was mixed with 
lOpg of total RNA from monolayer HepG2 cells, Day 8, 3-D HepG2 cultures and 
Day 15 3-D HepG2 cultures containing the same cell numbers, and human liver. 
In addition, to show comparative expected band sizes, the probes were mixed with 
human liver alone including the 18S control and with yeast RNA alone.
Two controls were set up for each probe to verify the efficiency of the 
hybridisation procedure. The tubes contained the same amount of labelled probe 
used for the experimental probes and yeast RNA equivalent to the highest amount 
of sample RNA (0.9pl). The volumes were adjusted with H2O and the probes and 
sample RNA were co-precipitated with ammonium acetate (0.5M, 20pl) and 2.5 
volumes of neat ethanol (0.5ml). Samples were incubated at -20°C for 30 minutes 
and the RNAs were pelleted by centrifugation at lOOOOg at 4°C, for 30 minutes 
(Eppendorf 5402, Germany). The supernatant was removed taking care not to 
dislodge the pellet, and tubes were centrifuged for 1 minute at lOOOOg (Eppendorf 
5402, Germany) to remove any residual liquid. Pellets were dried for 5 minutes 
on the bench. The samples were resuspended in 10pl of hybridisation buffer, 
vortexed to thoroughly mix for 5-10 seconds and then incubated at 95°C for 4 
minutes to denature the RNA in solubilisation buffer. The samples were
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incubated at 42°C overnight to hybridise probe to its complement in the sample 
RNA.
3.3.8 RNase digestion o f hybridised probe and sample RNA
Following hybridisation, RNase digestion buffer was made up with RNase 
A/RNase T1 mix at a dilution of 1/50, (higher than the recommended 1/100 
dilution suggested with the kit) and 150pl of the RNase mixture was added to 
each sample RNA and to one of the control tubes with yeast RNA prepared for 
each probe in the experiment. Theses tubes serve as positive controls for the 
function of the RNases and to check that the probe is being protected in the 
absence of homologous sequence. The samples were vortexed and centrifuged for 
1 minute at lOOOOg (Eppendorf 5402, Germany). RNase digestion buffer without 
RNase was added to the remaining yeast RNA controls. These tubes served as a 
control for probe integrity and should show a single band migrating of the 
expected size. All the samples were thoroughly mixed and vortexed and 
centrifuged for 1 minute at lOOOOg (Eppendorf 5402, Germany) to collect all the 
contents at the bottom of the’tube. The samples were incubated at 37°C for 30 
minutes. During this incubation, RNase will digest all unhybridised RNA and 
probe molecules leaving only the double stranded region in the RNA-RNA 
hybrids protected from nuclease digestion. Following the incubation 225pi of 
RNase Inactivation/Precipitation Solution was added with 150pl of ethanol to aid 
the precipitation of these very small fragments. The tubes were vortexed and 
centrifuged for 1 minute at lOOOOg (Eppendorf 5402, Germany). Samples were 
left at -20°C for 30 minutes and centrifuged at lOOOOg at 4°C for 30 minutes 
(Eppendorf 5402, Germany) to pellet the precipitated products of the RNase 
digestion. The supernatant was carefully removed as the pellet does not adhere to 
the tube. Final traces were removed by re-centrifuging the tubes for about 5 
seconds and then leaving them on the bench for 5 minutes.
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3.3.9 Separation and detection o f protected fragments
The pellets were resuspended in 4pl of gel loading buffer, vortexed and 
centrifuged for 1 minute at lOOOOg (Eppendorf 5402, Germany).
All the negative controls (no target/no RNase) were further diluted 1/10 as these 
were expected to have more counts than other samples. Samples were then 
incubated at 95°C for 5 minutes to completely solubilise the RNA, vortexed and 
centrifuged for 1 minute at lOOOOg (Eppendorf 5402, Germany). The tubes are 
stored briefly on ice before loading onto a gel, prepared as follows:-
Component Volume (ml)
7M urea and TBE 84
20% acrylamide and TBE 36
25% ammonium persulphate 0.262
TEMED 0.112
Prior to loading, the wells of the gel were rinsed with running buffer. The gel was 
run at 300V until the leading dye band had migrated to the bottom of the gel, this 
typically took about 3 hours. The gel was soaked in 10% acetic acid for 40 
minutes to fix and then transferred to filter paper, covered with Saran wrap and 
dried on a gel dryer for 1 hour, with heat at -80°C. The gel was then exposed to 
radiographic film (Kodax Biomax Cat No. 1435726) for an appropriate time with 
an intensifying screen to detect labelled probes.
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Results
3.3.10 Investigating expression o f liver-specific transcription factors as a 
possible mechanism for down regulation offunction at the mRNA level
3.3.10.1 RNA extraction
Sample Dilution A 260 A 280 A 260:280 Pg
RNA
Total
volume (pi)
pg/pl
Human Liver 1 1:50 0.176 0.106 1.70 176 500 0.352
Human Liver 2 1:50 0.228 0.138 1.65 228 500 0.456
Human Liver 3 1:50 0.247 0.140 1.76 247 500 0.494
Day 8 1:50 1.076 0.60 1.80 1076 500 2.151
Day 15 1:50 0.474 0.236 2.01 474 500 0.948
Monolayer 1:50 1.151 0.692 1.68 1151 500 2.302
Table 6 Absorbances and yields of RNA extracted from different samples used in 
the RPA
3.3.10.2 Reverse transcription and PCR reaction
cDNA was made from human liver RNA generated by reverse transcription. The 
cDNA was amplified by PCR using specific primers.
1 2 M 3 4 - - The molecular weight markers are 
1000, 800, 700, 600, 500, 400, 300, 
200, lOObp
1000
800
200
100
Fig. 4 PCR products of (1) HNF-1, 424bp (2) HNF-4, 292bp (3) C/EBPa, 139bp 
(4) C/EBPp 181 bp and (-) negative control with water and albumin primers.
The PCR products were run on a 1% agarose gel prior to in vitro transcription 
(Fig.4), to check they were of the expected size.
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3.3.10.3 Detection of Radiolabelled cDNA probes
The PCR products were transcribed with T7 RNA polymerase using P UTP to 
generate radiolabelled RNA probes. The probes were purified on a denaturing 
acrylamide gel to remove any unincorporated nucleotides (Fig.5). This shows that 
the radioactively labelled probes have been purified as shown by the strongest 
band at the top of each lane, representing a transcription factor.
1 2 3 4 5 6
1 ^ — M — H i
J& itriA
IftrltM A
Fig. 5 32P radioalabelled probes for transcription factors. The strongest band at 
the top of the “smear” is the product for each transcription factor.
1, HNF-1
2, HNF-4
3, C/EBPa
4, C/EBPP
5, 18S rRNA (internal control)
6, 18S rRNA (internal control).
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3.3.10. 4 Expression of mRNA levels
Each transcription factor and the 18S rRNA control was incubated with human 
liver alone to facilitate identification of the bands obtained with mixed probes in 
the monolayer HepG2 cells, Day 8 and Day 15 HepG2 cells in 3-D culture 
reactions (Fig.6).
In addition the following controls were run
1) negative controls - yeast RNA was incubated with each individual probe 
without the addition of RNase to indicate the integrity of the probe. (Band 
present).
2) positive control - yeast RNA was incubated with each individual probe and 
digested with RNase. (No protection and band absent).
3) 18S rRNA in all the samples with each target RNA and all the probes- 
intemal control and therefore signal should be the same in each sample.
For comparison between samples the area density for the 18S spot in each sample 
was divided by that in the liver sample and the area density of the transcription 
factor bands in the same lanes divided by these values.
The results in Fig.6 below show that there was insufficient digestion of the 
positive controls with yeast RNA and RNase, and therefore the results could not 
be interpreted as protected probes could not be distinguished from undigested 
probes.
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3.3.10.4.1 Detection o f mRNA levels
Human liver RNA with each Probes with liver Yeast RNA with (+) RNase and 
transcription factor probe and HepG2 cultures without (-) RNase for each 
 I  |  [_____ probe______
+  -  +  - +  - +  -  +  -
18S rRNA control with samples
19 20 21 22 23
/ / / / /
Fig. 6 RPA detection of transcription factor mRNA levels
1-4 (1) HNF-1, (2) HNF-4, (3) C/EBPa, (4) C/EBPp RNA probes with liver
RNA
5-8 Transcription factor probes with (5) Day 8, (6) Day 15, 3-D HepG2 cells (7) 
Monolayer HepG2 cells (8) Human Liver
9-18 Yeast RNA with (9,10) HNF-1, (11,12) HNF-4, (13,14) C/EBPa, (15,16) 
C/EBPp, (17,18) 18S rRNA control with (+) and (-) RNase 
19-23 Internal control 18S rRNA control with Liver, (19); and all transcription 
factors with (20) Day 8, 3-D HepG2 culture (21) Day 15 3-D HepG2 culture, (22) 
Monolayer HepG2 cells (23) Human Liver.
106
3.3.10.4.2 Detection o f mRNA levels after re-exposure to the gel for a longer
period, increased detection ofprotected fragments
Human liver RNA with Probes with liver Yeast RNA with (+) RNase 
each transcription factor probe and HepG2 cell cultures without (-) RNase for
   | each probe
+  -  +  -  +  - +  -  +  -
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
18S rRNA with samples
19 20 21 22 23
Fig. 7 RPA detection for transcription factor mRNA levels- long exposure
1-4 (1) HNF-1, (2) HNF-4, (3) CEBPa, (4) CEBPp RNA probes with liver RNA
5-8 Transcription factor probes with (5) Day 8, 3-D HepG2 culture, (6) Day 15, 3-
D HepG2 culture (7) Monolayer HepG2 cells (8) Human Liver
9-18 Yeast RNA with (9,10) HNF-1, (11,12) HNF-4, (13,14) C/EBPa, (15,16)
C/EBPp, (17,18) 18S rRNA control with (+) and without (-) RNase
19-23 Internal control 18S rRNA control with Liver, (19); and all transcription
factors with (20) Day 8, 3-D HepG2 culture (21) Day 15, 3-D HepG2 culture, (22)
Monolayer HepG2 cells (23) Human Liver.
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3,3.10,5 Generation o f modified probes to overcome the problem with 
insufficient digestion o f the positive controls
There was insufficient digestion of the positive controls with yeast RNA and 
RNase. This was exacerbated with longer exposure (Fig. 7) and interferes with 
interpretation of the results because it is not possible to distinguish protected 
probes from undigested probes in this situation. Longer probes with non­
matching sequence at the 3’ end were therefore generated (see below).
The original PCR products were gel purified with Wizard PCR Preps DNA 
Purification System (Promega, Madison, UK). Each PCR product was incubated 
with ImM dGTP, lx Terminal deoxynucleotidyl Transferase (TdT) buffer, 30 
units of rTdT and incubated for 30 minutes at 37°C. Incubation with TdT 
catalyses the addition of G’ multiple deoxyguanidines to the 3’ OH ends of the 
DNA (tailing the PCR products).
The template was amplified with the C-Prim Primer (5’- 
GGAATTCGCGGCCGCCCCCCCCCCCCCCCCC-3’) and the reverse primer 
with the T7 promoter region with the same PCR conditions used to generate the 
PCR products for the initial RNase protection assays. When these probes are 
generated and used with the target RNA in the RPA, assuming the same problem 
of insufficient digestion, there should be 2 bands for each probe (corresponding to 
undigested and protected probes) and the bottom band should be the protected 
fragment. In the yeast RNA controls and incubation with probes and addition of 
RNase, if incomplete digestion occurred only a single larger band should be 
present as the bottom band is due to protection of the probe.
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2 3 4 (-)
The molecular weight 
markers are 1000, 800, 700, 
600, 500, 400, 300, 200, 
lOObp
lOOObp
800bp
300bp
200bp
lOObp
Fig. 8 Tailing of transcription factor with dGTPs, with PCR products of the 
expected size with the addition of 20-30bps. (1) HNF-1 (2) HNF-4 (3) CEBPa (4) 
CEBPp and (-) negative control with water and albumin primers.
The probes were purified on a denaturing acrylamide gel to remove any 
unincorporated nucleotides as shown in Fig.5. However HNF-4 did not transcribe 
efficiently so was not used as a probe (results not shown).
The RPA was carried out with the modified probes and the gel had to be exposed 
a second and longer period of time (Fig.9). The protected fragment corresponding 
to the expected size for HNF-1 and C/EBPa was not present in the target RNA 
samples with all the transcription factors. Although some of the controls with the 
yeast RNA and RNase showed some protection, the signals were not as strong as 
the experimental samples so this value was deducted as background when the 
final quantitation was made.
109
3.3.10.5.1 Gel exposed for 2 weeks
Liver RNA with each Probes with Yeast RNA controls with
transcription factor liver and HepG2 cultures RNase(+) and without (-) RNase 
for each probe for each probe
+  - +  - + -  +
18S rRNA with samples
16 17 18 19 20
Fig. 9 RPA detection for transcription factor mRNA levels on gel exposed for 2 
weeks
1-3 (1) HNF-1, (2) CEBPot, (3) CEBPp RNA probes with liver RNA
4-7 Transcription factor probes with (5) Day 8, (6) Day 15, 3-D HepG2 culture
(7) Monolayer HepG2 cells (8) Human Liver
8-15 Yeast RNA with HNF-1, (8,9) CEBPa, (10,11) CEBPp, (12,13) 18S rRNA 
(14,15) without (-) and with (+) RNase
16-20 Internal control 18S rRNA control with Liver, (19); and all transcription 
factors with (20) Day 8, 3-D culture (21) Day 15 3-D culture, (22) Monolayer 
HepG2 cells (23) Human Liver.
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Unfortunately the band obtained with the C/EBPa probe co-migrates with the 
background undigested bands from other probes so that it was not possible to 
interpret these bands. The protected fragment for HNF-1 could not be observed in 
these samples suggesting that the RNA if present was only present at very low 
levels.
This method proved to be unhelpful in determining the contribution of 
transcription factors to the upregulation and downregulation of function observed 
in alginate culture. The transcription factors were present at very low levels and 
the gel had to be exposed for a longer period in order to detect the protected 
fragments corresponding to the transcription factors in the RNA samples from the 
different culture conditions, so the negative samples showed some protection. A 
Microarray analysis was therefore carried out to look at the expression of genes at 
the mRNA level comparing peak function at Day 8 with monolayer HepG2 cells, 
and diminished function at Day 15 with peak function at Day 8, 3-D culture. The 
database was initially interrogated for the expression of liver enriched 
transcription factors and to obtain more information on gene expression in HepG2 
cultures.
I l l
3.4 Microarray analysis of RNA from monolayer HepG2 cells, Day 8 and 15 
HepG2 cells in 3-D culture
Microarray technology offers vast amounts of information on the expression of 
genes by probing the mRNA content of cells and determining which genes are 
expressed under a given condition. It is possible to measure the levels of 
thousands of different mRNAs in a single hybridisation step. Microarrays are 
usually made by the deposition of DNA spots on a solid support allowing the use 
of fluorescence dyes for detection and miniaturising the procedure. Either 
oligonucleotides or cDNAs are used. In this system chips were used, which were 
made from oligonucleotides.
3,4,1 Overview o f methods usedfor RNA preparation fo r Microarray analysis 
HepG2 cells in monolayer culture and 3-D culture
DNase treat RNA
RNAeasy clean up —» Check purity on ethidium bromide stained 
|  formaldehyde agarose gels
Concentrate —> Measure amount /purity of RNA
1st strand cljNA synthesis 
2nd strand cDNA synthesis -» DNA ligase, RNase H, DNA polymerase 
phenol: chloroform: isoamyl alcohol extraction 
Phaselock gel to remove contaminating ethanol and protein from ds cDNA 
Precipitate with ammonium acetate and ethanol and resuspend in 12pl water
RNA Isolation
In vitro transcription ( T) -  Enzo kit - Single stranded non radioactive
RNA
Fragment cRNA
Hybridisation target and target clean up
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3.4.2 RNA extraction
For each culture condition, monolayer HepG2 cells, Day 8 and 15 HepG2 cells in 
3-D culture, RNA was extracted from an equal number of cells and for each 
culture condition n=3.
1 unit =40pg/ml for RNA samples taking into account the dilution factor
Sample Dilution Ab260 Ab280 Ab 260:280 Pg
RNA
Total
volume
Cut)
p g /p l
Day 8 1 50 0.123 0.063 1.94 18 80 0.23
Day 8 1 50 0.112 0.054 2.07 16 80 0.20
Day 8 1 50 0.143 0.072 1.99 20 80 0.25
Day 15 1 50 0.135 0.068 1.99 37.8 160 0.24
Day 15 1 50 0.123 0.065 1.90 51.06 240 0.22
Day 15 1 50 0.105 0.054 1.94 29.4 160 0.18
Monolayer 1 25 0.187 0.096 2.00 26.18 160 0.16
Monolayer 1 25 0.102 0.051 2.00 14.28 160 0.09
Monolayer 1 25 0.101 0.047 2.14 14 160 0.10
Table 7 The values given are after the RNeasy clean up stage after isolation with 
Promega Total RNagents system. Pure RNA has an Ab ratio at iemm of between 
1.80-2.0.
3.4.3 Clean up o f total RNA fo r Microarray
3.4.3.1 Materials
- Qiagen RNeasy Mini kit (Qiagen, UK Cat. No. 74104)
- Components of Buffer RLT, RW1 and RPE are proprietary
RLT- contains a guanidine thiocynate 
RPE- no indication
RWL-contains guanidium thiocynate and ethanol
- DNase I (Pharmacia)
1 OX DNase buffer
lMTris pH 7.5 
1M MgCl2 
1MDTT
- Recombinant RNasin Ribonuclease Inhibitor (Promega) 
P-Mercaptoethanol 14.3M (Sigma Aldrich).
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3.4.3.2 Method
RNA samples were subjected to DNase digestion to prevent any carry over of 
contaminating DNA. For each sample (from monolayer, Day 8 and Day 15 
cultures in 3-D), 72.5pl of sample containing l-2pg/pl of RNA, nuclease free 
water, IX DNase buffer, 2 units of DNase, 100 units of recombinant RNasin 
RNase Inhibitor, was mixed gently with a pipette or inverted gently (vortexing 
was avoided to prevent degradation), and incubated at 37°C for 30 minutes. The 
samples were placed on ice, prior to loading onto spin columns supplied with the 
Qiagen RNeasy Mini kit.
While samples were incubating at 37°C, lOpil of p-mercaptoethanol was added 
per 1ml of Buffer RLT. This solution was stable for 1 month. 4 volumes of neat 
ethanol were added to buffer RPE. All centrifugation steps were carried out at 
room temperature.
To each RNA sample (in 1.5ml eppendorf tubes), 350pl of buffer RLT was added 
and mixed thoroughly. 250pl of ethanol was added to the lysate, mixed well by 
pipetting, without vortexing. The sample was transferred (total 700pl) to a 
minispin column placed in a collection tube and centrifuged at lOOOOg for 1 
minute (Eppendorf 5402, Germany). The collection tube was discarded with the 
flow through. The column was transferred into a new 2ml collection tube. 700pl 
of buffer RWL was added and centrifuged for 1 minute at lOOOOg (Eppendorf 
5402, Germany). 500pl of buffer RPE was added to the columns, centrifuged for 
2 minutes at lOOOOg (Eppendorf 5402, Germany) to dry the column. The column 
was removed carefully in order to avoid contact with the flow through resulting in 
carry over of ethanol and placed in an RNase free 1.5ml eppendorf with the lid 
taken off. The samples were centrifuged again at lOOOOg for 1 minute (Eppendorf 
5402, Germany). The column was transferred into a 1.5ml tube supplied. 30- 
50pl of RNase free water (supplied) was placed directly onto the membrane.
The column and tube were centrifuged for 2 minutes at lOOOOg (Eppendorf 5402, 
Germany) to elute. This procedure was repeated as it was expected that the RNA 
yield would be greater than 30pg. The total RNA in solution was quantitated and 
analysed for purity measuring its optical density at 260nm and 280nm. RNA was
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aliquotted and stored at -80°C.
3.4.4 Checking RNA integrity 
As described in section 3.3.2.
3.4.4.1 RNA integrity
RNA samples run on an ethidium bromide formaldehyde agarose gel separating 
the RNA into its subunits determined the integrity of total RNA prepared from 
each culture condition. The 28S ribosomal subunit compared to the 18S 
ribosomal subunit should show an approximate 2: 1 ratio.
no-
Peak representing 
28S ribosomal 
subunit
100
90
90
IK Peak representing 
18S ribosomal 
subunit
70-
«0
50
40
.740
In tt>
Fig. 10 Graph representing a typical RNA sample demonstrating the 28S and 18S 
ribosomal subunits. Values given in the table represent the area under curves of 
peaks.
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Mo =Monolayer HepG2 cells 
8 =Day 8, 3-D HepG2 culture
15 =Day 15, 3-D HepG2 culture
Mo Mo Mo 8 marker 15 15 15
Amount in 
28S band 33.8 51.8 41.5 31.8 32.1 35.9 41.2 28.4 25.2
Amount in 
18S band 14.8 20.7 16.2 14.9 12.3 15.5 16.6 12.8 12.1
Ratio of 
28S : 18S 2.28 2.50 2.57 2.56 2.6 2.31 2.49 2.21 2.08
Table 8 Agarose gel electrophoresis to determine integrity of total RNA prepared 
from each culture condition.
The methods to generate the target RNA for hybridising to complementary 
sequences on the microarray chips are described in full in the Appendix.
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3.5 Results
3.5.1 Gene expression.
Genes considered relevant were those with a > 2 fold change occurring in > 44% 
of chips (representing 4 out of 9). This reflected a true change in expression and 
not occurring by chance or as a result of a single faulty chip. Using these criteria, 
the search of the database for liver enriched transcription factors, demonstrating a 
significant change in mRNA expression comparing the following culture 
conditions:-
A) Day 15 spheroidal 3-D HepG2 culture (diminished function) vs. Day 8 
spheroidal 3-D culture (peak function).
B) Day 8 spheroidal 3-D HepG2 culture (peak function) vs. Monolayer HepG2 
culture (less differentiated function),
produced the following result:-
Day 15 vs. Day 8
DECREASE % of chips
± S.D showine this change
Transcription factor HNF-3 -2.17 ±0.22 44
Table 9 Gene expression of liver enriched transcription factors.
The only change detected using the parameters defined was a decrease in HNF-3 
expression, which was downregulated in Day 15, 3-D HepG2 cultures compared 
to Day 8, 3-D HepG2 cultures.
A change in HNF-3 mRNA levels was not detected in Day 8, 3-D cultures 
compared to monolayer HepG2 cultures.
The U95Av2 Affymetrix chip contained arrays for the following liver enriched 
transcription factor genes including of course, HNF-3, as shown above:- 
HNF-1 
HNF-4 
C/EBPa 
C/EBPp
It should be noted that HNF-6 was not represented on the chip.
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3.5,2 Protein expression
The Powerblot data from the protein array was investigated for changes in 
expression of protein levels of liver enriched transcription factors, with the 
parameters defined in chapter 2. Of the liver enriched transcription factors, only 
an antibody to HNF-4 was present in the Powerblot protein array, and although it 
was expressed, a significant change between the culture conditions described was 
not detected.
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3.6 Discussion
The results obtained from the RNase protection assay were inconclusive, 
predominantly due to technical problems. There were problems with insufficient 
digestion of the positive controls with RNase, and the film had to be exposed to 
the gel for a longer period in order to detect the protected fragments 
corresponding to the transcription factors in RNA samples from the different 
culture conditions. Results could not be interpreted, as protected probes could not 
be distinguished from undigested probes. In addition, although it is a sensitive 
technique, in retrospect it may not have provided the sensitivity or specificity 
required for quantitating transcription factor activation.
In order to overcome these problems RNA probes for the transcription factors 
were modified by the addition of extra nucleotides, so that in the control samples, 
with the addition of RNase, of the two bands, which would be present for each 
probe, if there was incomplete digestion, only a top band should be present. The 
presence of a slightly lower band would be due to protection of the probe. The 
same problem occurred again and in addition HNF-4 did not transcribe efficiently. 
As the gel had to be exposed for longer, the control samples with the yeast RNA 
and RNase showed some protection. Normally this signal is taken away from the 
experimental samples and was subtracted as background from experimental 
samples, which was carried out for the RPAs with liver specific proteins and urea 
cycle enzymes (Khalil, 2000 personal communication). However, as can be seen 
in Fig.6 these control samples showed protection and the signals were stronger 
than the experimental samples or they could not be detected at all (Fig.9). This 
residual full-length probe in the RNase treated control lane is rarely due to using a 
suboptimal RNase concentration and this was increased in the samples. Using too 
much RNase can lead to overdigestion of the probe/target hybrid and loss of 
sensitivity.
Another cause for high background in the assay is using too much probe. For rare 
target such as these transcription factors, less probe is needed to be in molar 
excess. The explanations for these problems could be due to transcription factor 
RNA being present at very low levels, making it difficult to detect in a multiprobe
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analysis. RPA was selected over northern blot analysis, as it was required to 
detect multiple targets in a sample and to improve signal and sensitivity over 
northern blotting. Nevertheless, this may be an option for the future as 
transcription factors in samples have been detected in this way (Elizondo and 
Medina-Diaz 2003;Tacchini et a l 2001).
With the advent of Microarray technology, the experimental procedure was 
modified (Lemaigre et a l 1996;Shoemaker and Linsley 2002;Unger et al. 2001). 
Microarray analysis was carried on high purity intact total RNA extracted from 
monolayer HepG2 cells, Day 8 and Day 15 HepG2 cells in 3-D culture, in order to 
increase the sensitivity of detection, and the database generated was interrogated 
for changes in expression of liver-enriched transcription factors in the culture 
samples. The only change detected was for HNF-3, which showed a decrease in 
Day 15, 3-D HepG2 cultures compared to Day 8, 3-D HepG2 cultures. This 
transcription factor binds and transactivates numerous liver specific genes such as 
albumin and AAT (Cerosaletti and Fournier 1996;Hafenrichter et al. 1994). This 
parallels the observed decrease in albumin and AAT protein secretion seen from 
Day 8 onwards in Fig. 2a and decreased mRNA levels of this transcription factor 
may be contributing to the observed downregulation of function with extended 
culture.
However, as described there are other liver-enriched transcription factors which 
work in a regulatory manner with HNF-3 to activate liver specific genes (Landry 
et al 1997;Vallet et a l 1995). As examples, AAT gene contains binding sites for 
HNF-1, HNF-3, HNF-4 and HNF-6, that have been shown to interact with the 
liver enriched transcription factors HNF-1 a, HNF-3 p, HNF-4 a  and HNF-6P 
(Kanda et a l 2003;Samadani and Costa 1996). Furthermore, the transcription 
factors that bind to the AAT regulatory sequence also influence the transcriptional 
activity of each other. The HNF-3 factors have been implicated in the 
nucleosomal arrangement of the albumin gene, whose transcription is also 
transactivated by HNF-1 and HNF-4 (Griffo et a l 1993;Vallet et a l 1995). 
Therefore, not only do transcription factors have to be present, they have to be 
activated at the protein level.
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Currently, widely used and available methods, which were not available during 
the course of my research for measuring active transcription, include 
electromobility shift assay (EMSA) (Brundage et a l 2003;Peng et al. 2003) and 
colorimetric ELISA based assays (Thelen et a l 2004). Traditionally, functional 
analysis of transcription factors have required the use of EMSA, which 
determines the binding interaction between DNA and DNA-binding proteins, such 
as the interaction of transcription factors with regulatory regions (Auyeung et al. 
2003;Huang et al. 2002;Marten et a l 1996). The assay is based on the 
observation that protein-bound DNA will migrate slower though a non-denaturing 
polyacrylamide gel than free DNA. However, these assays can only investigate 
one transcription factor per reaction and are not amenable to high throughput 
applications. Colorimetric ELISA based assays can have low sensitivity (Allicotti 
et a l 2003).
The use of reporter genes has contributed greatly to the study of eukaryotic gene 
expression and regulation, and they are most frequently used as indicators of 
transcriptional activity in cells (Rosenthal 1987). The DNA regulatory region 
under investigation, can be subcloned upstream of a reporter, such as luciferase, 
which can then be transfected into a variety of cell types. The luciferase enzyme 
catalyses a reaction using D-luciferin and ATP in the presence of oxygen and 
Mg2+ resulting in light emission. Light is produced from an enzymatic chemical 
reaction, which can be measured with a luminometer. The total amount of light 
measured during a given time interval is proportional to the amount of luciferase 
reporter activity in the sample. To determine whether genes are activated by 
specific transcription factors, and play a role in a particular signalling pathway, 
one can transfect a luciferase construct bearing the promoter elements that bind to 
these complexes into cells. If the transcription factors under investigation were 
activated in these signalling pathways, they would then bind to and induce 
transcription of the luciferase gene (Park and Waxman 2001; Wang et a l 1996). 
The Microarray and Powerblot array, using the defined parameters did not 
provide sufficient information on the presence of or changes in levels of 
transcription factors when comparing the culture conditions, to support the initial 
hypotheses. One looked further at the Microarray and Powerblot array data, as it
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was known that you could obtain more information on gene and protein 
expression between the HepG2 culture conditions, and perhaps give an indication 
of other pathways or mechanisms associated with the activation of liver enriched 
transcription factors, or contributing to the optimal and diminished function 
observed.
In part, the role of the stress response and its subsequent effects after activation, 
were considered in maintaining function in 3-D HepG2 culture. An initial search 
of the Microarray database for “stress response” genes showed a decrease in 
MAPK protein kinase 3 mRNA levels in Day 15, 3-D HepG2 cultures compared 
to Day 8, 3-D HepG2 culture. MAPK protein kinase 3 induces the 
phosphorylation and activation of the nuclear transcription factor CREB, which 
acts as a coactivator for HNF-4 (Dell and Hadzopoulou-Cladaras 1999;Maizels et 
al 2001;Soutoglou et al. 2001). Although changes in HNF-4 mRNA levels were 
not detected between HepG2 culture conditions, as MAPK protein kinase 3 can 
activate HNF-4, it could therefore influence a possible decrease in the levels of 
HNF-4 mRNA in Day 15, 3-D culture compared to Day 8, 3-D culture. Both 
HNF-4 and HNF-3 are important for liver specific gene expression and decreased 
levels of these could account for the diminished function observed at Day 15.
The following chapter explores further, in more detail, stress response pathways 
and mechanisms and its role in maintaining differentiated function in 3-D HepG2 
culture.
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Chapter 4
The Stress Response and maintenance of 
function in HepG2 culture
123
Chapter 4- The Stress Response and maintenance of function in HepG2 
culture
4.1 Hypothesis
In this chapter, the Microarray and Powerblot data was explored further to look at 
the expression of stress induced genes and proteins. Two general hypotheses 
were formulated: - 1) stress response activation after prolonged activation causes 
the downregulation of function observed in later times of 3-D culture and 2) stress 
response genes and proteins are involved to ensure the function maintained at Day 
8, 3-D culture, either as an adaptive response to the successful environment 
created, or as a consequence of increased metabolic function. Therefore a 
complex relationship between stress and performance would be anticipated. The 
possible explanations for diminished function were investigated, in particular 
stresses that might be anticipated in culture. This chapter therefore starts off with 
a general introduction to stress response and stress proteins, and in particular 
hypoxic stress and oxidative damage.
4.2 General introduction to the Stress Response
The stress response - Changes in environment, injury, disease, even growth and 
differentiation place organisms under stress and organisms have evolved to cope 
with many different forms of stress by means of the “cellular stress response” 
(Mager and De Kruijff 1995;Pockley 2001).
Stress response genes and proteins- In response to adverse stresses, including 
bacterial endotoxins, UV irradiation, heat and chemical shock, hyperosmosis and 
hypoxia, multiple kinases act as important stress-activated elements. These 
kinases are activated by detection of stress factors at the cell surface, involving 
phosphorylation cascades, containing pathways of kinases. These in turn are 
activated and undergo nuclear translocation, where they activate multiple 
transcription factors to regulate gene expression in response to the external stress 
(Powell et a l 2003).
Paradoxically, many stress proteins and genes are switched on or off which
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perform “house-keeping functions”; examples are heat shock proteins and genes, 
which constitute the archetypal stress response, and molecular chaperones that 
help nascent polypeptides assume their proper configuration (Mager and De 
Kruijff 1995). Enzymes are expressed due to normal increased metabolic activity 
or other types of stress-responsive proteins, such as the haemoxygenase (HO) 
family and cyclooxygenase (Cox); these enzymes catalyse the formation of end 
products that protect against cellular stress (Otterbein et a l 2003;Steer and 
Corbett 2003).
MAPKinase Signalling Pathways- This large group of protein kinases contains 
over a dozen members that participate in many eukaryotic regulatory pathways. 
The extracellular signal-regulated protein kinase (ERK) is also referred to as the 
mitogen-activated protein kinase (MAPK) superfamily of enzymes. These 
enzymes comprise at least three parallel, yet interwoven, signal transduction 
cascades that are differentially regulated in response to mitogens, growth factors, 
cytokines and various forms of stress. Each cascade consists of a minimum of 
three enzymes activated in series: a MAP kinase/ERK kinase kinase or MEKK (a 
MEK activator), a MAP kinase/ERK kinase or MEK (a MAP kinase activator), 
and a MAP kinase/ERK homologue (Yang et a l 2003).
Four distinct MAPK pathways have been characterised 1) extracellular signal- 
related kinase 1 (ERK1), ERK2 also referred to as p42/44 MAPK), 2) the c-Jun 
N-terminal kinase/stress-activated protein kinase (JNK/SAPK), 3) p38 and 4) 
ERK5 kinase (Eckert et a l 2003).
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Mitogenic signals Cellular stresses Extracellular
a
Raf-1
MEK1,2
ERK1,2
\  1 
\ l
Cytoplasm
JNK/SAPK
(MEKK1,3) (MAPKK kinase) p38
/  \  \
MKK5 MAPK kinase (MKK4,7) MKK3,6
/  \ \
ERK5 (S APK1,2,3/MAPKp49/JNKl ,2,3) p38a0xS
M A P K  APK7
Nucleus
1 \
ELK-1
EGF receptor
c-Jun, ATF-2, p53 CHOP-1
ATF-2
Schematic representation of MAP kinase activation. MAP kinases are involved in 
phosphorylation cascades initiated by detection of stress factors at the cell surface. 
In red, the main stress activated pathway.
The ERK1. 2 pathway (Raf—>MEK1. 2—>ERK1. 2) is activated by mitogens via 
Ras and by phorbol esters via protein kinase C. Growth signals such as epidermal 
growth factor and platelet derived growth factor activate ERKs by tyrosine 
phosphorylation of their receptors. Depending on the cell type, ERK activation 
results in either proliferation or differentiation (Santen et al 2002). ERK5 is 
activated by cellular stress as well as mitogens such as growth factors and serum 
(Gutkind 2000). The MAPK pathways JNK/SAPK (MEK kinase 1,3->MAPK 
kinase 4,7 [MKK4,7]->JNK1,2,3) and p38 (MAPK kinase kinase
[MAPKKK]-»MKK3,6-»p38a,Px 8) are activated by cellular stresses, e.g. UV
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light, osmotic and oxidative stress, hypoxia, and inflammatory cytokines (Irving 
and Bamford 2002).
MAPKs are activated by phosphorylation of their threonine and tyrosine residues 
by dual specificity MAPK kinases, which in turn are activated by phosphorylation 
of two serine residues by upstream MAPKKKs (Torres et a l 2004). Activities of 
MAPK kinases are inhibited by dephosphorylation by phosphatases (Ratcliffe et 
al 1998;Zhu et al 2002). Modulation of gene expression involving transcription 
factors is a crucial mechanism in response to cellular stress. Transcription factors, 
such as NFkB, and AP-1, which is the transcription factor complex formed by 
c-jun and c-fos, are predominantly the targets of the SAPK/JNK pathway 
(Moriguchi et al 1997;Shi and Kehrl 1997). Another important transcription 
factor, hypoxia inducible factor (HIF)-la is stimulated by conditions of oxygen 
deprivation and activates the expression of multiple genes responsible for 
maintaining oxygen homeostasis (Gupta et a l 2000a).
4.3 Hypoxia as a possible cause fo r the downregulation o f function observed in 
Day 15 o f 3-D HepG2 cultures
It was hypothesised that downregulation of function observed in Day 15, 3-D 
HepG2 cells compared to Day 8, 3-D HepG2 cells could be attributed to hypoxia 
as oxygen solubilisation in culture medium is possibly insufficient and may be 
rate limiting when spheroids are larger as they are at later times of 3-D culture. 
As mentioned in chapter 3, an initial investigation of the microarray database for 
stress response genes, demonstrated a decrease in HNF-3 in Day 15, 3-D HepG2 
cultures compared to Day 8, 3-D HepG2 cultures. This transcription factor binds 
and transactivates numerous liver specific genes such as albumin, AAT, and AFP, 
and hypoxic stress has also been shown to reduce AFP expression (Lee et al 
1999;Mazure et a l 2002). A pattern of decreased liver specific protein secretion 
is observed from Day 8, 3-D culture to Day 15, 3-D culture.
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4.3.1 Expression of hypoxia related genes
The Microarray database was interrogated for increases and decreases for genes 
specifically associated with hypoxia, hypothesising that the spheroids in 3-D 
culture at Day 15 are hypoxic, as sufficient oxygen may not diffuse through the 
medium into the beads as the spheroids become larger at later time points.
Day 15 vs. Day 8 FOLD
INCREASE % of chips
± S.D showing this change
Vascular endothelial +1.97 ±0.19 100
Growth Factor (VEGF)
Table 10 Expression of genes associated with hypoxia
There was an increase in VEGF in Day 15, 3-D culture compared to Day 8, 3-D 
culture. As mentioned previously, HIF-la is activated in cells exposed to 
hypoxia, although HIF-la itself was not detected by microarray analysis, with the 
parameters defined in section 3.5.1 However, VEGF does contain enhancer 
elements with functionally critical sites for HIF-la. Ratcliffe et al 1998 reported 
a number of genes, which contain binding sites for the HIF-la transcription 
factor, which are upregulated upon HIF-la activation to modulate their 
environment in response to hypoxic stress.
The Microarray database was therefore interrogated for the expression of these 
genes comparing diminished function at Day 15, 3-D culture with Day 8, 3-D 
culture. The results in Table 11 show that there is an increased expression of 
these genes in Day 15, 3-D HepG2 culture compared to Day 8, 3-D HepG2 
culture.
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Table 11 Expression o f genes with binding sites for HIF-la, comparing Day 15,
3-D cultures with Day 8, 3-D cullures.
Gene
% of 
chips
Increase
or
Decrease 
with Fold 
Change
Pubmed
Accession
number
Standard 
Deviation 
± S.D n=9
Description
Enolase (Eno 1) 55 t  3.4 - 4.92 Glycolysis
Lactate
Dehyhydrogenase A
55 1 2.14 2.92 Glycolysis
Adolase A,
Fructose biphosphate
55 1 4.01 X05236 5.71 Glycolysis
Pyruvate kinase 44 1 1.56 M26252 1.85 Glycolysis
Glucose-6-phosphatase 
Catalytic (glycogen 
storage disease)
77 1 3.57 U01120 1.87 Glucose
transporter
Adenylate kinase-3 55 t  7.78 Y09788 7.3 High energy
phosphate
metabolism
Short chain alcohol 
dehydrogenase family 
member
44 1 1.87 U31875 2.71 Glucose
transporter
Carbohydrate
metabolism
Transferrin 55 t  5.57 S95936 7.7 Iron transport
Human insulin like 
growth factor binding 
protein
66 1 2.2 M74587 0.75
Quiescin (growth factor) 66 t  5.28 L42379 3.64 Cell growth,
maintenance,
proliferation
Platelet-derived growth 
factor beta polypeptide 
(simian)
66 1 17.5 M12783 25.59 Angiogenesis 
and tumour 
progression
Prostate differentiation 
factor
55 1 1.78 AB000584 1.64
Inhibin, beta B 55 t  5.34 M31682 8.33
Insulin like growth factor 
binding protein 2 
(36kDa)
66 1 1.37 X16302 2.46 Binds IGF-1,2. 
Found in 
periportal liver
VEGF gene 66 1 3.22 2.4
VEGF mRNA 100 1 1.97 AF
024710
0.19 Angiogenesis
Transforming Growth 
factor, beta 1
66 1 2.67 M38449 1.03 Anti-apoptosis
Cell-Cell
signalling
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To complement the Microarray analysis, Western blot analysis was performed for 
a panel of proteins upregulated during hypoxia.
4.3.2 Detection o f stress related proteins
4.3.2.1 Methods
Total Protein Determination by the Lowry method (Schacterle and Pollack 1973).
Protein lysates were prepared from an equal number of cells from monolayer 
HepG2 cells, Day 8 and Day 15, HepG2 cells in 3-D culture.
Sample Total Volume 
(ml)
Concentration
(mg/ml)
Dilution to give final 
concentration of 1 mg/ml
(Protein + 2 x sample buffer)
Monolayer (A) 4.5 1.889 1ml protein + 0.889ml buffer
Monolayer (B) 4.5 3.2634 1ml + 2.2634ml buffer
Day 8 (C) 4.5 3.562 1ml + 2.562ml buffer
Day 8 (D) 4.0 3.507 1ml + 2.507ml buffer
Day 8 (D) 4.5 3.098 1ml + 2.098ml buffer
Day 15 (E) 4 2.0356 1ml + 1.0356ml buffer
Day 15 (F) 4 1.8124 1ml + 0.8124ml buffer
Day 15 (G) 4 1.916 1ml + 0.916ml buffer
Table 12 Concentrations of protein lysates from the different culture conditions.
The monolayer, Day 8 and Day 15 cultures were pooled and aliquotted into lOOpl 
and 500pl samples.
Protein concentrations were assessed a second time in the diluted samples to 
confirm equal loading on gels. Once the samples were diluted it was not possible 
to determine the protein concentration by the Lowry method as the colour from
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the sample buffer interfered with the readings from the plate reader.
Protein estimation was therefore carried out using a method by Warburg and 
Christian by measuring the absorbance at 260nm and 280nm and then multiplying 
by a published factor for the ratio to give a final protein concentration (Stoscheck 
1990). This demonstrated further that the protein lysates had all been diluted to 
the same concentration.
HepG2
Culture
Ab260 Ab280 Ab 280/260 Factor Ab28oxFactor
Monolayer 
HepG2 cells
0.066 0.075 1.136 0.886 1.006mg/ml
3-D Day 8 0.060 0.071 1.183 0.911 1.008mg/ml
3-D Day 15 0.057 0.068 1.193 0.918 1.009mg/ml
Table 13 Protein concentrations from the different culture conditions.
The presence of the housekeeping, constitutively expressed P-actin protein in 
equal amounts in the samples, serves as a further loading control for the 
subsequent proteins detected by western blot analysis and confirms the integrity 
of the protein lysates.
p-Actin
250
160
105
75
50
35
30
M d8 dl 5
42 kDa
Fig. 11 Expression of p-actin in HepG2 cultures.
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4.3.2.2 Analysis
Equal amounts of protein lysates from monolayer HepG2 cells (M) Day 8 (d8) 
and Day 15 (dl 5) HepG2 cells in 3-D culture, and control lysates supplied 
commercially for the relevant antibodies (+) were separated by SDS-PAGE, 
blotted and probed with specific primary antibodies and an appropriate enzyme 
linked secondary antibody prior to detection by chemiluminescence.
Comparisons were made of the abundance of these stress proteins in the different 
culture conditions comparing Day 8, 3-D cultures (peak performance) with 
Monolayer HepG2 cells (poor performance) and Day 15, 3-D cultures (diminished 
function) with Day 8, 3-D cultures (peak performance). The evidence to 
demonstrate that hypoxic stress was contributing to the diminished function 
observed was investigated at the protein level.
Western blots of hypoxia related proteins
HIF-1 a
250 
160 
105
75 
50
35 
30 
25
Fig. 12 Expression of HIF - la  in HepG2 cultures.
HIF-1 is a heterodimeric protein, and though the actual molecular weight of the 
protein is 120kDa, the band at 50kDa probably represents a proteolytic cleavage 
product or some post-translational modification of the protein. From both bands 
the protein is more abundant in the monolayer sample and Day 15 samples and an
Actual molecular 
weight 120kDa
50kDa
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expected band from the positive control sample was observed with lysate from 
HeLa cells (+).
MKK3b MEKK3
Fig.13 Expression of hypoxia related proteins in HepG2 cultures.
MKK3b protein was detected in all samples with the strongest signals observed 
with monolayer HepG2 cells and Day 15, 3-D samples. A faint signal was 
observed with the positive control lysate from HeLa cells (+).
MEKK3 (MAPK/ERK kinase kinase) protein was detected weakly in the samples 
but the strongest signal was observed in the Day 15 sample, a very weak signal 
was observed with the positive control lysate from SW-13 cells (+).
4.3.3 Densitometry
Densitometry allows for the generation of both semi-quantitative, and fully 
calibrated density or intensity data from experimental samples. Densitometry was 
carried out to confirm the differences in protein expression demonstrated, using 
the GS-670 Imaging Densitometer (Bio-Rad Laboratories). This scanner is 
supported by the Molecular Analyst PC image analysis software, allowing for 
image display and quantitation. The software was used to identify and select the 
relevant bands in each sample by marking around each band. This provided many 
parameters for each band, including mean absorbance (OD) values, and OD 
volume x mm2
133
71kDa
The results below show that the densitometry measurements confirm a) 
constitutively expressed p-actin protein is present in equal amounts in the samples 
and b) hypoxia related proteins are more highly expressed at times of diminished 
function.
Protein Monolayer 
OD x mm2
Day 8 
OD x mm2
Day 15 
ODxmm2
p-actin 16.78 17.754 17.370
HIF-la 2.429 0.901 2.616
MKK3b 12.683 9.337 11.901
MEKK3 0.067 0.065 0.071
Table 14 Densitometry measurements for protein expression in monolayer, D8 
and D15 lysates, probed with p-actin, HIF-la, MKK3b, MEKK3.
The results from the western blots and the densitometry measurements suggest 
that hypoxia in later times of 3-D culture, at Day 15 and monolayer HepG2 cell 
culture was contributing to the downregulation of function observed, therefore it 
was attempted to correct hypoxia by increasing ambient oxygen concentration in 
order to enhance cell performance.
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4.4 Manipulating the 3-D culture system, by modulating the environment to 
improve cell performance
4.4.1 The hypoxic response
The Western blot data and Microarray analysis identified genes and proteins 
implicated in a hypoxic stress response. This led to the hypothesis that 
downregulation of function observed in Day 15, 3-D HepG2 cells compared to 
Day 8, 3-D HepG2 cells could be attributed to lack of oxygen in the medium. To 
explore this, culture in three oxygen concentrations were investigated, 35%, 80% 
and 50%, compared with ambient oxygen concentration at -21%.
4.4.2 Increasing oxygen concentration to 35%
The results demonstrate that maintaining 3-D cultures at 35% O2 did not improve 
protein function and there was not a significant change in the proliferation of 3-D 
HepG2 spheroids at either time point under the different culture conditions. There 
was also no change in the morphology or viability of the spheroids at either time 
point.
4.4.2.1 Effect on cell proliferation
Control 3-D HepG2 (21%) 
35% 0 23-D HepG2
Day
Fig. 14 Cell proliferation in 3-D HepG2 cultures in 35% O2 vs. 21%. Mean 
values ± S.D, n=6 for each time point.
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Fig. 15 Protein secretion from 3-D HepG2 cell cultures maintained at 35% O2 VS. 
21% O2 concentration. Mean values ± S.D, n=6 for each time point.
4.4.2.3 Morphology and viability
r  »
Control spheroids under 
phase contrast ____
35% 0 2 spheroids under 
phase contrast
Control viable spheroids
35% 0 2 viable spheroids
Control non-viable
35% 0 2 non-viable 
spheroids
Fig. 16 Morphology of 3-D cultures at Day 8 in the 2 different oxygen 
concentrations taken at x4 magnification and cell viability assessed by PI and 
FDA staining.
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As 35% was neither beneficial nor detrimental, the experiment was repeated in a 
much higher O2 concentration at 80%.
4.4.3 Increasing the oxygen concentration to 80%
The results in Fig. 17 show that maintaining the 3-D cultures at 80% O2 did not 
improve protein function and in addition had a detrimental effect on cell 
proliferation and protein function per cell.
The oxygen level generated more non-viable cells as a proportion of the total 
number of spheroids and the morphology of the spheroids under phase contrast 
microscopy again verified that the cells were not proliferating.
4.4.3.1 Effect on cell proliferation
5
6 3
c
iSJ 2
3c
1
0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Control 3-D HepG2 
(21% 02>
80% 0 23-D HepG2
Day
Fig. 17 Proliferation of HepG2 spheroids in 3-D culture over 15 Days at 80% O2 
vs. 21% (ambient) O2 concentration. Mean values ± S.D, n=6 for each time point.
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Fig. 18 Protein secretion of albumin and Al AT in 3-D HepG2 cultures 
maintained at 80% O2 vs. 21% (ambient) O2 concentration. Mean values ± S.D, 
n=6 for each time point.
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Control spheroids un3er
4.4.3.3 Morphology and viability
Control viable spheroids
phase contrast
Control non-viable 
spheroids
80% O2 spheroids under 
phase contrast
80% O2 viable spheroids 80% O2 non-viable 
spheroid
Fig.19 Morphology of 3-D cultures at Day 8 with 2 different oxygen 
concentrations taken at x4 magnification. Cell viability assessed by PI and FDA.
W
Control spheroids under
phase contrast
'
, . ' ; M a
Control viable spheroids
80% O2 spheroids under 80% O2 viable spheroid 
phase contrast
Control non-viable
80% O2 non-viable 
spheroids
Fig. 20 Morphology of 3-D cultures at Day 15 in the 2 different oxygen 
concentrations taken at x4 magnification and cell viability assessed by PI and 
FDA staining.
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It was decided to decrease the O2 concentration lower than 80%, because as 
demonstrated, at that concentration, there was a detrimental effect on cell 
performance.
Therefore 3-D HepG2 cultures were exposed to 50% O2 concentration, mid-way 
between ambient (21%) O2 concentration and 80% O2 . This concentration is also 
higher than 35% O2 concentration and at that concentration, although cell 
performance was not enhanced, it was not detrimental, so an improvement in cell 
performance was anticipated.
4.4.4 Changing the oxygen concentration to 50%
Maintaining the 3-D cultures at 50% O2 did not improve protein function and also 
had a detrimental effect on cell proliferation and protein function per cell. In 
parallel the cells were maintained as monolayers and in increased oxygen 
concentration, their proliferation was also inhibited as shown in Fig.21.
4.4.4.1 Effect on cell proliferation in monolayer HepG2 culture
7-1
6c
73
73
Culture conditions
Fig. 21 Proliferation of HepG2 cells in monolayer culture at 2 different oxygen 
concentrations, 50% vs. 21%. Mean values ± S.D, n=6 for each time point.
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4.4.4.2 Effect on cell performance in 3-D HepG2 culture
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t/5  Ac  4o
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1
0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Control 3-D HepG2 
(21 % 02)
50% 0 23-D HepG2
Day
Fig. 22 Proliferation of HepG2 spheroids in 3-D culture over 15 days in two 
different oxygen concentrations, 50% vs. 21%. Mean values ± S.D, n=6 for each 
time point.
4.4.4.3 Protein synthesis
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Control 3-D HepG2s 
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Fig. 23 Albumin secretion from HepG2 spheroids in 3-D culture over 15 days in 
two different oxygen concentrations, 50% vs. 21%. Mean values ± S.D, n=6 for 
each time point
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4.4.4.4 Morphology and viability
50% O2 spheroids under 50% O2 viable spheroids 50% O2 non- viable 
phase contrast spheroids
Fig. 24 Morphology of 3-D cultures at Day 15 in the 2 different oxygen 
concentrations taken at x4 magnification and cell viability assessed by PI and 
FDA staining.
Overall, from the three different oxygen concentrations investigated, only the 
35% oxygen concentration did not have an inhibitory function on proliferation or 
function but increasing the oxygen from 21% did not improve function per cell 
particularly at Day 15.
However, all known effects of signalling cascades can be activated by a variety of 
different stimuli, and 2 of these MAPKinases which were upregulated, indicative 
of a hypoxic stress response, can also be activated by an oxidative stress response 
and this was investigated at different stages in culture.
142
4.5 Oxidative stress is contributing to the downregulation of function 
observed at Day 15 of 3-D HepG2 culture
4.5.1 Background
In order to demonstrate whether oxidative stress could be contributing to the 
downregulation of function observed at Day 15, 3-D cultures, techniques can be 
employed to measure the products of modification of lipids and proteins 
undergoing oxidative stress. Reactive oxygen species (ROS) are produced by all 
aerobic cells and the higher the metabolic rate of an organism, the greater the 
production of ROS. The balance between ROS production and antioxidant 
defences determines the degree of oxidative stress (Finkel and Holbrook 
2000;Finkelstein et a l 1983).
Consequences of this stress include modifications to cellular proteins (carbonyl 
formation), oxidative modifications of amino acid residues which include 
derivatization of those such as proline, arginine, and lysine to carbonyl 
derivatives, which can be detected by ELISA and Western blotting (Verbeke et al 
2001). Modifications to lipids undergoing oxidative stress can be assessed by 
measuring the breakdown products of lipid peroxidation including 
malondialdehyde (MDA) and 4-hydroxynonenal (HNE). MDA is a bi-product of 
polyunsaturated fatty acid peroxidation (Ling et a l 2003;Lorenzo et a l 1996).
4.5.2 Western blotting to show levels o f phosphorylated MAPKinase in 3-D and 
monolayer HepG2 cultures activated in response to stress stimuli
Western blot analysis of key MAP kinases expressed in HepG2 cultures showed 
increased levels of these proteins in monolayer HepG2 and/or Day 15, 3-D 
culture where differentiated function is low or diminished compared to peak 
function at Day 8, 3-D culture. In particular, MAPKp49/SAPKl/JNKl is a 
downstream regulator of the JNK/SAPK stress activated pathway, whose 
activation is most sensitive to increased ROS (Turpaev 2002), and a downstream 
end terminal kinase, which when activated, results in the activation of
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transcription factors, c-Jun, ATF-2 and p53 which in turn regulates gene 
expression to adapt to their survival in a new environment.
An equal amount of protein lysate from monolayer HepG2 culture, Day 8 3-D 
HepG2 culture and Day 15 3-D HepG2 culture was loaded onto a gel. By 
Western blot analysis, the levels of phosphorylated MAPKp49/SAPKl/JNKl in 
these HepG2 cultures was measured and compared to the levels of the 
unphosphorylated form of this protein in these HepG2 cultures. It was
demonstrated that this stress pathway 
monolayer and Day 15, 3-D culture.
MAPKp49/SAPKl/JNKl
+ d l5 d8 M
Fig. 25 MAPKp49/SAPK1 /JNK1 and 
expression in monolayer HepG2 and 
commercially supplied with antibody 
antibody).
is activated and at increased levels in
phosphospecific
MAPKp49/SAPKl/JNKl
56 kDa 
43kDa
phosphorylated MAPKp49/SAPKl/JNK 
3-D HepG2 cultures (+ = cell lysate 
to serve as a positive control for the
Protein Monolayer 
OD x mm2
Day 8 
OD x mm2
Day 15 
OD x mm2
MAPKp49/S APK 1 /JNK 1 11.526 9.128 13.146
Phosphospecific 
M APKp49/S APK 1 /JNK 1
4.366 0.466 3.505
Table 15 Densitometry measurements from protein expression of 
M APKp49/S APK 1 /JNK 1 and phosphorylated MAPKp49/SAPKl/JNK
expression in monolayer HepG2 and 3-D HepG2 cultures to confirm the 
observations made from Western blot detection.
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4.5.3 Western blotting to measure protein oxidation in HepG2 culture
Proteins are one of the major targets of oxygen free radicals and other reactive 
species. The OxyBlot™ Kit was used to investigate protein oxidation through the 
detection of carbonyl groups (aldehydes and ketones) on proteins that occurs at 
and modifies the side chains of lysine, arginine, proline or threonine residues, and 
forms cysteine disulfide bonds as a result of several types of oxidative damage. 
The carbonyl groups in the protein side chain are derivitised to 
2,4-dinitrophenylhydrazone by reaction with 2,4-dinitrophenylhydrazine (DNPH) 
which are then separated by polyacrylamide gel electrophoresis, followed by 
Western blotting. Oxidised proteins are revealed by an anti-dinitrophenyl 
antibody and subsequent procedures following a Western blotting procedure. 
This method was used as a semi-quantitative method for measuring oxidative 
stress in the samples.
4.5.3.1 Materials
Protein Lysis Buffer- Final concentration, 50mM Tris-HCl pH 8.0,
300mM NaCl, 0.5% Triton X-100-X, 0.1% SDS, 
ImM EDTA,
2% p-mercaptoethanol,
Protease inhibitor mix (lOpg/ml leupeptin, 
lOpg/ml pepstatin, lOpg/ml aprotinin, ImM PMSF, 
lOpg/ml antipain)
4mM EDTA in 0.15M NaCl pH 7.4
Oxyblot™ Oxidised Protein Detection Kit, (Chemicon International, 
USA) containing- 10X 2, 4-Dinitrophenylhydrazine 
Neutralisation solution 
1° Antibody : Rabbit Anti-DNP Antibody 
2° Antibody : Goat Anti-Rabbit IgG (HRP-conjugated)
10X Derivitisation-Control Solution 
NuPage Bis Tris 12% gels (Invitrogen, Scotland)
20X MOPS SDS Running Buffer 
NuPage Transfer Buffer
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1% Bromophenol Blue in 2M Tris Base 
10XPBS
ECL+ Detection Kit (Amersham, UK)
4.5.3.2 Method
4.5.3.2.1 Positive control fo r oxidative stress assays
As a positive control for the assay, cells were made hypoxic by incubating them in 
deoxygenated medium, in which the medium was degassed by bubbling argon 
throughout the medium, and maintaining the cells overnight in an hypoxic 
environment at 37°C with the addition of argon gas. The cells were reperfused 
with oxygen for one hour prior to harvesting.
4.5.3.2.2 Monolayer Culture
Cells in a T175 cm2 flask, -25 x 106 cells were washed twice with ice cold PBS, 
and 3mls of lysis buffer was added. Cells were scraped off and transferred to a 
Nunc tube, vortexed and homogenised thoroughly with a Potter Elvjeham manual 
glass homegeniser. The samples were sonicated on ice for 10-20 seconds 
(Soniprep 150, Sanyo, Leicestershire, England) and centrifuged at 16000g at 4°C 
for 30 minutes (MSE Europa) to pellet the cells. The supernatant was removed 
and a protein concentration was determined. The sample was aliquotted and 
stored at -80°C. A protein concentration of at least 4pg/pl was required to obtain 
a 20pg protein sample in a 5pi sample. A protein concentration of more than 
lOpg/pl would render the protein sample insoluble with SDS.
4.5.3.2.3 3-D HepG2 culture
Beads, equivalent to -  25 x 106 cells for each time point, Day 8, Day 11 and Day 
15 were transferred to a Nunc tube and allowed to settle. They were washed twice 
with ice cold PBS. Ice cold EDTA solution was added to the beads 
(1.9mls/0.25mls of beads) and mixed manually until the alginate dissolved and the 
spheroids were released. The solution was centrifuged at 200g for 10 minutes at 
4°C (Heraeus, UK) to pellet the cells. The supernatant was removed and 2mls of 
lysis buffer was added. The samples were vortexed and then processed as for 
preparation of monolayer cultures.
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4.5.3.2.4 Sample preparation fo r SDS-PAGE
The 20pg of protein (5jnl) was denatured and solubilised by the addition of 5 pi of 
12% SDS, to obtain a final concentration of 6% SDS. After brief vortexing, lOpl 
of IX DNPH solution (for derivatisation of carbonyl groups) was added to each 
tube, and lOpl of IX Derivitisation-Control Solution to the negative control 
samples. After brief vortexing, the samples were incubated for 15 minutes at 
room temperature. To stop the derivitisation reaction, 7.5pi of neutralisation 
solution was added to each tube. A further neutralisation step was carried out by 
adding 4pl of 1% bromophenol blue in 2M Tris Base.
4.5.3.2.5 SDS-PAGE and Western blot Transfer
The samples were loaded onto a 12% Bis Tris gel and run for 1 hour at 200V. 
The gel was transferred to a PVDF membrane for 2 hours at 30V, and the 
membrane incubated for 1 hour at room temperature in 1% BSA in PBS with 
0.1% Tween 20 with gentle agitation to block non-specific binding sites. The 1° 
antibody was diluted, 1:150 in dilution buffer (1% BSA with 0.05% Tween 20) 
just before use and the membrane incubated in this solution for 2 hours at room 
temperature with gentle agitation. The membrane was washed every 5-10 
minutes in lx PBS with 0.1% Tween 20 over 1 hour at room temperature with 
gentle shaking. It was incubated with 2° antibody 1:300 in dilution buffer for 1 
hour at room temperature with gentle agitation, and again washed every 5-10 
minutes in IX PBS with 0.1% Tween 20 over 1 hour at room temperature with 
gentle shaking. After washing, the membranes were transferred to a dark room, 
excess wash buffer was drained and the signal developed by immersion in active 
ECL+ reagent and exposed to autoradiographic film. Initial exposures were of 10 
seconds and extended as necessary. Exposed films were developed in a bench top 
developer (Compact X4, X-ograph Imaging Systems, Malmesbury, Wiltshire).
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4.5.4 Results
The data below shows the increased levels of oxidised proteins with prolonged 
time in 3-D HepG2 culture. There were significant increases in levels of oxidised 
proteins (p<0.05) in both Day 15, 3-D HepG2 culture compared to Day 8, 3-D 
culture and Day 11, 3-D culture compared to Day 8, 3-D culture.
1 2 3 4 5  6 7 8 9
0 ^ 0 -
The area in this 
box indicates the 
region measured 
by densitometry 
in each lane
Fig. 26 Western blot for detection of oxidised proteins in 3-D HepG2 cultures.
Lane Number Sample Densitometry 
OD x mm2
1 Protein marker (kDa) n/a
2
■v
Positive control for assay- 80.934
>■ Day 8 spheroids subjected to 92.562
3 hypoxia/reperfusion
4
>- Day 15 (*)
74.861
5 65.976
6
>- Day 11 (*)
66.543
7 45.190
8
Day 8
13.1439
9 14.500
10 Negative control
Table 16 Densitometry values of oxidised proteins in 3-D culture. Statistics (*) 
represents comparisons between Day 15 & 8, & then Day 11 & Day 8 p<0.05 = *
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To demonstrate further the enhanced performance of HepG2 cells in 3-D culture 
compared to monolayer HepG2 cell culture in protecting HepG2 cells from 
oxidative stress, oxidised proteins were measured in HepG2 cells in 3-D culture 
and monolayer HepG2 cell culture. Levels of oxidised proteins were compared in 
3-D HepG2 cultures compared to HepG2 cells in monolayer culture. The 
protective function of HepG2 cells in 3-D culture was demonstrated further when 
HepG2 cells in 3-D and monolayer culture were both subjected to hypoxia then 
reperfusion, and then similar comparisons of levels of oxidised proteins were 
made.
250
160
105
75
50
35
*-----  25
Fig. 27 Western blot for detection of oxidised proteins in monolayer cultures and 
Day 8, 3-D cultures under normoxia and subjected to hypoxia/reperfusion.
1 2 3  4 5 6 7 8 9  10
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Lane Number Sample Densitometry 
OD x mm
1 Negative control n/a
2 —s 43.472
3
^Monolayer HepG2 cells subjected to 
hypoxia/reperfusion (*) 46.137
4 9.270
5
Day 8, spheroids
7.858
6 ■s. 24.163
7
>»Day 8 spheroids subjected to 
hypoxia/reperfusion (***) 30.241
8
. ..  .
26.092
9
^  Monolayer HepG2 cells
35.502
10 Protein marker (kDa) n/a
Table 17 Densitometry values of oxidised proteins in Day 8, 3-D culture 
compared to monolayer HepG2 culture under control and hypoxic conditions. 
Statistical analysis (*) represents comparisons between hypoxic Day 8 vs. control 
Day 8, and hypoxic monolayer HepG2 cells vs. control HepG2 monolayer cells. 
p<0.05 = *, p<0.0005= ***
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The results below in Fig.28 show the increasing levels of oxidised proteins with 
prolonged 3-D HepG2 culture as demonstrated before, but also human liver as an 
additional control for the experiment.
Human liver
I
1 2 3  4 5 6 7 8 9  10
Fig. 28 Western blot for detection of oxidised proteins in 3-D HepG2 cultures, 
with human liver as a negative control to show lack of protein oxidation in normal 
human liver compared to Day 15.
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Lane Number Sample Densitometry
ODxmm2
1 65.401
^  Day 8 spheroids subjected to
2
-j
hypoxia/reperfusion 114.751
3 Human Liver 4.791
4 118.794
^  Day 15 spheroids (*)
5 67.448
6 Day 11 spheroids 52.181
7 66.276
8 ■"N 43.379
>» Day 8 spheroids
9 32.858
10 Protein marker (kDa) n/a
Table 18 Densitometry values of oxidised proteins in 3-E) cultures, with
comparison to human liver as a negative control. Statistics (*) represents 
comparisons between Day 15 vs. Day 8, 3-D culture. p<0.05 = *
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4.5.5 The Thiobarbituric acid reactivity test to measure lipid peroxidation in 
HepG2 culture
One of the most commonly applied assays to measure the products of lipid 
peroxidation is the thiobarbituric acid (TBA) test. The sample under test is heated 
with TBA at a low pH, and the assay involves the reaction between
malondialdehyde and TBA to yield a pink chromogen which is measured
colorimetrically at 532nm using a spectrophotometer.
4.5.5.1 Materials
- Hank’s x MDA (0.015g CaCl2> 1.6g glucose, 0.4g KC1, 0.06g
KH2P04, 0.2g MgS04. 7H20, 8g NaCl, 0.048g Na2HP04, 0.35g
NaHC03) to a final volume of 1 litre pH 7.4
- 10% TritonX-100
- cold 4mM EDTA in 0.15M NaCl pH 7.4
- 50% TCA
1,1,3,3-tetramethoxypropane (malonaldehyde) Sigma
- HC1
- 5% TBA -Made in 1M NaOH and left to stir on a hot plate for 1-2 
hours until it dissolves- turns a hazy yellow colour
10% Butylated hydroxytoluene (BHT)
ImM menadione sodium bisulphite 
1 OOmM hydrogen peroxide
- n-butanol
- Argon cylinder
- Oxygen cylinder
4.5.5.2 Method
4.5.5.2.1 Monolayer cultures
HepG2 cells in monolayer culture were grown to 70-80% confluency. Cells were 
washed twice with Hanks x MDA and to the flask 7.5mls of Hanks x MDA alone 
was added with or without the pro-oxidant, 100pm menadione sodium bisulphite 
to induce oxidative stress and serve as positive controls. As a further positive
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control for the assay, a hypoxic positive control was used for the assay as 
described. The method adapted from Iguchi et al 1993 and Bassi et al 1998, 
allows us to measure the intra and extracellular Thiobarbituric Acid Reactive 
Substances (TBARS) released from the cells. After the incubation period, 150ul 
of 10% TritonX-100 was added to give a final concentration of 0.2% 
TritonX-100. The flasks were incubated for a further 5 minutes at 37°C to lyse 
the cells. The cells and medium were transferred to a Nunc tube and 
homogenised thoroughly and kept on ice.
4.5.5.2.2 Human liver
7.5mls of Hanks x MDA was added to small piece of human liver tissue (5- 
lOmg), with 150ul of 10% TritonX-100 to give a final concentration of 0.2% 
TritonX-100. The tissue was homogenised thoroughly with a glass homogeniser 
and the samples were kept on ice.
4.5.5.2.3 3-D HepG2 cultures
2mls each of beads from Day 8, 11 and 15 of 3-D culture were transferred to a 
Nunc tube. The beads were allowed to settle and then washed twice with Hanks x 
MDA. 7.5mls of Hanks x MDA was added to each of the 2mls of beads with or
•y
without the pro-oxidant and transferred to T80cm flasks and incubated for 2 
hours at 37° C. 3-D HepG2 cultures were subjected to hypoxia, then reperfusion 
injury to serve as another positive control for the assay as described for monolayer 
culture. The beads and Hanks x MDA medium were transferred to Nunc tubes 
and once the beads had settled the conditioned medium with the released TBARS, 
was transferred to fresh Nunc tubes and kept on ice. To the beads, 15.2mls of 
cold 4mM EDTA in 0.15M NaCl pH 7.4 was added to chelate the calcium ions 
out of the alginate and release the spheroids. The tubes were mixed manually 
until the alginate had dissolved and centrifuged at 200g for 10 minutes at 4°C 
(Heraeus, UK) to obtain a pellet of spheroids. The supernatant was removed and 
to the remaining pellet, the conditioned medium was added with 150pl of 10% 
TritonX-100 to give a final concentration of 0.2% TritonX-100 in order to lyse the 
cells. The spheroids were homogenised thoroughly with a glass homogeniser and
154
the samples were kept on ice.
4.5,5,3 Assay fo r measuring lipid peroxidation
All samples were protected from light. To 1ml of cell suspension, 2mls of 
solution was added to give a final concentration of 0.375% TBA, 15% TCA, 
0.25N HC1 and 0.01% BHT in Hanks x MDA buffer. BHT acts as an antioxidant 
to prevent further lipid peroxidation in the samples.
The samples with the TBA solution were mixed thoroughly and boiled for 30 
minutes, and cooled to room temperature with tap water. 3mls of n-butanol was 
added and each sample was vortexed thoroughly for 30 seconds to extract the 
TBARS formed during heating. The samples were centrifuged at 1250g for 10 
minutes at room temperature (Heraeus, UK) to separate the organic layer 
(TBARS). This supernatant was carefully removed and placed in fresh tubes 
wrapped in aluminium foil. The fluorescence intensity of the TBARS released 
was read at 515nm excitation and 552nm emission with a flourimeter 
(Spectroflourophotomoeter, RF-5001 PC, Shimadzu, Japan).
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4.5.5.4 Results
A standard curve was plotted using a serial dilution of known concentrations of
1,1,3,3-tetramethoxypropane (malonaldehyde) in Hanks x MDA using 1ml of this 
standard solution and 2mls of the TBA solution mix and processed in the same 
way as the HepG2 samples. Sample optimal densitometry (OD) readings were 
measured against the curve to obtain a known value in nm. A small amount from 
the remaining sample was removed and measured for total protein content by the 
Lowry method and TBARS were expressed as nmol/mg protein.
M alon a ldehyd e  S tandard  Curve for TBARS
y = 0.0295X + 11.433 
R2 = 0.977
100 n
80 -
♦  nm cone 
 Linear (nm cone)
0 250 500 750 1000 1250 1500 1750 2000 2250 2500 2750 3000
Concentration nm
Fig. 29 Standard curve of absorbances corresponding to known concentrations of 
malondialdehyde
The data in Fig.30 shows the increasing level of lipid peroxidation with prolonged 
time in 3-D HepG2 culture. There were significant increases in levels of lipid 
peroxidation (p<0.05) in Day 15, 3-D HepG2 culture compared to Day 8, 3-D 
culture.
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Fig. 30 Lipid peroxidation in 3-D HepG2 cultures over time, with liver as a 
negative control. Mean values ± S.D, n=3 for each time point. Statistics (*) 
represent comparisons between Day 15 and Day 8. p<0.05 = *
To demonstrate further the enhanced performance of HepG2 cells in 3-D culture 
compared to monolayer HepG2 culture in protecting HepG2 cells from oxidative 
stress, lipid peroxidation was measured in HepG2 cells in 3-D culture and 
monolayer HepG2 culture. Levels of lipid peroxidation were compared in 3-D 
HepG2 cultures compared to HepG2 cells in monolayer culture. The protective 
function of HepG2 cells in 3-D culture was demonstrated further when HepG2 
cells in 3-D and monolayer culture were both subjected to hypoxia then 
reperfusion, and then similar comparisons of levels of lipid peroxidation was 
made.
157
1500-1
s  1250-
S  1000-
750-
500-
250-
Culture
Fig. 31 Lipid peroxidation in monolayer HepG2 cells compared to 3-D HepG2 
cells to show that HepG2 cells are protected against oxidative stress in 3-D culture 
compared to monolayer culture. Mean values ± S.D, n=3 for each time point. 
Statistics (*) represent comparisons between hypoxia/reperfusion cultures and 
control cultures. p<0.05 = *, p<0.0005= ***
4.6 Overcoming oxidative stress observed at later times of 3-D culture with 
supplementation of additional anti-oxidants
Oxidative stress has been observed at later times of 3-D culture from Day 11 
onwards, when function starts to diminish as demonstrated by increased protein 
oxidation and lipid peroxidation from Day 11 onwards. In addition, it was shown 
that phospho-specific MAPKp49/SAPKl/JNKl is activated and showed increased 
expression in monolayer and Day 15, 3-D culture compared to Day 8, 3-D culture. 
Therefore, in order to overcome the oxidative stress observed, with the aim of 
increasing function per cell at times of diminished function or increasing cell
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numbers at times of peak function, the medium was supplemented with additional 
anti-oxidants just prior to culture time points when function starts to diminish. 
The culture medium was already supplemented with anti-oxidants e.g. sodium 
selenite so anti-oxidants were not added at the beginning to prevent disturbance of 
the oxidant/anti-oxidant balance.
4.6.1 Materials
Glutathione (GSH)
Vitamin E 
DMSO
N-acetylcysteine (NAC)
4.6.2 Methods
3-D HepG2 cultures were generated as previously described and maintained up to 
15 days. At Day 8, of 3-D culture, beads were harvested as previously described. 
24 hours prior to the Day 11 harvesting time point, the control plate was set up 
with 5mls of HG medium, as before and 3 additional 6 well plates, the medium 
was supplemented with 50pM Vitamin E (dissolved in DMSO), 30mM NAC, and 
20mg/litre GSH respectively (Goasduff and Cederbaum 1999;Waris et a l 2001). 
For beads harvested at Day 15, a control plate and 3 additional 6 well plates were 
also set up, and the medium was supplemented with the corresponding anti­
oxidants at Day 10 and 12 in 8mls of medium as before, and Day 14, 24 hours 
prior to harvesting in 5mls of HG medium. Conditioned medium was collected 
for measurement of liver specific proteins by ELISA and cell number was 
elucidated by crystal violet staining.
4.6.3 Results
The results below show that with the supplementation of additional anti-oxidants, 
an increase in cell number or protein secretion per cell was not demonstrated, 
particularly from Day 11 onwards, when function starts to diminish.
(Sigma)
(Sigma)
(BDH)
(Sigma)
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Fig. 32 Cell proliferation in 3-D culture with and without the supplementation of 
additional anti-oxidants. Mean values ± S.D, n=6 for each time point.
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Fig. 33 Albumin secretion in 3-D culture with and without the supplementation of 
additional anti-oxidants. Mean values ± S.D, n=6 for each time point.
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Fig. 34 Fibrinogen secretion in 3-D culture with and without the supplementation 
of additional anti-oxidants. Mean values ± S.D, n=6 for each time point.
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Fig. 35 Alpha-1-antitrypsin secretion in 3-D culture with and without the 
supplementation of additional anti-oxidants. Mean values ± S.D, n=6 for each 
time point.
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Although there was evidence of hypoxic and oxidative stress, attempts to alleviate 
this stress were unsuccessful. The Microarray database was searched further and 
western blots were carried out to look for changes in genes and proteins, which 
triggered a general stress response.
4.7 Evidence for a general stress response in HepG2 culture
4.7.1 From Microarray analysis
Day 8 vs. Monolayer
INCREASE Fold Chanee ± S.D % of chins 
showing 
this change
Heat shock protein 70 (HSP 70) +3.46 ±2.50 100
Catalase + 2.44 ±0.30 100
MHC Class I + 3.20 ±0.60 100
DECREASE
HSP 47 -3.15 ±0.94 55
RNA Polymerase II -2.38 ± 0.24 55
Day 15 vs. Day 8
DECREASE
Glutathione-S-transferase -3.83 ±1.98 44
MAPK protein kinase 3 -4.45 ± 1.39 44
Table 19 Expression of genes associated with cellular stress by Microarray 
analysis
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4.7.2 By Western blotting
Western blots were carried out with total cellular protein from monolayer HepG2 
cells, Day 8 and Day 15, 3-D culture for the presence of key proteins expressed as 
a result of these stress inducing stimuli to complement the Microarray analysis.
MAPKp49/SAPKl/JNKl
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25
49kDa
\
+ M d8 d l5
Fig. 36 MAPKp49 protein expression in HepG2 cultures
MAPKp49 protein is detected as 2 strong bands in all the samples including the 
control. The upper band is the band of interest as the lower band is a post- 
translational modification of the protein. Stronger signals were detected in 
monolayer and Day 15 samples than the Day 8 sample.
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P386/SAPK4 JNKK1/MKK4
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Fig. 37 P386 and JNNK1 protein expression in HepG2 cultures
JNKK1 or MKK4 protein was not detected in any of the samples but a faint signal 
was observed with the positive control lysate from rat cerebellum (+). 
P388/SAPK4 protein was present in equal amounts in all the samples and showed 
no change in signals, a faint signal was observed with the positive control lysate 
from A431 cells (+).
STl/Hop-p60
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Fig. 38 ST1 protein expression in HepG2 cultures
ST1 (Hop p60) shows a similar pattern of expression to MAPKp49 and again, an 
expression of a slightly smaller band is due to post-translational modification of
44 kDa
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that protein. The strongest signal here was shown in the monolayer samples 
compared to Day 8 and Day 15. A clear signal was shown with the positive 
control lysate from A431 cells (+).
HO-1 HO-2
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Fig. 39 HO-1 and HO-2 protein expression in HepG2 cultures
Haemoxygenase (HO)-l protein was abundant in the Day 8 sample and gave the 
strongest signal compared to the monolayer sample and Day 15 sample. A very 
weak signal was observed with the positive control lysate from SW-13 cells (+). 
HO-2 showed no change in signal strength between all the samples and a clear 
signal was seen with the positive control lysate from SW-13 cells. The expected 
expression of HO-2 confirmed equal loading of samples as HO-2 is constitutively 
expressed in mammalian cells, whereas the expression of HO-1 is induced upon 
external stresses (+).
Cyclo-oxygenase (COX)-2 protein was not detected in any of the samples but a 
strong signal was observed with the positive control lysate from macrophages 
(figure not shown).
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The densitometry measurements quantify the observations made from Western 
blot detection that these “stress” proteins showed increased levels of expression 
at times of diminished function in monolayer and Day 15, 3-D HepG2 culture. 
Densitometry
Protein Monolayer 
OD x mm2
Day 8 
OD x mm2
Day 15 
OD x mm2
MAPKp49 9.749 8.364 11.288
P386/SAPK4 2.595 2.754 2.653
ST1-Hop60 13.992 7.697 4.585
HO-1 5.501 13.367 5.873
HO-2 2.979 2.891 3.154
Table 20 Densitometry measurements for general stress protein expression
4.7.3 Powerblot-Protein Array
As a complement to the Microarray, a protein array was carried out. 
Approximately 8mg of protein, from all culture conditions was analysed by 
Western blot, using the Becton Dickinson (USA) Powerblot, which includes 
antibodies to more than 700 antigens. The comparisons made were.
1) 3-D Cultures at optimal function at Day 8 vs. monolayer (M) cultures
2) 3-D cultures at Day 15 (Diminished Function) vs. Day 8 (Optimal Function) 
The Powerblot results were comparable with the results obtained from the western 
blots carried out in the laboratory for the following proteins;
Day 8 vs. Monolayer
Protein Cat. No Fold change in 
expression
Heme oxygenase 
(HO) 1
H59320 INCREASE
4.84
MAPKp49 M54920 DECREASE
2.54
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Day 15 vs. Day 8
Protein Cat No. Fold change in 
Expression
STI / Hop-p60 S65720 INCREASE
1.84
Heme oxygenase 
(HO) 1
H59320 DECREASE
2.51
Tables 21 Densitometry measurements of stress response proteins from the 
Powerblot
The Powerblot results were interrogated further and the most significant results 
are shown, grouped into various biological functions. Confidence levels range 
from 5-1 so changes in level 5 and 4 are shown as the most significant, as a result 
of reproducibility of results and fold increases.
Tables 22, 23 and 24 below demonstrate a complex result; some stress proteins 
were turned on at time of poor performance, indicating the role of stress response 
mechanisms during diminished function. Other stress proteins were turned on at 
the time of enhanced function, or perhaps more likely that this increased 
expression was an adaptive response to enhanced performance.
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4.7,3.1 Day 8 vs Monolayer-Adaptive Stress
Table 22 Most significant results when comparing Day 8 vs. monolayer showing 
proteins expressed as a result of the enhanced metabolic performance and in vivo 
like morphology observed at Day 8, 3-D cultures
Adaptive 
stress proteins
Catalog.
No
Confidence
Level
Fold Change Function
pi 15 P67420 5 INCREASE
2.09
Vesicular transport from 
the ER to Golgi
Plectin-144 P92020 5 INCREASE
3.04
Filament binding protein- 
crosslinking in 
cytoskeleton
E-cadherin C377020 5 INCREASE
1.98
Calcium dependent 
adhesion molecule, 
Increase reduces invasive 
carcinoma, important for 
epithelial junction 
formation
Fibronectin FI4420 5 INCREASE
4.03
ECM protein -via integrin 
binds to collagen and 
attachment to cell, cellular 
signalling
HSP60 H99020 4 INCREASE
2.01
Heat shock protein, 
constitutively expressed in 
normal and apoptotic cells
Annexin IV A29920 4 INCREASE
2.44
Family of calcium and 
phopsholipid binding 
proteins
Adaptin alpha A43920 4 INCREASE
2.21
Recruits membrane
proteins-vesicular
transport
REF-1 R64820 4 INCREASE
2.51
Redox factor. Increase by 
AP-1 DNA binding-DNA 
repair
HRF H42020 5 DECREASE
6.37
Histamine releasing factor
Nip-1 N79420 4 DECREASE
1.95
Pro-apoptotic proteins- 
target proteins to 
mitochondria
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4.7.3.2 Day 8 vs Monolayer-Cellular stress
Table 23 Most significant results when comparing Day 8 vs. monolayer showing 
proteins expressed as a result of cellular stress
Cellular Stress 
Response Protein
Catalog.
No
Level Fold Change Function
Cathepsin D-29 C47620 5 INCREASE
9.2
Tissue remodelling in 
response to oestrogen
CDC42 C70820 5 DECREASE
4.3
Rho protein- activates 
MEKK1
HSF4-38 H65520 5 DECREASE
4.25
Heat shock factor- mediates 
transcription of HSPs, 
increases when there is a 
decrease of HSP70, 90
4.7.3.3 Day 15 Vs Day 8-Cellular Stress
Table 24 Most significant results when comparing Day 15 vs. Day 8 showing 
proteins expressed as a result of cellular stress
Cellular stress
Response
Protein
Catalog.
No
Level Fold
Change
Function
Gelsolin G37820 5 INCREASE
5.54
Severs actin filaments in a 
calcium dependent manner
Annexin IV A14020 5 INCREASE
4.52
Calcium and phospholipid binding 
proteins. Unphosphorylated forms 
causes aggregation of chromatin 
granules
STI-1 S65720 4 INCREASE
1.84
Human Stress Inducible factor- 
induced by heat shock
panERK E17120 4 INCREASE
2.21
Extracellular signal related kinase
Mekl Ml 7020 4 INCREASE
2.80
MAP/ERK kinase
HsPBPl H98620 4 INCREASE
6.6
Heat shock 70 binding protein. 
Negative regulator of HSP70
Bid cl.7 B97920 5 DECREASE Member of BC1-2 family. Pro- 
apoptotic
Rap2 R23020 5 DECREASE Member of Ras family -activated 
by growth factors, mitogenic 
stimuli
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This complex relationship between stress and performance was demonstrated 
further at the functional level, by carrying out enzyme activity assays, of key 
genes at the mRNA level activated by a general stress response.
4.8 Assays to demonstrate functional activity of genes at the mRNA level 
activated by a general stress response, contributing to the maintenance of 
optimal function in 3-D HepG2 culture
Amongst the changes observed in levels of gene expression of genes associated 
with a general cellular stress response was an increase in catalase mRNA in Day 8 
spheroidal 3-D HepG2 cultures compared to monolayer HepG2 culture and a 
decrease in glutathione-S-transferase mRNA levels in Day 15 spheroidal 3-D 
HepG2 cultures compared to Day 8 spheroidal 3-D cultures.
In order to investigate whether these changes were also occurring at the functional 
level, assays were carried out in the HepG2 cultures to assess enzymatic activities 
of their gene products.
4.8.1 Catalase Activity Assay 
Enzyme reaction
4.8.1.1 Materials
HBSS on ice
IX PBS on ice
4mM EDTA in 0.15M NaCl pH 7.4 on ice 
Protein Homogenisation buffer
0.32M sucrose 
ImM EDTA 
lOmM Tris pH 7.4
0.5M  K H 2P 0 4
Hydrogen peroxide solution (30%)
Catalase (from bovine liver, Sigma cat. C-40)
Apparatus
UV 300-Dual Beam Spectrophotometer (Unicam, Cambridge, UK) 
Waterbath.
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4.8.1.2 Method
4.8.1.2.1 For 3-D cultures
Beads were cultured in 6 well plates as previously described. On the day of 
harvesting for Day 8 and Day 15, 3-D cultures, the beads were transferred from 
each cell strainer containing 0.25ml of beads into respective sterile microfuge 
tubes. The beads were washed once with ice cold HBSS and washed once with 
ice cold PBS. The beads were allowed to settle and 1ml cold 4mM EDTA in 
0.15M NaCl pH 7.4 was added. The tubes were mixed manually until the alginate 
dissolved and released the HepG2 spheroids. The samples were centrifuged at 
85g for 10 minutes at 4°C (Eppendorf 5402, Germany). The supernatant was 
removed and 1ml of homogenising buffer (0.32M sucrose, ImM EDTA, lOmM 
Tris pH 7.4) was added. The samples were homogenised thoroughly with a Potter 
Elvjeham manual glass homegeniser to homogenate the samples. At this stage, 
120pl of the homogenate was removed and kept on ice. The total protein content 
of the homogenate was measured by the Lowry method. The remaining sample 
was centrifuged at 350g for 10 minutes at 4°C (Eppendorf 5402, Germany). The 
supernatant was removed and placed in a fresh tube and kept on ice. The total 
protein content of the supernatant was determined by the Lowry method and 
assayed for enzymatic activity.
4.8.1.2.2 For monolayer culture
HepG2 cells were seeded in 6 well plates at the same time of preparation of 3-D 
culture and at the same initial seeding density. For protein preparation, cells were 
washed with cold HBSS and once with cold PBS. The cells were trypsinised on 
ice (1ml per well) and after gentle agitation with a cell scraper, cells were 
transferred to a microfuge tube and centrifuged at 120g for 4 minutes at 4°C 
(Eppendorf 5402, Germany). The supernatant was removed and 1ml 
homogenising buffer was added. The sample was homogenised thoroughly and 
processed as described for 3-D culture.
4.8.1.2.3 For liver tissue
Normal human liver tissue was homogenised in 1ml protein homogenising buffer 
and the sample was processed as described above.
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4.8.1.3 Measuring catalase enzyme activity
Catalase activity was determined at 25°C, by measuring the rate of decomposition 
of hydrogen peroxide by ultraviolet spectroscopy at 240nm (UV 300-Dual Beam 
Spectrophotometer (Unicam, Cambridge, UK).
The reaction was performed using a solution of 50mM KH2PO4, 30pg of protein 
homogenate and 20mM hydrogen peroxide added at the end in a final volume of 
lml. Before measuring each sample, n=6 for each culture condition, the 
spectophotometer was zeroed with the above solution excluding the protein. The 
specific activity of the catalase was measured against this reference. The rate of 
decomposition of hydrogen peroxide by catalase was measured over 10 minutes. 
A graph was plotted showing absorbance at 240nm over 10 minutes. The 
software calculated a rate from the slope of the graph. From the slope of the 
graph, optimal rate was observed, usually in the initial 3 minutes from the reaction 
initiating. Specific activity was calculated as (units/mg of protein/min) = 
AA24onm (1 min) x 1000/43.6 x 0.3 mg protein. As positive controls, 10 and 30 
units of catalase were used and human liver tissue.
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Fig. 40 A typical slope observed over time of decomposition of hydrogen 
peroxide by catalase over time.
4.8.2 Glutathione-S-transferase enzyme activity 
Enzyme reaction
4.8.2.1 Materials
HBSS on ice
IX PBS on ice
4mM EDTA in 0.15M NaCl pH 7.4 on ice
l-chloro-2,4-dinitrobenzene (CDNB), Sigma Cat No. C6396)
Glutathione reduced form (GSH), Sigma Cat No. G4251.
4.8.2.2 Methods 
Sample preparation
Protein homogenates from monolayer HepG2 cells, 3-D culture and human liver 
tissue were prepared as previously described for the catalase enzyme assay. 30pg 
of cytosolic protein was used in each assay.
4.8.2.3 Measuring glutathione-S-transferase (GST) enzyme activity
GST activity was determined at 25°C by measuring the rate of conjugation of
GSH to CDNB with ultraviolet spectroscopy at 240nm (UV 300-Dual Beam 
Spectrophotometer (Unicam, Cambridge, UK). Final substrate concentrations 
were ImM CDNB and 0.1M potassium phosphate buffer pH 6.5 in a final volume 
of 1ml. The reaction was started with the addition of 25pl of 40mM GSH. 
Before measuring each sample, the spectrophotometer was zeroed with the above 
solution excluding the protein. The specific activity of the protein sample was 
measured against this reference. As a positive control, human liver tissue was 
used. The change in extinction at 340nm with incubation time was measured. 
Results were expressed as units of specific activity defined as the amount of the 
enzyme that produces the conjugated product per minute per milligram of protein 
using the extinction coefficient 9.6 /mM/cm at 340 nm. Therefore GST activity 
was calculated as AA34onm (1 min) x 9.6 x 0.03 mg protein.
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Fig. 41 A typical slope observed from the conjugation of GSH to CDNB to 
measure glutathione-S-transferase activity over time.
4.8.3 Results
4.8.3.1 Catalase Assay
The results show that catalase activity is optimal in Day 8, 3-D cultures, and is 
increased at Day 8, 3-D culture compared to monolayer HepG2 culture. The fold 
increase is comparable to the fold increase observed at the mRNA levels for this 
gene. Catalase activity is also upregulated in Day 15, 3-D culture compared to 
Day 8, 3-D culture.
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Fig. 42 Specific activity of catalase in 3-D HepG2 cultures and monolayer HepG2 
cultures. Statistics (*) represents comparisons between Day 8 to Day 15 and then 
Day 8 to monolayer. Mean values ± S.D , n=6 for each time point. 
p<0.0005= ***
4.8 3.2 GST activity
The results show that GST activity is optimal in Day 8, 3-D cultures, and is 
increased at Day 8, 3-D culture compared to monolayer HepG2 culture. GST 
activity is also greater in Day 15, 3-D culture compared to Day 8, 3-D culture.
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Fig. 43 Specific activity of glutathione-S-transferase in 3-D and monolayer 
HepG2 cultures. Statistics (*) represents comparisons between Day 8 to 
monolayer and then Day 8 to Day 15, 3-D culture.
Mean values ± S.D, n=6 for each time point. p<0.0005=***
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4.9 Discussion
From the results obtained from Microarray and Western blotting it was 
concluded:-
(1) stress associated genes and proteins were present at times of peak function, 3- 
D culture (at Day 8) compared to monolayer culture.
(2) The stress responses at later time points of culture, Day 15 spheroids in 3-D 
culture (diminished function) compared to Day 8 spheroids in 3-D culture (peak 
function) causing downregulation of function, could be caused by cellular stresses 
such as oxidative stress and/or hypoxia.
(3) in 3-D cultures at optimal function (Day 8), there are some cellular stress 
responses which may be turned on as an adaptive response as a consequence of 
increased metabolic activity (Nilsson et a l 2002). These stress responses early on 
may reflect increased function of healthy cells.
The results were complex, with some stress-induced genes proteins being more 
strongly expressed at the time of peak performance, at Day 8, 3-D culture, while 
others were strongly expressed in Day 15, 3-D cultures as performance 
diminished. An example is the catalase gene which constitutes an anti-oxidant 
defence in cells (Bai et a l 1999;Bai and Cederbaum 2000). There was an 
increase in expression of this gene at the mRNA level and functionally at the 
protein level, in Day 8, 3-D cultures compared to monolayer HepG2 culture and 
functionally at the protein level in Day 8, 3-D culture compared to Day 15, 3-D 
culture, reflecting both the optimal function at Day 8 and the adaptive response of 
the cells, requiring more catalase due to increased metabolic activity at Day 8, 
3-D culture.
Stress Response- Day 15 HepG2 3-D cultures (diminished function) vs. Day 8 
HepG2 cultures (optimal function)- The changes in expression of genes and 
proteins between Day 15 and Day 8 are associated with liver enriched 
transcription factors and various forms of cellular stress including both hypoxia 
and oxidative stress.
Western blots detected various proteins associated with cellular stress in 3-D
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cultures at Day 8, Day 15 and monolayer HepG2 culture. 
MAPKp49/SAPKl/JNKl is activated by an upstream MAPKK such as MEKK1 
(Boldt et al. 2003;Cuenda and Dorow 1998) and in its corresponding western blot 
analysis, the protein was abundant in the culture conditions. The upper band 
illustrates the activated form of the protein was most abundant in monolayer 
HepG2 culture and in Day 15, 3-D culture. MKK4 directly activates the c-jun 
NH2 terminal kinases (JNK) in response to cellular stresses and proinflammatory 
cytokines. These MAP kinases are involved in phosphorylation cascades initiated 
by detection of stress which include mitogenic stimuli and cellular stresses 
(schematic diagram p. 126). However, Rap2, a member of the Ras superfamily of 
GTPases which could activate MKK4 via mitogenic stimuli (Boldt et al. 
2003 ;Yue and Mulder 2000) rather than cellular stresses, showed decreased levels 
of expression in Day 15 3-D culture compared to Day 8 3-D culture (Table 24) 
suggesting that the JNK/SAPK pathway, which constitutes MKK4, is activated by 
cellular stresses rather than mitogenic stimuli (Ellinger-Ziegelbauer et al. 
1997;Haussinger et al. 1997). MKK4 also activates p38S in vitro (Cuenda 2000). 
Interestingly, MKK4 protein was not detected in the culture conditions, and 
although p388 was evident, there was no difference in expression between the 
culture conditions. p388 is also activated by MKK3 and MKK6 (Fleming et al. 
2000;Keesler et al. 1998), but there may not have been any difference in levels of 
expression of p38S in the culture conditions because MKK4 was not present in the 
culture conditions.
ST 1/hop p60 is a stress-inducible phosphoprotein and also complexes with HSP 
70 and HSP 90 (Lassie et al. 1997). The strongest signal was observed in 
monolayer HepG2 cultures, although it was also evident in 3-D cultures.
The Powerblot data highlighted proteins comparing Day 15 vs. Day 8 cultures, 
increases of more stress inducible protein kinases, panERK and MEK1, which 
increase to phosphorylate microtubule associated proteins. Specific cellular 
stresses were then investigated in more detail, with respect to evidence obtained 
from microarray analysis, powerblot and western data analysis.
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Hypoxic stress response
It was hypothesised that hypoxia could be contributing to the downregulation of 
function in spheroids at Day 15 of culture. There was an increase in VEGF in 
Day 15, 3-D culture compared to Day 8, 3-D culture. VEGF is implicated in 
angiogenesis and vascular tone, and more importantly is activated or upregulated 
as a consequence of hypoxic stress (Carmeliet et a l 1998;Stein et a l 1995).
Oxygen is assumed to be one of the key factors in the maintenance of the 
metabolic functions of cultured hepatocytes, as the liver is known to consume a 
large quantity of oxygen in vivo (Else 1991;Kaur et a l 2000).
Hypoxia is known to upregulate expression of several genes including 
erythropoietin (EPO) (Fisher 2003), tyrosine hydroxylase (Hohler et a l 1999), 
vascular endothelial growth factor (VEGF) (Carmeliet et a l 1998), platelet 
derived growth factor (Gorlach et a l 2001;Kourembanas et a l 1990), and lactate 
dehyrogenase A (Ebert and Bunn 1998). These and other biologically important 
genes have in common either promoter or enhancer elements that respond to 
hypoxia. Among these, the EPO gene has the most robust response to hypoxia 
(Greco et a l 2002).
VEGF contains a functionally critical site for HIF-la, a DNA binding complex 
which transcribes VEGF in response to hypoxia, thereby enabling growth of new 
blood vessels needed for tissues to recover from oxygen deprivation (Ratcliffe et 
al 1998;Zhu et al 2002). VEGF contains enhancer elements with functionally 
critical sites for HIF-la.
HIF-la is activated in cells exposed to hypoxia although HIF-la itself was not 
detected by Microarray analysis. Ratcliffe et al 1998 reported a number of genes, 
which contain binding sites for HIF-la. The Microarray database was 
interrogated for the expression of these genes comparing diminished function at 
Day 15, 3-D culture with Day 8, 3-D culture. The results presented in Table 11 
showed increases in all the genes reported with binding sites for HIF-la. 
Glycolytic genes such as lactate dehydrogenase A and enolase were increased. 
HIF-1 is a heterodimer composed of basic helix-loop-helix proteins. HIF-1 is 
composed of two subunits, a  and p genes (Tsuchiya et a l 2002). The steady state
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levels of both HIF-la and p mRNA are not significantly affected by oxygen 
tension. At the protein level the p subunit is constitutively expressed and is not 
significantly affected by oxygen (Ratcliffe et a l 1998). However, in cells 
exposed to 21% oxygen, the HIF-la subunit is unstable as it is controlled by an 
oxygen dependent degradation domain within HIF-la (Ratcliffe et al. 1998). The 
degradation is catabolised through the ubiquitin-proteosome pathway (Huang et 
al 1998). The steady state levels of HIF-1 a  mRNA are not significantly affected 
by oxygen tension and in the majority of studies, mRNA was not found to be 
inducible by hypoxic stimulation which would explain why increases or decreases 
in the expression of HIF-1 a  mRNA levels were not detected by Microarray 
analysis with the defined parameters, and that activation of HIF-1 involves post- 
translational or translational mechanisms (Bunn et a l 1998;Ratcliffe et a l 1998). 
Other growth factors demonstrating increased expression in Day 15, 3-D culture 
compared to Day 8, include insulin-like growth factor binding protein-1 (IGFBP- 
1). IGFBP-1 is primarily expressed in the adult liver and IGRBP-1 gene 
expression has been reported to be activated by hypoxia through a HIF-1 - 
mediated pathway in HepG2 cells (Sugawara et a l 2000).
Therefore, Western blot analysis was carried out to detect HIF-la protein in the 
HepG2 culture samples and it was shown that this protein was more abundant in 
monolayer HepG2 culture and Day 15, 3-D culture (diminished function) as 
shown in Fig. 12 suggesting that hypoxic stress may be contributing to the 
downregulation of function observed.
Western blot analysis was also carried out for 2 MAP Kinase proteins induced in 
response to hypoxic stress; MEKK3 and MKK3b. Upstream regulatory 
components of these kinase cascades, are the MAPK/EKK. kinase kinases 
(MEKKK), MEKK3 activates SAPK activity and ERK pathways whereas the 
other isoform MEKK1 can only activate the SAPK pathway (Xu and Cobb 1997). 
MKK3b is an isoform of MKK3 (Han et a l 1997), and the protein is activated in 
all culture conditions but most abundant in monolayer HepG2 cells and Day 15 
HepG2, 3-D culture.
HIF-1 activity can be induced by hypoxia in a variety of nonerythropoietin
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producing cells but its activation may require phosphorylation as it is affected by 
alkaline phosphatases (Minet et a l 2001). Minet at al 2001 showed that c-jun 
protein accumulates in hypoxic HepG2 cells. AP-1 activation involves the 
phosphorylation of the amino-terminal domain of c-jun by the JNK SAP kinase. 
In the presence of a dominant negative mutant of MEKK1, an upstream kinase of 
the SAPK pathway, AP-1 activity is inhibited and northern blotting shows that 
hypoxia can induce the transcription of c-jun.
Interpretation of the stress response led to the hypothesis that downregulation of 
function observed in Day 15, 3-D HepG2 cells compared to Day 8, 3-D HepG2 
cells could be attributed to lack of oxygen: oxygen solubilisation in culture 
medium is not very good and maybe rate limiting when spheroids are larger. 
Therefore, the culture environment was modulated with increasing oxygen 
concentration to improve cell performance.
Modulating the culture environment with increasing oxygen concentration to 
improve cell performance
There are many reports regarding the fate of cells when they are placed in hypoxic 
conditions, but there is little previous published work to indicate any 
measurements taken to modulate the environment for hypoxic cells (Yanagi and 
Ohshima 2001). Yanagi et al., 2001 investigated the effect of oxygen 
concentration (10-40%) on metabolic functions of rat hepatocytes maintained up 
to 4 days. The albumin secretion rate of hepatocytes in the 40% oxygen 
concentration was 2.2 fold higher than in the 20% oxygen on Day 1. Oxygen is 
assumed to be one of the key factors in the maintenance of the metabolic 
functions of cultured hepatocytes because the liver is known to consume a large 
quantity if oxygen in vivo. The oxygen requirements of hepatocytes are normally 
very high (Jasmund et al 2002). The maximum oxygen saturation rate of normal 
culture medium is 21%, but at the later time points there may not have been 
sufficient oxygenation for cells at the centre of the bead.
In order to overcome this problem, oxygen tension in which these cultures were 
maintained, was increased from ~21% ambient oxygen concentration to 35%, 
80%, and finally 50%. Function was measured in terms of protein secretion, cell
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proliferation, morphology and viability. 35% oxygen tension was chosen, as this 
was almost twice the ambient oxygen tension. However, as observed, increasing 
the oxygen tension to this amount had no improved effect on the parameters 
measured.
As no difference was observed at 35%, the oxygen concentration was increased to 
80%. However, this was detrimental to the cells in terms of viability, 
proliferation and therefore, protein secretion per cell. The oxygen concentration 
was subsequently lowered to 50% as Nishikawa et al 1996 had reported that 
hepatocytes cultured as monolayers under an atmosphere of 10% to 50% oxygen 
maintained the same levels of cell viability and metabolic functions.
There was a detrimental effect on cell proliferation both on monolayer HepG2 
cells and HepG2 cells in 3-D culture; this impacted on cell viability and therefore 
function per cell.
Although HepG2 cells in 3-D culture demonstrated an apparent hypoxic response, 
the observed negative detrimental effects of increasing oxygen concentrations 
suggested the spheroid had become predominantly glycolytic with extended 
culture, and therefore increasing oxygen concentration would not have any 
positive effect.
However, it has also been reported that HIF-la has been upregulated in tumour 
cells under conditions of normoxia by peptides such as insulin and IL-1 and 
tumour necosis factor (TNF)a, angiotensin II and thrombin (Stiehl et a l 2002). 
The Microarray database could be interrogated further, comparing Day 8 to 
Monolayer to demonstrate the changes in expression of these genes and to see 
whether a decrease in these genes are observed, as the data suggests that at Day 8 
of 3-D culture (optimal function) HepG2 cells demonstrate normal metabolic 
activity and whether these genes are switched off or expressed at lower levels.
The negative effects of increasing levels of oxygen concentrations in HepG2 
culture on cell performance may have been as a result of the oxidisation of 
essential metabolic intermediates such as thiols, the O2 can “drain away” the 
reducing equivalents required for biosynthetic reactions within the cell. These 
oxidations often simultaneously reduce O2 to oxygen free radicals and other toxic
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oxygen derived species (Halliwell and Gutteridge 2002).
Although, the Western blot, Powerblot data and Microarray analysis identified 
genes and proteins implicated in a hypoxic stress response, manipulation of the 
environment to overcome this stress was unsuccessful. However, the signalling 
cascade, constituting many of the MAPKinases investigated, activated by hypoxic 
stresses, can also be activated by a variety of different stimuli, and 2 of these 
MAPKinases which were upregulated, MEKK3 and MKK3b, indicative of a 
hypoxic stress response (Kunz et a l 2001) can also be activated by an oxidative 
stress response (Bruckner and Estus 2002). In addition to this evidence 
suggesting that hypoxic stress was responsible for the diminished function 
observed, further investigation of the Microarray, Powerblot and Western blot 
data demonstrated additional evidence, which will be discussed further, that an 
oxidative stress was contributing to the diminished function observed.
Oxidative stress response
Changes in the levels of catalase in 3-D HepG2 culture compared to monolayer 
HepG2 culture, reflect not only changes in metabolic activity (Carlo, Jr. and 
Loeser 2003;Nebbia et a l 2004), but the decreased levels of catalase both at the 
mRNA level and at a functional level demonstrate the reduced anti-oxidant 
defence abilities of these cultures at Day 15. Hydrogen peroxide, one of the 
major reactive oxygen species is produced at a relatively high rate as a product of 
aerobic metabolism. Dismutation of superoxide generates hydrogen peroxide 
(Takada et a l 2002). The main cellular defence systems against hydrogen 
peroxide are the glutathione redox cycle and catalase (Bai and Cederbaum 
2000;Bai and Cederbaum 2001). Activation of the JNK/SAPK stress activated 
pathway, whose activation is most sensitive to increased ROS° (Turpaev 2002) 
was shown via increased expression of phospho-specific 
MAPKp49/SAPKl/JNKl in Day 15, 3-D culture and monolayer HepG2 culture.
In addition, the oxyblot results demonstrates the presence of increasing levels of 
oxidised proteins in 3-D HepG2 cultures over the culture period, and a significant 
increase at Day 15 compared to Day 8. Levels of oxidised proteins in Day 15 of 
3-D HepG2 culture were parallel to levels observed in spheroids which served as
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a positive control for the assay. The positive control for the assay was created by 
subjecting spheroids to hypoxia, then hyperoxia. However, the results also 
demonstrate the beneficial effects of 3-D culture than monolayer culture. In 
addition, albumin can also act as an anti-oxidant defence as it binds haem and 
copper ions and the anti-oxidant bilirubin is transported in an albumin bound 
form. As demonstrated, albumin, one measure of liver specific function is 
decreased considerably at Day 15, 3-D culture (Brass et a l 1998).
Modulating the culture environment with additional anti-oxidants to improve 
cell performance
The supplementation of additional anti-oxidants, to overcome the oxidative stress 
observed, may have decreased the overall levels of lipid peroxidation and protein 
oxidation (Locatelli et al. 2003) which would have to be elucidated further, but in 
terms of the ultimate end-point, it did not improve function per cell with respect to 
the measurement of secretion of liver specific proteins or increased cell numbers. 
The oxidative stress may be a result of the natural “ageing” process in cells 
(Golden et a l 2002;Hamet and Tremblay 2003).
A general stress response and its role in maintaining differentiated function
A general stress response which is activated and the effects triggering this 
response, and its contribution to diminished or enhanced function was then 
investigated. Many of the MAPKinases which showed a difference in expression 
between HepG2 cultures, MAPKp49, p388, MKK4 and STl-p60 have been 
discussed previously, and are upregulated at times of diminished function. 
However, the Microarray and Western blot data highlighted proteins and genes 
which were involved in a complex relationship between the activation of the 
stress response, and its subsequent effects on cell performance. Where optimal 
function was observed between Days 8-10 of 3-D culture in comparison to 
monolayer culture, there was an increase in expression of genes and proteins, 
which contributed not only to the enhanced cell performance observed, but to the 
protective function observed in normal differentiated cells in vivo as a result of the 
successful environment created in 3-D culture, either morphologically or due to
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increased metabolic activity or even as a combination of both.
The Adaptive Response- Day 8, 3-D culture vs, monolayer HepG2 culture- In 
Day 8 HepG2 cells in 3-D culture vs. monolayer HepG2 cells, an increase in 
HSP70 was observed. In monolayer HepG2 culture, during initial culture,
HSP70 binds to unfolded proteins to prevent their accumulation as the 
accumulation of unfolded preoteins could potentially be toxic. HSP70 also 
functions as a molecular chaperone to enhance survival of the cell by preventing 
the denaturation of other cellular proteins and is essential for the initial folding of 
newly synthesised proteins (Papp et a l 2003;Patel et a l 1995). The elevated 
expression of HSP70, demonstrates that at Day 8, 3-D HepG2 culture it is serving 
a normal protective function and as a result of an adaptation of the increased 
function of healthy cells at Day 8, due to the successful environment created in 
3-D culture (Bassi et al 2000;Hosoi et al 2002;Patel et a l 1995). Comparing 
Day 8 HepG2 cells in 3-D culture vs. monolayer HepG2 cells also showed an 
increase in MHC Class I antigen and catalase. MHC Class 1 Ag, as a cell surface 
marker, signals cytotoxic and helper T cells and is essential in eliminating 
infected cells (Basta and Bennink 2003). Therefore, demonstrating further that 
HepG2 cells in 3-D culture mimic the in vivo architecture of hepatocytes and the 
expression of this gene may simply reflect the “normal” morphology 
demonstrated by HepG2 cells in 3-D culture.
Hydrogen peroxide, one of the major reactive oxygen species is produced at a 
relatively high rate as a product of aerobic metabolism. The primary cellular 
enzymatic defence systems against hydrogen peroxide are the glutathione redox 
cycle and catalase. An increase in catalase, both at the mRNA level and 
functionally may reflect a greater need due to overall increased metabolic activity 
in 3-D culture at Day 8, and thus a requirement to produce more catalase (Bai et 
al 1999;Bai and Cederbaum 2000;Patel et a l 1995).
Two isoforms of haemoxygenase proteins are present. Haemoxygenases break 
heme into carbon monoxide and biliverdin; HO-1 is the inducible form whereas 
HO-2 is constitutively expressed, and catalyses the formation of end products that 
protect against cellular stress, oxidative stress and its consequences (Elbirt and
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Bonkovsky 1999;Ghattas et al 2002). The HO product biliverdin is converted 
into bilirubin, a potent anti-oxidant and free iron is sequested into ferritin (Bunn et 
al 1998;Westermarck et a l 2001).
HO-1, the inducible form which showed the strongest signal in the Day 8 3-D 
cultures, is induced by agents causing oxidative stress but can also function as a 
cytoprotective molecule against oxidative stress (Poss and Tonegawa 1997). Poss 
and Tonegawa (1997) demonstrated this function by generating HO-1 (-/-) mice 
by targeting deletion of the mouse HO-1 gene. The majority of these mice did not 
survive to adulthood and cells obtained from these mice were more vulnerable to 
oxidative stress induced by endotoxin. The Western blot shows no difference in 
signal of HO-2 between the different culture conditions and also served as a 
control to show there was equal loading of samples.
Gene Microarray studies also suggested that there were different stress 
mechanisms involved in the upregulation and the subsequent downregulation of 
function, some of which were protective and adaptive due to the increased 
metabolic function observed in Day 8, 3-D culture, and various stresses such as 
hypoxia and/or oxidative stress could be contributing to the downregulation of 
function. The Powerblot results confirmed early observations made by Western 
blot analysis of specific stress response proteins. For example, HO-1 expression 
was increased in the Day 8, 3-D culture vs. monolayer as shown in the Western 
blot and the fold change in expression was comparable to the Powerblot data. In 
the Day 15 vs. Day 8 cultures there was a similar decrease in HO-1, also shown in 
the Western blot carried out in the laboratory and from the Powerblot. MAPKp49 
also showed comparable results from the Western blots carried out in the 
laboratory and the Powerblot data, as did ST1 and JNKK1, giving us the 
confidence to accept the Powerblot data.
In addition to HO-1 being detected in the Powerblot data comparing Day 8 with 
monolayer cultures, other adaptive stress proteins were present, E-cadherin, 
fibronectin and annexin IV, plectin -144 which reflect the normal in vivo like 
morphology of these cells in 3-D culture (Clark et a l 2003;Margulis et al
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2003;Schlaepfer and Haigler 1990). In response to stress, HSF was released from 
HSP 70 and forms a trimer that binds with high affinity to heat shock gene 
promoters. Heat shock factors (HSF) transcriptionally activate the heat shock 
proteins (Nakai et a l 1997), and as it was shown that there was an increase of 
HSP70 mRNA; as expected one observed a decrease in HSF4 (Table 23). 
Cycloxygenase (COX) converts arachidonic acid to prostaglandin H that is further 
metabolised to prostanoids. COX-2, the inducible form is induced by 
proinflammatory stimuli (Vane et al 1994), as this protein was not detected in 
any of the culture samples, this suggested that inflammatory stress was not 
contributing to changing levels of function. In the Day 15 HepG2, 3-D cultures 
(diminished function) vs. Day 8, 3-D HepG2 cultures (optimal function) a 
decrease in HSP47 was observed. HSP47 is another member of the heat shock 
protein family, however, it is a collagen specific molecular chaperone and 
conditions that alter collagen levels also affect HSP47 levels, the only exception 
being prolonged heat shock stress, when HSP47 levels rise independently of 
collagen synthesis (Kawada et a l 1996;Thomson and Ananthanarayanan 2000). 
At Day 8, collagen, a component of the ECM is synthesised, and the group has 
shown previously that extracellular proteins are expressed and upregulated in 3-D 
HepG2 culture compared to monolayer HepG2 culture (Selden et a l 2000), 
reflecting the decreased levels of expression of this heat shock protein. This 
suggests that cells in 3-D culture compared to monolayer HepG2 cells, would be 
better protected from heat shock stress, should this stress be present, and the in 
vivo morphology demonstrated by the presence and upregulation of extracellular 
proteins, is as a result of the successful environment created in 3-D culture.
HepG2 cells are a good model for stress response studies, cDNA arrays have been 
used to monitor the expression of over 5,000 genes in response to toxic stress in 
the HepG2 liver cell line after treatment with cytotoxic doses of acetaminophen, 
caffeine or thioacetamide (Gore et al 2000), and Timbrells group showed that 
liver spheroids could provide a model for studying stress protein expression in 
particular, heat shock protein expression (Dilworth et a l 2000).
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The studies demonstrated that there is a complex relationship between activation 
of the stress response, and its effects to maintain differentiated function, and cell 
performance. However, in particular, attempts to alleviate hypoxic and oxidative 
stress were unsuccessful by manipulating the 3-D culture system to improve cell 
performance by increasing oxygen concentration and increasing the concentration 
of anti-oxidants.
In the next chapter, the cell cycle is investigated in the 3-D culture system, and its 
manipulation using a biological differentiating agent, ECM to increase cell 
numbers at times of peak function and/or improve cell performance at later times 
of 3-D culture.
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Chapter 5
Investigating the role of the cell cycle in 3-D
HepG2 culture
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Chapter 5- Investigating the role of the cell cycle in 3-D HepG2 culture
5.1 Introduction
As mentioned previously, function could be improved in the 3-D cultures in either 
of two ways. Firstly, increasing the specific activity per cell i.e. at Days 11-15 
when cell numbers are greater per bead, in order to use a smaller number of beads 
to replace function in the BAL, or secondly one could increase cell number at a 
time point when the cells are working optimally.
In this chapter, a previous observation made in the laboratory was investigated 
further. Previous data indicated that the addition of human placental ECM to 3-D 
HepG2 culture resulted in an increase in cell number and function per cell, 
particularly at later time points of 3-D culture i.e. at Day 11 when function per 
cell in conventional 3-D HepG2 culture starts to diminish. It is well known that 
ECM can help maintain differentiated function (cell organisation, migration and 
intracellular signalling pathways) through surface integrins which bind specific 
integrin ligands such as the arginine-glycine-aspartic acid (RGD) tripeptide found 
in ECM proteins (Hansen et al 1994).
The aims of experiments presented in this chapter were to increase performance 
by culture with extracellular matrices of various origins and to assess proliferation 
immunohistochemically. Both DNA synthesis, analysed by 5-bromo- 
deoxyuridine (BrdU) incorporation and the number of cells in the growth fraction 
analysed by Ki-67 immunostaining are presented.
In addition, proliferation was investigated using Powerblot analysis of proteins, to 
demonstrate cell cycle related proteins. The Powerblot data demonstrated 
changes in expression of proteins associated with cell cycle regulation. HepG2 
cells in 3-D culture initially demonstrate a slow rate of proliferation (lag) until 
Day 8 and then cell number doubles every 3-4 days (linear to 15 days) and this is 
reflected in the Powerblot data. The Powerblot data shows common groups of 
proteins expressed in HepG2 cultures, and many proteins that were expressed, 
were associated with the cell cycle.
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5.2 AIM- Using Ki-67 and/or BrdU staining to show evidence of increased 
cell number and cell proliferation, with addition of ECM
5.2.1 Background
It has been previously shown that the addition of human placental ECM enhanced 
cell performance by increasing protein synthesis and cell number, when function 
starts to diminish. The increase in cell number was demonstrated by total nuclei 
staining with crystal violet, which quantifies viable cells and non-viable cells, in 
all parts of the cell cycle. However, cell proliferation can also be measured by 
assessing DNA synthesis in situ using BrdU incorporation and measuring the 
growth fraction with Ki-67 labelling.
During cell proliferation, DNA replication occurs before the cell is divided into 
two daughter cells. This close association between DNA synthesis and cell 
doubling makes the measurement of DNA synthesis very attractive for assessing 
cell proliferation, although in primary hepatocyte culture DNA synthesis can 
occur without subsequent mitosis (Cortes et a l 2003; Wright et a l 1999).
BrdU is a thymidine analogue which can be used for the study of DNA synthesis 
(cells in S phase) where it is incorporated into newly synthesised DNA strands of 
actively proliferating cells (Wright et al 1999). Cells will incorporate BrdU and 
can be subsequently detected by immunohistochemistry (light microscopy) for the 
BrdU antigen in 3-D spheroids. The advantage of using this method, over 
methods which employ the use of [3H]-TdR, is that it avoids radioactive isotope 
handling and storage problems. Immunohistochemical staining for BrdU also 
allows quantitative detection of S-phase cells, and counterstaining of the tissue 
simultaneously to reveal tissue morphology and position and pattern of BrdU 
incorporation. However one disadvantage of this technique is that BrdU must be 
administered before detection, so retrospective investigations of archival material 
cannot be performed (Gerlach et a l 1997).
The Ki-67 antigen reacts exclusively with nuclei of proliferating cells in human 
tissues. Detailed cell cycle analysis has demonstrated that this protein is 
expressed during all active parts of the cell division cycle (Gl, S, G2 and M), but 
it is absent in resting cells (GO) (Gerdes et a l 1984). Therefore by using the
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monoclonal antibody Ki-67, there is an additional advantage of being able to 
detect all proliferating cells in the cell cycle and not only those in the S phase. 
After initial analysis of DNA synthesis and the growth fraction in the established 
3-D system, the effect of ECM on these parameters will be investigated.
5.3 Methods for measuring cell proliferation in 3-D HepG2 culture
5.3.1 Powerblot analysis (Chapter 2, Section 2.6)
5.3.2 Total cell count as described in section 2.1.4
5.3.3 BrdU incorporation
5.3.3.1 Materials
1 % low gelling temperature agarose in 0.15M NaCl pH 7.4 
xylene (3 baths)
- Acid Alcohol 
100% ethanol 
70% ethanol
Gills Haemotoxylin, (Sigma)
Eosin
- IX PBS
0.1% trypsin in 0.1 % CaCb in 0.05M Tris/HCl and
0.15MNaCl pH 7.8
0.3% hydrogen peroxide in IX PBS
DAKO Pen for immunohistochemistry (Dako Cat No. S2002)
- Rabbit Serum (Sigma Aldrich, Cat No. M0744)
- Mouse anti rat BrdU (Dako Cat No. M0744)
- Biotinylated rabbit anti mouse (Dako Cat No. E0464)
Strept ABC complex/HRP (Dako Cat No. K0492)
Sigma Fast 3,3’-Diaminobenzidine Tablet Sets (DAB Peroxidase 
Substrate) Cat no. D4293 
DPX for mounting slides.
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5.3.3.2 Methods
5,33,2,1 Sample preparation
3-D HepG2 cultures were set up as previously described in section 2.1.3.5. Beads 
were seeded into 6 well plates containing 0.25mls of beads per well in 8mls of a- 
MEM complete medium with HG. One plate was set up for each time point, 
Day 8 and Day 15 of 3-D culture and for each concentration of BrdU and the two 
different types of medium (see below for further details). A negative control plate 
was set up in the absence of BrdU.
The medium was replenished every 48 hours as described earlier. Initially, three 
different concentrations of BrdU was added to the medium, 40pM (Sugiyama et 
al 2002), lOOpM and 200pM and fresh BrdU in these concentrations was added 
to these 6 well plates in 5mls of medium every 12 hours, for 60 hours prior to the 
harvesting time point. HepG2 cells in 3-D culture double their cell number every 
3-4 days, so by ensuring that the BrdU was added 2 Vi days before harvesting, it 
should be incorporated during DNA synthesis. The cultures were maintained in 
normal a-MEM complete medium with HG until 60 hours before the harvesting 
time point, when BrdU was added to a-MEM complete medium with HG without 
ribonucleosides and deoxyribonucleosides, to assess whether ribonucleosides and 
deoxyribonucleosides in the medium would interfere with the sensitivity of the 
assay. At the highest concentration of BrdU, a parallel plate was set up in which 
BrdU was added at the same time intervals in normal a-MEM complete medium 
withHG.
Beads placed in strainers in each well of a 6 well plate were washed twice with 
IX PBS and afterwards placed in a fresh 6 well plate and immersed in 10% 
buffered formalin for 1-2 minutes to fix the cells immediately. The beads in the 
cell strainers of 6 wells of each plate were pooled together and the pooled cell 
strainer now containing 1.5mls of beads was transferred to a fresh well. 5mls of 
1% low gelling temperature agarose in 0.15M NaCl pH 7.4 was added to this 
well. The agarose was left for 40 minutes to set. The cell strainer was lifted out 
of the well with a spatula and the block placed upside down with the surface 
holding the beads facing upwards. This was placed in a fresh well and another 
5mls of agarose was added to sandwich the beads in a solid block. After 40
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minutes leaving it to set at room temperature, 5mls of formalin was added as a 
fixative. After overnight processing, the blocks were embedded in paraffin and 
6pm sections were cut and placed on 3-aminopropyltriethoxysilane (APES) 
coated slides for immunohistochemical staining for the BrdU antigen in spheroids 
from Day 8 and Day 15.
53.3.2.2 BrdU staining in rat liver sections and 3-D HepG2 spheroids by mouse 
anti BrdU-Streptavidin /Biotin Complex (ABC) immunoperoxidase detection 
As a positive control for the staining, one rat received, a BrdU injection at a 
concentration of 50mg/kg in 1ml every 6 hours from 15 -72 hours after partial 
hepatectomy and sacrificed 96 hours later to show active regeneration of the liver 
by proliferating hepatocytes. This work was carried out under the approval of 
Home Office Project License No. PPL 70/5115, “Use of growth factors to 
enhance liver function” which was approved on 24 May 2000.
5 3 3 3  Method
5 3 3 3 .1  Dewaxing ofparaffin embeddedf formalin fixed  tissues
Xylene (3 baths)
Acid Alcohol 
100% ethanol 
70% ethanol.
APES slides with embedded spheroids and liver tissue were dewaxed in 3 baths 
for xylene for 3 minutes each, and rehydrated in 1 minute of 100% ethanol, 1 
minute 70% ethanol and 1 minute in running water. The slides were kept in 
distilled water.
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5.33.3.2 Antigen demasking and immunostaining
After dewaxing, the sections were covered with warm 0.1% trypsin in 0.05M 
Tris/HCl, 0.15M NaCl pH 7.8 for proteolytic digestion of tissue and to demask 
antigens and allow epitope retrieval, for 30 minutes in a 37°C humid incubator. 
The reaction was stopped by rinsing sections with distilled water. The sections 
were placed in a trough and immersed in a 0.3% hydrogen peroxide in PBS for 20 
minutes on a rotating platform to block endogenous peroxidase. The sections 
were washed three times with distilled water. Normal rabbit serum was diluted 
1:20 in PBS to block non-specific binding sites.
With a paper tissue the sections were carefully dried and a wax pen used to mark 
around the sections to maximise antibody contact with the sample. It was 
important that the sections were not allowed to dry out thereafter.
The sections were incubated for 10 minutes at room temperature in a closed 
humid incubator with normal rabbit serum diluted 1:20 with PBS (approximately 
200-250pl for each section). During this incubation period, the 1° antibody 
solution was prepared, mouse anti rat BrdU: at a dilution of 1:100 in PBS.
The serum was gently tapped off, without rinsing and immediately incubated with 
the 1° antibody for 2 hours at room temperature in a closed humid container. For 
the negative controls only PBS was added to the sections.
After incubation, the sections were washed well in 3 x 5 minute changes of IX 
PBS in a trough on the shaking platform. The 2° antibody was prepared, 
biotinylated rabbit anti-mouse immunoglobulins at the optimal dilution 1:200 in 
IX PBS. The sections were incubated with the 2° antibody for 90 minutes in a 
humid closed incubator at room temperature. The ABC was made up freshly less 
than 30 minutes before use, lOpl A + 1  O j l l I  B (peroxidase) for every 1ml PBS.
The sections were washed well with 3 x 5  minute changes of PBS in a trough on 
the shaking platform and incubated for 1 hour with ABC at room temperature in a 
humid closed incubator, the sections were washed with 3 x 5  minute changes of 
PBS in a trough on the shaking platform. Before the third wash, the substrate was 
made up, consisting of two tablets, one consisting of the DAB peroxidase 
substrate and a tablet made up of urea hydrogen peroxide in Tris buffer in 5ml of
194
(IH2O deionised water. The sections were developed in this substrate with 250pl 
for each section for 20 minutes or for as long as there was a real colour change. 
The reaction was stopped by rinsing with distilled water. The sections were 
counterstained for 30 seconds with haemotoxylin, and then rinsed in running 
water for 1 minute. The sections were dehydrated for 1 minute with 70% ethanol, 
1 minute with 100% ethanol and 3 baths of xylene for 3 minutes. The sections 
were mounted with dpx and left for at least 2 hours, before viewing under the 
microscope.
5.3.4 Ki-67 labelling
53.4.1 Materials
As for section 533.1  and;
IX TBS
0.5% hydrogen peroxide in methanol 
0.01M citrate buffer
NCL-L-Ki-67-MMl (Novacastra Labs, UK).
53.4.2 Method
5.3.4.2.1 Dewaxing o f paraffin embedded, formalin fixed  tissues 
As described for BrdU labelling
53.4.2.2 Antigen demasking and immunostaining
After dewaxing, the sections were placed in a trough and immersed in a 0.5% 
solution of hydrogen peroxide in methanol for 10 minutes in a rotating platform to 
block endogenous peroxidase. The slides were loaded onto a metal rack and 
placed in 1500ml of 0.01M citrate buffer pH 6.0 which was heated to boiling 
point in a pressure cooker for 1 minute to demask the antigens and for epitope 
retrieval. The sections were removed from the heat as quickly as possible and 
placed in a cold water bath to stop the reaction. The sections were washed once in 
IX TBS for 5 minutes at room temperature. Normal rabbit serum was diluted 
1:20 in IX TBS to block non-specific binding sites.
The sections were incubated for 10 minutes at room temperature in a closed 
humid incubator with normal rabbit serum diluted 1:20 with PBS (approximately
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200-250(j.l for each section). During this incubation period, the 1° antibody 
solution was prepared, (NCL-L-Ki-67-MMl) at the optimal dilution, 1:100 in IX 
TBS.
The serum was gently tapped off, without rinsing and immediately incubated with 
the 1° antibody for 1 hour at room temperature in a closed humid container. For 
the negative controls only TBS was added to the sections.
The sections were washed well in 2 x 5 minute washes of TBS. The sections were 
then incubated with the 2° antibody, biotinylated rabbit anti mouse 
immunoglobulins at the optimal dilution 1:100 in IX TBS for 1 hour at room 
temperature. The ABC reagent was made as described for BrdU labelling and the 
following procedures were carried out as for BrdU labelling.
5.4 Methods for manipulating HepG2 culture, to enhance cell performance
To demonstrate the ability of ECM to enhance cell performance in 3-D HepG2 
culture, ECM was added initially to monolayer HepG2 culture and cell 
performance was assessed with respect to liver specific protein secretion and cell 
proliferation.
5.4.1 Effect on proliferation and function from monolayer HepG2 cultured 
on EHS matrigel ECM
Ideally, ECM from a human source should be used in the cell culture system to 
prevent bioincompatibility from cells as the biological component of a BAL. 
However, human ECM is very difficult to obtain, so many optimisation 
experiments were carried out on EHS gel prepared from sarcoma produced in 
mice. It contains laminin as a major component, collagen type IV, heparan 
sulphate proteoglycan and entactin.
5.4.1.1 Materials
ECM Gel (From EHS mouse sarcoma) Sigma, UK 
Dispase (protease), Roche, UK.
196
5.4.1.2 Methods
HepG2 cells were seeded as monolayers in 24 well plates either on plastic or on a 
layer of ECM gel and grown to confluency. 24 hour conditioned medium was 
collected from both plates and 1.5 units/ml of dispase was added to the cells 
remaining in the well to disassociate the cells from the gel. To the cells cultured 
on plastic, the cells were gently scraped out of the wells. The cells were 
centrifuged at 120g for 4 minutes at room temperature (Eppendorf 5402, 
Germany) and the pellet washed twice with IX PBS. The pellet was resuspended 
in 200pl of crystal violet. A cell count was obtained and ELISAs were performed 
on the conditioned medium for levels of secreted proteins.
5.4.2 Effect on proliferation and function in 3-D HepG2 cells cultured with 
human placental ECM
An increase in cell proliferation of cells in monolayer on ECM was shown, so it 
was hypothesised that there would be an increase in cell proliferation with the 
addition of human ECM in 3-D culture, and that due to the cell-cell matrix 
interactions already present and the ECM proteins and integrins expressed, 
addition of exogenous ECM should enhance cell function further, particularly at 
Day 11 of 3-D culture.
5.4.2.1 Materials
- Human placental ECM (Becton Dickinson)
- 200pm BrdU.
Human placental ECM is comprised of laminin, collagen IV and heparan sulphate 
proteoglycan.
5.4.2.2 Methods
Two sets of 3-D HepG2 cultures were prepared as previously described. 
However, to one set 88ug/ml of ECM was added to the alginate/cell/medium 
suspension so that the exogenous ECM was present in alginate beads in which 
cells aggregated and formed spheroids. The beads were maintained in 6 well
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plates and medium was changed as previously described. As function per cell in 
the 3-D culture starts to diminish from Day 11, this time point was specifically 
looked at. In order to obtain a growth fraction from Ki-67 labelling and to 
measure cells in the S phase of the cell cycle, 200um BrdU was added every 12 
hours, 60 hours prior to harvesting. BrdU has a short half life and was therefore 
added every 12 hours. 2 wells with beads in each 6 well plate were fixed in 
agarose and processed for histology and immunohistochemistry for both antigens.
5.4.3 Addition of ECM to alginate/cell suspension mix and culture medium to 
increase cell proliferation and function per cell in 3-D HepG2 culture
In the event that adding ECM to the beads alone may not have provided a 
sufficient stimulus, ECM was also added to the culture medium, as well as in the 
bead preparation. ECM was added at 2 different concentrations albeit at slightly 
lower concentrations than when ECM was added only to the beads.
5.4.3.1 Materials
- ECM Gel (From EHS mouse sarcoma)
(Sigma, UK).
5.4.3.2 Methods
Three sets of 3-D HepG2 cultures were prepared as previously described. In 
addition to the conventional 3-D culture preparation, 30ug/ml and 60ug/ml of 
ECM was added to the culture mix and the culture medium. The medium was 
changed every 2 days with fresh ECM and the cells were harvested at two time 
points; Day 10 when peak function is still maintained and Day 11 when function 
per cell starts to diminish.
Expression of a number of cell cycle related proteins was demonstrated by the 
Powerblot analysis. These are summarised in Tables 25 and 26.
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5.5 Results
5.5.1 Evidence from  Powerblot analysis to show regulation o f the cell cycle in 
control o f cell proliferation in HepG2 culture
Table 25 Most significant results when comparing Day 8 vs. monolayer, 
showing proteins associated with the cell cycle.
Cell Cycle 
Proteins
Product
No.
Level Change Function
KAP-27 K32120 4 INCREASE
3.55
Cdk associated phosphatase­
cell cycle regulation
NBS1 N 10720 4 INCREASE
2.67
Nijmejin breakage syndrome- 
complex with Rad 50 and 
MRE11, important for both 
DNA damage and repair, and 
telomere length maintenance
Bub3 cl.31 B11520 5 DECREASE
3.46
Sensing kinetochore 
attachment to microtubules 
during prometaphase to 
metaphase transition
GCAP-1 G54220 4 DECREASE
6.74
Guanylate cyclase binding 
protein, cell cycle progression
NEK2-46 N52120 4 DECREASE
2.71
Nima related kinase-conditions 
-Controls entry of cells into S 
phase and mitosis
IAK1-46 171320 4 DECREASE
2.68
Mammalian chromosome 
segregation
Cyclin B C23420 4 DECREASE
2.26
Regulate the protein kinases of 
the cell cycle, by binding to 
cell cycle kinases
After comparing the Day 8 3-D HepG2 cell culture versus monolayer HepG2 cell
culture, it was found as expected that the majority of the cell cycle proteins 
showed a decrease in expression and this was demonstated further in Day 15, 3-D 
cultures compared to Day 8, 3-D cultures. This was expected as the doubling 
time of HepG2 cells in monolayer decreased from 24 hours to 3-4 days when 
proliferating in 3-D culture. Control of cell proliferation is important in all 
multicellular organisms, as a number of pathological processes, such as cancer are 
characterised by failure of the normal regulation of cell turnover (Macallan et al
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1998).
5.5.2 Table 26 Day 15 vs Day 8 ,3-D cultures
Cell cycle 
proteins
Product
No. Level
Fold change Function
PLK-1 P47920 5 INCREASE
3.12
Poliolike kinase-DNA synthesis, 
increases in primary tumours, 
important for chromosome 
segregation
Rb2 R27020 4 INCREASE
2.29
Regulates transcription to control 
cell growth
BM28-117 B58720 5 DECREASE
2.25
Phosphorylated -important for 
entry into S phase and cell division
Cdkl/
Cdc2
C12720 5 DECREASE
4.43
Cyclin dependent protein kinase- 
Catalytic subunit of the MPF (bi­
phase promoting factor) and cyclin 
B acts as a regulatory component, 
binding of these two subunits - 
drives cells into mitosis.
GCAP-1 G54220 5 DECREASE
7.23
Guanylate cyclase binding-imp.for 
cell cycle progression
Eg 5 E83920 5 DECREASE
5.48
Mitotic motor protein-regulates 
spindle formation by 
phosphorylation
hsMAD2 H57520 5 DECREASE
3.92
Mitotic Arrest Deficient protein - 
important for spindle assembly.
MCM6 M13120 5 DECREASE
5.52
Minichromosome Maintenance 
Protein-Initiates DNA replication
Cyclin A C88020 4 DECREASE
4.99
Required during S phase through 
G2 -binds Cdc2 (CdklO).
DNA
Polymerase 
epsiln cat.
D86520 4 DECREASE
2.24
DNA replication and repair. With 
PCNA promotes primer 
recognition.
HRAD9 R90820 4 DECREASE
2.31
Checkpoint control protein, 
regulates cell cycle progression 
through DNA damage.
MSH6 G70220 4 DECREASE
1.68
DNA Mismatch Repair
Tau- 48.9 T57120 4 DECREASE
3.03
Microtubule associated protein
IAK-1 171320 4 DECREASE
3.5
Mammalian chromosome 
segregation.
After comparing Day 15, 3-D cultures with Day 8, 3-D cultures, it was
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demonstrated further that the majority of the cell cycle proteins showed a decrease 
in expression. The results presented in Table 26 demonstrate further the 
beneficial effect of 3-D culture with respect to cell performance, as not only is the 
cell proliferation rate more controlled, but HepG2 cells in 3-D culture retain the 
ability to proliferate longer, confirming Khalil’s results (2000) had shown up to 
22 days in culture, compared to up to 7-8 days in monolayer culture depending on 
the initial seeding density of HepG2 cells.
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5.5.3 BrdU staining in rat liver and 3-D HepG2 spheroids
Initial experiments performed established typical staining patterns in HepG2 
spheroids as shown in Fig.44.
Spheroids
3
1- Top spheroid: Majority unstained with occasional positively stained 
nuclei
2- Majority positively stained (~> 90%) with occasional unstained nuclei
3- Staining around periphery and throughout the spheroid
4- Bottom spheroid: Staining around periphery
Fig. 44 Different patterns of staining displayed in spheroids in 3-D culture
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Rat liver was used as a positive control for the immunohistochemistry and 
staining, demonstrated in Fig.45.
Rat liver
rat liver x40 mag rat liver x40 negative control
Fig. 45 BrdU staining in rat liver sections to serve as a positive control for
staining
Several concentrations of BrdU were used to establish the optimal conditions of 
assessing DNA synthesis. The results are illustrated in Fig, 46, 47, 48, 49.
Spheroids
40 pM BrdU x4 mag
<-------------- 40pM BrdU x40 ----------------- ►
Fig. 46 BrdU staining in 3-D spheroids with 40pM BrdU.
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lOOpM BrdU x4 mag <------  lOOpM BrdU x40 mag  ►
r'v 'y *  • ’
1 OOpM BrdU x40 mag 1 OOpM BrdU x40 negative control
Fig. 47 BrdU staining in 3-D spheroids with lOOpM BrdU.
■ Svv ’ •
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200pM BrdU x4 <—  200pM BrdU x40 mag
A*
;<vv
200pM BrdU x40
200pM BrdU x40 mag 
negative control
Fig. 48 BrdU staining in 3-D spheroids with 200pM BrdU.
200pM BrdU in normal m  200jiM BrdU in normal medium x40 mag ►
medium x4 mag
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200pM BrdU in normal medium x40 
negative control
Fig. 49 BrdU staining in 3-D spheroids with 200pM BrdU in 
a  MEM medium.
5.5.4 Analysis o f results from immunohistochemical staining
The pattern and intensity of staining appeared to be similar with the 3 different 
concentrations of BrdU and in the 200pM concentration of BrdU in which 3-D 
cultures were maintained in normal a-MEM complete medium with HG and 3-D 
cultures maintained a-MEM complete medium with HG without ribonucleosides 
and deoxyribonucleosides. Four different patterns of staining was observed, as 
shown with BrdU incorporation in spheroids, and this was expressed as a total 
percentage of all the cell positively stained in spheroids, and separately expressed, 
observing the two main patterns of BrdU staining observed; around the periphery 
and throughout the spheroid. The same was evident with Ki-67 labelling. It was 
also observed that similar levels of positive incorporation were observed in small 
and large spheroids as shown in Fig. 50 and Fig. 54, suggesting that incorporation 
of BrdU or labelling of Ki-67 is not determined by spheroid size.
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The results showed that 3-D cultures maintained in a-MEM complete medium 
with HG without ribonucleosides and deoxyribonucleosides did not interfere with 
the uptake of BrdU and affect the sensitivity of the assay. There was also no 
significant difference when comparing the uptake of 40pm BrdU with 200pm 
BrdU (Fig. 51). It was therefore decided to use 200pm BrdU in subsequent 
studies.
5.5.5 Quantitation o f BrdU staining in spheroids
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Fig. 50 Comparison of spheroid size with percent of BrdU incorporation in 
spheroids with positive staining around the periphery and throughout the spheroid.
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*5 80
1 1 11
Day 8- Day 8- Day 8-
40um 200um 200um
depleted normal depleted
medium medium medium
Day 15- 
40um 
depleted 
medium
Day 15- 
200um 
normal 
medium
Day 15- 
200um 
depleted 
medium
Sections
Fig. 51 Comparison of BrdU doses in normal and depleted HG medium.
5.5.6 Ki-6 7 labelling in rat liver sections and 3-D spheroids
Rat liver was used as a positive control for the immunohistochemistry and
staining demonstrated in Fig.52.
Rat liver
rat liver x40 mag rat liver x40 negative control
Fig. 52 Ki-67 labelling in rat liver sections to serve as a positive control for
staining.
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Fig. 53 Ki-67 labelling in day 8 and day 15 spheroids
5.5.7 Quantitation o f BrdU and Ki-67 staining in spheroids 
The result in Fig.53 showed similar percentages of positive staining of BrdU 
incorporation compared with Ki-67 staining. However, the main patterns of 
staining observed were similar to the patterns of staining from no. 3 & 4, section 
5.5.3 demonstrating actively proliferating cells throughout the spheroids and not 
only the periphery. These patterns of staining were quantitated in BrdU 
incorporation and Ki-67 labelling in Day 8 and Day 15 spheroids.
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Fig. 54 Comparison of spheroid size with percentage of Ki-67 labelling in 
spheroids with positive staining around the periphery and throughout the spheroid.
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35 40
JS 30
Day 8- BrdU Day 8- K i-67 Day 15- BrdU Day 15- K i-67 
Sections
Fig. 55 Comparison of BrdU incorporation and Ki-67 labelling in Day 8 and Day 
15 spheroids from positively stained cells, in total of all spheroids demonstrating 
all patterns of staining observed. Mean values ± S.D. n=4 for each time point.
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Fig. 56 BrdU and Ki-67 staining in Day 8 and Day 15 spheroids showing 
incorporation of positively stained cells throughout the spheroids. Mean values ± 
S.D. n=4 for each time point. Statistics (*) represent comparisons between Ki-67 
staining with BrdU incorporation at each time point. p<0.005 = **
The results demonstrated a higher percentage of incorporation from Ki-67 
labelling as Ki-67 measures a broader spectrum of cell cycle stages than BrdU 
incorporation. The Ki-67 results also show that approximately half the cells are 
undergoing active proliferation in Day 8 and Day 15 spheroids and demonstrated 
further that the cells double at a rate of every 3-4 days.
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5.5.8 Cell performance in monolayer HepG2 culture with additional EHS gel 
ECM
HepG2 cells as a monolayer were seeded on ECM and cell performance was 
assessed with respect to cell number and liver specific protein secretion. The 
results showed that there was an approximately 16% (statistically significant, 
p<0.005) increase in cell proliferation when cells were cultured on ECM gel 
compared to culture on plastic. However, in terms of synthetic function, protein 
secretion per cell did not increase.
I HI Day 0
day 0 on plastic on ECM
Culture
Fig. 57 Cell proliferation of monolayer HepG2 cells seeded on or without ECM. 
Mean values ± S.D. n=4 for each time point. Statistics (*) represent comparisons 
between cultures with ECM and control cultures. p<0.005 = **
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Fig. 58 Albumin secretion in monolayer HepG2 cells seeded on ECM and plastic. 
Mean values ± S.D n=4 for each time point.
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Fig. 59 Fibrinogen secretion in monolayer HepG2 cells seeded on ECM and 
plastic. Mean values ± S.D n=4 for each time point.
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As increase in cell number of HepG2 cells in monolayer was demonstrated with 
EHS gel ECM. This source of ECM was used, as the difficulties of obtaining 
human ECM have been previously described, and therefore was used to optimise 
some experiments, in this case with HepG2 cells in monolayer. Many of the 
components that comprise EHS gel ECM are common to human placental ECM, 
so it was feasible to assume that the addition of ECM would have a beneficial 
effect in 3-D culture. However, as biocompatibility is a concern, for eventual use 
in a BAL and to demonstrate improved cell performance in 3-D culture, the 
following experiment was carried out with human placental ECM.
Human placental ECM contains laminin as a major component, collagen type IV, 
heparan sulphate proteoglycan and entactin.
5.5.9 Cell performance in 3-D HepG2 at D ayll with human placental ECM
An increase in cell number of 3-D HepG2 cells at Day 11 of 3-D culture, when 
human placental ECM was added, was observed. The data shows that there was a 
significant, (p<0.005), 17.68% increase in cell number by total cell nuclei count 
with crystal violet. However, protein secretion per cell did not increase.
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Day 0 control with ECM
3-D culture
Fig. 60 Cell proliferation of 3-D HepG2 cells cultured with or without ECM. 
Mean values ± S.D. n=4 for each time point. Statistics (*) represent comparisons 
between cultures with ECM and control cultures. p<0.005 = **
40*i
ES2 3-D HepG2 with ECM 
ESM Control 3-D HepG2s
albumin fibrinogen
Day 11
Fig. 61 Protein secretion in 3-D HepG2 cells cultured with or without ECM. 
Mean values ± S.D. n=4 for each time point
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As described previously, the main patterns of staining observed were similar to 
the patterns of staining from no. 3 & 4, section 5.7.3 demonstrating actively 
proliferating cells throughout the spheroids and not only the periphery and this 
was also quantitated in 3-D cultures with additional ECM.
Day 11-control BrdU Day 11 with ECM BrdU Day 11-control Ki-67 Day 11-with ECM Ki-67 
staining staining labelling labelling
Sections
Fig. 62 Comparison of BrdU incorporation and Ki-67 labelling in Day 8 and Day 
15 spheroids with additional human placental ECM from positively stained cells 
in total of all spheroids demonstrating all patterns of staining observed. Mean 
values ± S.D. n=4 for each time point.
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Fig. 63 BrdU incorporation and Ki-67 staining in Day 11 spheroids with or 
without the addition of ECM, showing incorporation of positively stained cells 
throughout the spheroids. Mean values ± S.D. n=4 for each time point.
The data shows that there was a significant, (p<0.005), 17.68% increase in cell 
number by total cell nuclei count with crystal violet. This was similar to the 
12.1% increase observed in Ki-67 expression with the addition of ECM. The 
pattern and intensity of staining was similar to that obtained from conventional 
3-D culture as previously shown in this chapter.
As mentioned, ideally, ECM from a human source should be used in the cell 
culture system to prevent bioincompatibility from cells as the biological 
component of a BAL. However, human ECM is very difficult to obtain, so the 
following optimisation experiment was carried out with EHS gel ECM, which as 
for human placental ECM was added to the alginate/cell suspension mix at Day 0 
of 3-D HepG2 culture, and additionally to the culture medium.
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5.5.10 Cell performance in 3-D HepG2 culture with additional EHS gel ECM 
to alginate/cell suspension mix and culture medium.
The data shows that there was a significant, (p<0.005), -20% increase in cell 
number by total cell nuclei count with crystal violet. However, protein secretion 
per cell did not increase.
o3
control 
—■ with 30ug / ml ECM 
with 60ug / ml ECM
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i
Fig. 64 Cell proliferation in 3-D cultures with EHS gel ECM in alginate 
suspension and culture medium. Mean values ± S.D. n=4 for each time point. 
Statistics (*) represent comparisons between cultures with ECM and control 
cultures. p<0.005 = **
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Fig. 65 Albumin secretion 3-D cultures with EHS gel ECM in alginate 
suspension and culture medium. Mean values ± S.D. n=4 for each time point
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Fig. 66 Fibrinogen secretion 3-D cultures with EHS gel ECM in alginate 
suspension and culture medium. Mean values ± S.D. n=4 for each time point.
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5.6 Discussion
This chapter has explored the role of the cell cycle in HepG2 cells in 3-D culture 
alone, and the ability of exogenous ECM added to 3-D culture, to affect both 
proliferation and performance of this culture system. Cell performance in 
monolayer and 3-D HepG2 culture was assessed by protein synthesis as a measure 
of liver specific function and cell number. As discussed, function can be 
improved by increasing function per cell at later times of 3-D culture when cell 
numbers are greater, and/or increase cell number at times of peak function i.e. at 
Days 8-10.
Khalil (2000) showed that the addition of many differentiating agents to 3-D 
culture preparations and medium, such as DMSO, sodium butyrate, and retinoic 
acid, at optimal concentrations of each of the agents, did not maintain function 
after Day 11, even though cell growth was inhibited dramatically in some cases 
e.g. 2 % DMSO and 2 mM sodium butyrate. A decline in biosynthetic function 
was still evident with extended culture.
In addition to chemical differentiating agents, mechanical systems have been 
developed which can increase cell proliferation and improve function. The rotary 
cell culture system (RCCS) (Khaoustov et al. 2001), can culture cells in a 3-D 
spheroidal form, but unlike the static 3-D culture system, it provides an 
environment in which the cells are cultured in a unique microgravity environment 
of low shear force and high-mass transfer, allowing better membrane oxygenation 
and nutrient availability. Work utilising this culture system is currently in 
progress in the group. In order to investigate cell performance further, the role of 
the cell cycle in 3-D culture and compared to monolayer HepG2 culture was 
assessed using a protein array analysis of cell cycle proteins expressed, when 
performance is enhanced and diminished. Cells were also quantified in the 
growth fraction and specifically in DNA synthesis. Finally it was attempted to 
manipulate cell performance by the addition of ECM.
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Powerblot analysis of cell cycle proteins
The major group of proteins represented were cell cycle proteins. After 
comparing the Day 8 cultures in 3-D versus monolayer HepG2 cultures, and then 
comparing further Day 15, 3-D cultures compared to Day 15, 3-D cultures, as 
expected it was found that the majority of the cell cycle proteins showed a 
decrease in expression. This was expected as the doubling time of HepG2 cells in 
monolayer decreased from 24 hours to 3-4 days when proliferating in 3-D culture. 
Cyclin B, when newly synthesised, produces active Maturation Promoting Factor 
required for mitosis; the decrease in cyclin observed in Day 8 3-D culture 
compared to monolayer HepG2 culture, supports the faster doubling time 
observed in monolayer HepG2 culture. The increase observed for KAP-27, a 
CDK associated phosphatase also supports the decrease in cell proliferation rate 
demonstrated in 3-D culture compared to monolayer culture. KAP binds to cdc2 
and CDK2 in mammalian cells, indicating its role in cell cycle control (Hannon et 
al 1994). CDK2 cyclin dependent kinases are delayed response proteins and are 
present at a constant level in exponentially growing cells but disappear when cells 
enter G0. CDK2 participates in control of the Gi and S phase (Bartek and Lukas 
2001). Cyclins are key molecules in cell cycle control because of their specific 
and periodic expression during cell cycle progression.
In Day 15 vs. Day 8 cultures, there was an increase in Rb (Retinoblastoma 
protein). HepG2 cells contain normal Rb, which is a tumour suppressor, and 
plays a central role in the control of cell cycle progression, by acting as a brake on 
cell cycle progression to regulate transcription and control cell growth (Radulescu 
et a l 2000;Zauberman et a l 1997). The D-type cyclins (cyclins Dl, D2 and D3) 
complex with cdk4 and cdk6 to regulate transition from the Gl phase into the S 
phase by phosphorylation and inactivation of Rb (Suzui et a l 2002). Therefore, 
the increase in Rb protein could be supported from the finding that cyclin D 
proteins or cdk4 and cdk6 were not upregulated in the culture conditions.
All other proteins associated with cell cycle progression showed a decrease in 
expression in both comparative conditions, demonstrating that HepG2 cell 
proliferation is more controlled in 3-D culture than in monolayer culture.
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Assessing cell proliferation in 3-D HepG2 cultures and with additional ECM
Conventional nuclei counts give an indication of total cell number but by 
incorporating measurement of BrdU and Ki-67 staining, an indication of the 
localisation and pattern of proliferation in spheroidal culture was obtained. 
Similar percentage increases of cell number were seen with all manipulations of 
ECM. BrdU and Ki-67 showed positively labelled cells throughout the spheroid 
indicating that even at the centre of the spheroids; there was maintenance not only 
of viability but also the capacity to proliferate. This demonstrates a population of 
actively proliferating cells throughout the spheroid and suggests that the 
diminished function observed in later times of 3-D culture was not as a result of 
non-viable cells within the centre of spheroids, and not due to a lack of nutrients 
or oxygenation, particularly in the centre of larger spheroids at later times of 
culture, which could have lead to loss of function. In fact similar levels of 
positive incorporation were observed in small and large spheroids as shown in 
Fig.50 and Fig.54. The pattern of staining revealed by BrdU and Ki-67 labelling 
also supports the evidence obtained with PI/FDA staining.
In one study, which investigated BrdU incorporation and Ki-67 expression during 
rat liver regeneration after a standard two-thirds partial hepatectomy, the 
expression pattern of Ki-67 labelling correlates with the labelling pattern obtained 
by BrdU incorporation (Gerlach et a l 1997). At Day 8 and Day 15, 3-D HepG2 
culture, approximately 50% of cells were in the active phases of the cell cycle.
Role of ECM
Selden et al 2000 showed that ECM expression was increased in 3-D cultures 
compared to monolayer HepG2 cultures. The following ECM proteins were 
detected immunohistochemically:- collagens I, III, V and VI, the glycoproteins 
fibronectin, tenascin and vitronectin, and the basement membrane protein laminin. 
In 3-D cultures, all proteins except tenascin were strongly expressed, as compared 
with weak or undetectable expression in monolayer cultures, even with 10-fold 
increases in the antibody concentration used. In addition, various integrin chains
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on the cell surface which bind ECM proteins were also upregulated in 3-D 
culture, such as a2, a5, aVp5 which binds laminin, and pi and demonstrated that 
the 3-D environment created by alginate encapsulation of cell lines leads to cell 
behaviour mimicking that in vivo. Therefore, it was anticipated that the addition 
of ECM substratum at Day 0 of 3-D culture might mimic the improved function 
earlier on, which was observed later on at times of 3-D culture i.e. from Day 8 and 
maintain and improve this already upregulated function, particularly from Day 11 
of 3-D HepG2 culture when cells are still proliferating but function per cell starts 
to diminish.
ECM and its role in hepatocytic differentiated function
Components of ECM contribute to the development and normal functioning of all 
cell types, together with growth and differentiation factors, and cell adhesion 
molecules. A specialised ECM is a prerequisite for the existence of multicellular 
organisms. It maintains tissue architecture and cellular polarisation and is 
important for cell migration, morphogenesis, and differentiation and wound 
healing. ECM is made of structural components, such as collagen, 
noncollagenous structural proteins, elastin, proteoglycans, glycosaminoglycans 
(Rosso et a l 2004).
Hepatocytes cultured on plastic attach poorly, function badly, and soon die 
(Gomez-Lechon et al. 1998;Sanchez et al. 2000;Yin et al. 2003). Modifications 
to conventional culture conditions have resulted in dramatic improvements in the 
maintenance of hepatic function and the use of complex ECM substrata e.g. 
Matrigel (mouse sarcoma derived matrix led to preservation of liver specific 
functions such as CYP450 expression (Davila and Morris 1999), and sustained 
higher expression of liver enriched transcription factors (Sugimoto et al. 2002).
In contrast to the flattened cells with prominent intracellular microfilaments on 
thin collagen, on EHS (matrigel) hepatocytes cluster in multicellular aggregates 
maintaining a rounded shape and exhibiting prominent endoplasmic reticulum 
(Lindblad et al. 1991).
However, in this study, the addition of ECM enhanced cell numbers both in
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monolayer HepG2 culture and 3-D HepG2 culture, particularly at Day 11, when 
function starts to diminish, but did not improve function per cell measured by 
protein secretion. Previous work in the group, using human placental ECM 
demonstrated improvements in both proliferation of spheroids and function per 
cell. However, this work was carried out 3 years ago and ECM is a biological 
preparation that varies from batch to batch. These findings were unfortunately not 
reflected in my investigations.
The data suggests that loss of function at Day 15, 3-D culture is not as a result of 
dead, non-viable cells in the centre of spheroids, and this is supported by 
downregulation of proteins such as Bid 1.7 and Nip-1, both pro-apoptotic proteins 
(Kim et a l 2000;Zhang et a l 2003).
With respect to the increased proliferation observed, further work could involve 
looking at ECM signalling pathways and molecules in these signalling pathways, 
such as ERK1 and 2, which are activated in response to increased cell 
proliferation (Agarwal and Glasel 1999;Neuhaus et a l 1996). To demonstrate 
initially whether this signalling pathway is activated, the levels of phosphorylated 
kinases, such as ERK1 and ERK2 in this pathway can be compared in spheroids 
with and without exogenous ECM. In addition, by blocking this pathway with an 
MEK inhibitor such as PD184352 (Allen et a l 2003), and observing the effects, 
one could determine whether the increase in proliferation observed with the 
addition of endogenous ECM, was attributed to the activation of this pathway. 
Many integrins, which provide receptors for molecules of the ECM, have shown 
to be upregulated in 3-D culture (Khalil 2000). By investigating the levels of 
expression of these integrins over the 3-D culture period, particularly at times of 
peak and diminished function, with and without the addition of exogenous ECM, 
it could be demonstrated whether expression of these integrins could be 
manipulated to enhance function per cell as well as increasing cell proliferation 
(Wilson et a l 2003).
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Chapter 6
Overall Discussion
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6.0 Overall Discussion
Summary o f work
This investigation has shown that liver specific functions approaching in vivo 
levels can be achieved using a 3-D HepG2 culture system, compared to 
monolayer culture, in which differentiated function is considerably less. Function 
in 3-D culture is optimal between Days 8-10, and thereafter there is a decline in 
function in spite of continued proliferation and viability. For cells to be used 
therapeutically, to replace function in a BAL, it is necessary to increase function 
per cell either at later time points of 3-D HepG2 culture when cell numbers are 
greater, and/or increase cell number at times of peak function i.e. Days 8-10 of
3-D culture.
The initial hypothesis that changes in the levels of or presence of different 
transcription factors were either responsible for optimal or diminished function 
could not be elucidated from the RNase protection assay studies alone and 
sufficient information to support this hypothesis could not be obtained from 
microarray analysis.
However, Microarray analysis did provide considerably more information on gene 
and protein expression between the HepG2 culture conditions and led to the 
hypotheses that a) genes and proteins were expressed upon activation of stress 
factors, which may be turned on as an adaptive response as a consequence of 
increased metabolic activity. These stress responses early on may reflect 
increased function of healthy cells i.e. at Day 8, 3-D culture (Nilsson et al. 2002), 
and b) the diminished function observed is attributed to stress factors such as 
hypoxia and/or oxidative stress, and genes and proteins are expressed to modulate 
their environment in response to these stresses.
Hypoxic stress was initially investigated as a possible cause for the 
downregulation of function observed, and although evidence for this stress was 
evident, manipulating the 3-D culture environment to overcome this was 
unsuccessful, with respect to enhancing cell performance. Hypoxic stress can 
trigger a signalling cascade, constituting many of the MAPKinases investigated 
i.e. MEKK3 and MKK3b, which could also be activated by oxidative stress
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factors.
Evidence of increased expression of these proteins and increased levels of lipid 
peroxidation and protein oxidation at times of diminished function at Day 15, 3-D 
culture compared to peak function at Day 8, 3-D culture, also suggested that 
oxidative stress was present. However, attempts to diminish this stress in order to 
improve cell performance were ineffective.
The role of the cell cycle was investigated in 3-D cultures alone with Powerblot 
analysis of proteins, to demonstrate cell cycle related proteins, conventional 
nuclei counting and immunostaining in 3-D cultures alone initially, and then 
proliferation studies were carried out after the addition of ECM, which was used 
to enhance cell performance. Although ECM increased cell number at times of 
peak function, it was not at adequate levels to replace function in a BAL. The 
results nevertheless did demonstrate that there was active proliferation throughout 
the spheroid, and the diminished function observed was not as a result of necrosis 
at the centre of spheroids, but could be due to other environmental changes.
There are a number of strategies for future work which could have been carried 
out, in order to enhance cell performance.
Gene expression at the transcriptional level and Microarray Studies
Methods to measure gene expression with respect to investigating the presence 
and levels of transcription factors were carried out and alternative methods, which 
were not readily available during the course of the research, but are now, have 
been described in the discussion of chapter 3. If certain genes were found to be 
upregulated at times of diminished function, then using either antisense 
oligonucleotides (AS ONs) or short interfering RNAs (siRNAs), specific 
inhibition of gene expression could have been mediated via binding to 
complementary regions on the mRNA molecules encoded by these target genes 
(Wall and Shi 2003). Gene expression may have been manipulated and for 
example, downregulating these genes could enhance cell function at later times of 
3-D culture.
However, the practical application of siRNA technology has been limited because
226
these molecules can also generate a number of less specific and undesired side 
effects within a cell. It is difficult to distinguish between the true effects of gene 
inhibition and those generated by other mechanisms. Finding ways to better 
control siRNA specificity to reduce these side effects is absolutely critical.
Manipulating “stress response” signalling pathways to improve cell 
performance
Western blotting for “key” stress related proteins demonstrated that the JNK stress 
activated pathway was switched on in Day 15, 3-D HepG2 culture and in 
monolayer HepG2 cell culture, where differentiated function is diminished or low, 
as shown by increased phosphorylation of JNK/SAPKl/MAPKp49 protein. 
These results, along with increased levels of protein oxidation and lipid 
peroxidation in these culture conditions, suggested that oxidative stress was 
causing the diminished function observed. However, the supplementation of 
additional anti-oxidants did not increase cell numbers or increase synthetic 
function per cell, therefore suggesting that any evidence of oxidative stress may 
be a result of the natural “ageing” process in the cells (Rafique et al 2004;Tahara 
1993).
Nevertheless, JNK can be activated by other stressors and mediates apoptosis, as 
well as causing downregulation of function in various culture systems (Mielke et 
al 1999;Takagi et al 2004) and therefore, may have a role in downregulation of 
function observed in this culture system, so by the addition of chemical inhibitors 
of JNK, one could observe whether blocking the activity of JNK could improve 
cell performance (Tong et al 2001;Vivo et al 2003).
It was also shown that diminished function at Day 15 was not as a result of 
necrosis at the cell centre as cell viability was shown by PI/FDA staining and 
positively labelled BrdU and Ki-67 stained cells throughout the spheroids. 
Various differentiating agents were supplemented in the medium i.e. retinoic acid, 
DMSO and did not improve function (Khalil 2000).
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The role o f ECM and other differentiating agents to enhance cell performance
The addition of ECM however did enhance cell number at Day 11, when function 
starts to diminish. Many integrins have been shown to be upregulated in 3-D 
HepG2 culture (Khalil 2000) and as discussed in chapter 5, the levels of integrins 
at times of peak and diminished function could be investigated and this would 
also help determine which ECM molecules they are binding to, with and without 
the addition of exogenous ECM and manipulating the expression of these ECM 
molecules to enhance cell function.
Paradoxically, ECM proteins may be detrimental to cell performance as it has 
certain negative effects, which may explain why an increase in cell proliferation 
was observed and not synthetic function per cell. Fibronectin, for example, 
operates through its as pi integrin receptor and induces RNase activity and cell 
spreading which results in the loss of both CYP2C11 and CuZnSOD mRNAs. 
Therefore, fibronectin at certain concentrations, either in 3-D cultures alone, or 
with addition of exogenous ECM, could be inhibiting cell performance. It is also 
important to determine levels of ECM proteins at different time points of 3-D 
HepG2 cell culture and in monolayer HepG2 cell culture. If fibronectin was 
upregulated at times of diminished function, and could be contributing to the loss 
of function observed, then using genistein, a tyrosine kinase inhibitor, which 
could block the activity of the as Pi integrin and possibly inhibit the function of 
fibronectin, could prevent this loss of function (Hodgkinson et al 2000;Paine and 
Andreakos 2004;Xu et al. 2003).
Other differentiating agents, which could been used, include a compound called 
trichostatin A (TSA) that is known to affect histone proteins that regulate 
transcriptional promoters by acting as a potent and specific inhibitor of 
mammalian histone deacetylase (HDAC) both in vivo and in vitro. TSA inhibits 
the eukaryotic cell cycle and induces morphological reversion of transformed 
cells (Hwang et al 2004;Liu et al 2003). TSA has been shown to induce 
hepatocyte differentiation in human hepatoma cell lines.
In this project, manipulation of the 3-D HepG2 culture system with TSA may 
have been a useful experimental approach, as Yamashita et al 2003 demonstrated
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that TSA increased the expression of many liver specific genes. For example, 
C/EBPa, HNF-la, HNF-3a and HNF-4a were upregulated from 1.5-to 3.0-fold 
by TSA (Yamashita et al. 2003), and in both the HepG2 and Huh-7 cell lines, 
TSA significantly decreased ammonia concentrations and has been shown to 
increase function in HepG2 cells under reduced serum conditions (Herold et al 
2002).
In addition, TSA not only has an effect on cell lines, as Henkens Tom et al 
showed in a presentation their work at the Hepatocyte Users Group meeting in 
2003 that primary cultures of rat hepatocytes treated with 25pM TSA which 
became morphologically more differentiated compared to control cultures, shown 
by the in vivo like cuboidal shape, presence of bile canaliculi and secretion of 
higher levels of albumin. Nevertheless, at the concentration used, phase I and II 
biotransformation activities were not significantly affected.
Nevertheless, Yamashita et al 2003 did show that TSA did not reactivate 
expression when the genes were unexpressed so the basis for gene selectivity of 
TSA is not known and needs to be examined.
Alternative approaches 
Increasing mass transfer
Another approach to manipulating the 3-D culture environment, is to improve 
culture conditions to allow for sufficient mass transfer, which is not provided in 
the static cell culture system in which 3-D spheroids are maintained. As 
previously described, the group is working on providing an environment for 
spheroids, allowing high-mass transfer and providing membrane oxygenation. In 
static experimental culture, nutrient depletion and toxin build up become more 
likely as the encapsulated cell population becomes denser within the bead. In a 
bioreactor system where the culture medium in constantly replenished, the 
function of the cells may improve. Although, oxygen concentration in the 3-D 
culture environment was increased and had no effect in enhancing performance, in 
a continuous culture system, rather than static culture, this may have proved 
beneficial.
Increasing the number of spheroids/cells within the alginate bead would reduce
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the volume of “dead space” which exists, although some “dead space” is required 
to allow for sufficient oxygen transport and nutrient diffusion.
Other forms o f spheroidal culture
Alternative approaches for inducing spheroidal culture have been demonstrated by 
Liver spheroidal cultures have been prepared by plating cells into 6 well plates 
and placing them on a gyrotatory shaker (Ma et al 2003). After 6 days from 
initial culture, spheroids were morphologically classified as mature.
Interestingly, Purcell’s group recommended the period from Day 6 to Day 15 for 
functional and toxicological tests. This recommendation is strongly supported by 
the kinetic change in albumin secretion. The culture period used for assessment 
by Purcell’s group parallels the culture time period used to assess liver specific 
function in the 3-D culture system described here. In addition, up to Day 15, 3-D 
culture, certain liver specific functions i.e. albumin secretion, although much 
diminished, is still greater in Day 15, 3-D culture than monolayer HepG2 culture. 
They also characterised and compared cytotoxicity endpoints using liver 
spheroids and HepG2 spheroids as in vitro models and concluded that all model 
hepatoxins, which included propranolol and paracetamol, caused in vitro toxicity 
in both rat liver spheroid and HepG2 spheroid models, so providing reliable 
models for hepatic cytotoxicity screening (Xu et al 2003).
Manipulation o f HepG2 cells and other cell sources for potential use in a BAL
The main advantage of a cell line over primary cells, which otherwise would be 
the ideal cell component for use at the biological component of a BAL, is their 
ready availability and their proliferative capacity. The HepG2 cell line described 
fulfils some of the criteria required for use in a BAL, including the retention of 
both replicating capacity and highly differentiated hepatocyte-specific functions, 
and being of human origin. However, although cell performance in 3-D culture is 
better than in monolayer culture, many liver specific functions such as urea 
synthesis are absent due to the absence of genes such as OTC, the rate-limiting 
enzyme in the urea cycle (Wilcken 2004). Currently others in the group are 
working on overexpressing OTC in HepG2 cells by transfection and cloning, and
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HepG2 cells could also be transfected with a mixture of other genes, such as 
cytochrome P450s, and the main liver enriched transcription factors such as 
HNF-4, which OTC and cytochrome P450 are both transactivated by, in order to 
maintain differentiated function long term.
A possible indefinite source of hepatocytes for a BAL could be stem cells. 
However at present, the stable pluripotent stem cell lines established show 
heterogeneous differentiation, producing a mixture of cells, instead of a pure 
population of a defined cell type. As stem cells have the ability to differentiate 
into multiple cell types, by manipulating stem cells towards a specific 
differentiated pathway, progress would be made (Stockmann and IJzermans 
2002).
Until then, immortalised cell HepG2 spheroidal culture in alginate is a promising 
and reliable basis for the biological component of a BAL.
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B .l Preparing cRNA targets for microchip analysis 
Synthesis of Double-Stranded cDNA from Total RNA
B 1.1 Materials
- T7- (dT)24 primer (HPLC purified)
- DEPC treated water
- Superscript Choice System, (Invitrogen, Life Technologies P/N 18090- 
019)
- Phase Lock Gel, Eppendorf-5 Prime, Inc., P/N pl-188233
- Phenol/chloroform/isoamyl alcohol. Ambion P/N 9732
B 1.2 Method
Starting with 5.0 to 40pg of high quality RNA, the appropriate amount of 
Superscript II Reverse Transcriptase enzyme to be added was calculated and 
DEPC treated water to make a total volume of 20pl.
B 1,2.1 First strand cDNA synthesis
Reagents in reaction
Step 1: primer hybridisation
Incubated at 70°C for 10 minutes. 
Quickly spun and placed on ice.
DEPC-H20  (variable) x pi 
RNA (variable 5.0 - 40pg) y pi 
T7-(dT)24 primer (1 OOpmol / p i) 1 pi
Step 2: temperature adjustment 
Incubated at 42° C for 2 minutes.
5X First Strand Buffer 4 pi 
0.1MDTT 2 pi 
lOmMdNTPmix 1 pi
Step 3: first strand synthesis 
Mixed well.
Incubated at 42° C for 1 hour.
SSIIRT z pi
Total Volume 20pl
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B 1,2.2 Second strand cDNA synthesis
First strand reactions were placed on ice and then centrifuged for 1 minute at 
lOOOOg (Eppendorf 5402, Germany). The following reagents were added to the 
First Strand synthesis tube.
Component Volume (pi) Final concentration or 
amount in reaction
DEPC-treated water 91pl
5X Second Strand Reaction 
Buffer
30pl IX
lOmM dATP, dCTP, dGTP, 
dTTP
3pl 200pM each
lOU/pl DNA Ligase lp l 10U
lOU/pl DNA Polymerase I 4pl 40U
2U/pl RNase H lp l 2U
Final Volume 150pl
The tube was gently tapped to mix, centrifuged for 1 minute at lOOOOg 
(Eppendorf 5402, Germany) to remove condensation and incubated at 16° C for 2 
hours in a cooling waterbath. T4 DNA, 2pi (10U) polymerase was added 
thereafter. This was incubated for 5 minutes at 16° C. lOpl of 0.5M EDTA was 
added and the double stranded cDNA was cleaned up using Phase Lock Gels 
(PLG)- Phenol/Chloroform Extraction. PLGs form an inert sealed barrier 
between the aqueous and organic phases of phenol-chloroform extractions. The 
solid barrier allows more complete recovery of the sample (aqueous phase) and 
eliminates possible contamination of the sample. Briefly, an equal volume of 
phenol:chloroform:isoamyl:alchohol (saturated with lOmM Tris-HCL pH 
8.0/lmM EDTA) was added to the final cDNA synthesis preparation and 
vortexed. The entire cDNA-phenol/chloroform mixture was transferred to the 
PLG tube. Without vortexing, the tube was centrifuged at full speed 12000g for 2
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minutes. The aqueous upper phase was transferred to a fresh 1.5 ml tube.
To concentrate the cDNA, the solution was precipitated with ethanol. To the 
sample, 0.5 volumes of 7.5M NH4AC and 2.5 volumes of absolute ethanol (stored 
at -20°C) were added, vortexed and immediately centrifuged at > 12 OOOg in a 
microcentrifuge at room temperature for 20 minutes. The supernatant was 
removed and the pellet washed with 0.5ml of 80% (ethanol stored at -20°C). The 
sample was centrifuged again at > 12000g at room temperature for 5 minutes. 
The ethanol was removed very carefully and the ethanol wash was repeated again. 
The pellet was air dried and resuspended in 12pl of RNase-free water.
4 5 6  7 8  9 marker marker 1 2 3
DNA 
smear of_ 
right size
Fig.67 Double stranded cDNA after 2nd strand cDNA synthesis 
B 2 RNA transcript labelling
Using a labelling kit, large amounts of hybridisable biotin labelled RNA targets 
can be produced by in vitro transcription using T7 RNA polymerase and biotin 
labelled nucleotides. RNA-DNA hybrids have a higher melting temperature than 
corresponding DNA-DNA hybrids and single stranded RNA targets offer higher 
target avidity and greater sensitivity than DNA probes.
Biotin labelled RNA targets can hybridise to arrays of DNA probes on chips and 
detected by a reporter molecule linked to streptavidin, by excitation of a 
fluorophore conjugated to streptavidin.
m
VI
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B 2.1 Materials
- Enzo BioArray RNA Transcript Labelling Kit P/N 900188 (Enzo 
Diagnostics, NY, USA)
- RNeasy Mini Kit (Qiagen Cat No. 74104
Reagent Volume
Template double stranded DNA variable-1 pg of cDNA
Distilled water variable- to give a final reacti
volume of 40pl
10 X HY Reaction Buffer 4pl
10 X Biotin Labelled Ribonucleotides 4pl
10XDTT 4pl
10 X RNase Inhibitor 4pl
20 X T7 RNA Polymerase 2pl
Total Volume 40pl
B 2,2 Methods
Tubes were incubated in a waterbath at 37° C for 4-5 hours, mixing gently 4-5 
times during the incubation.
The in vitro transcription reaction was treated to remove unincorporated 
nucleotides. A small sample of product was saved for analysis by gel 
electrophoresis. The sample of product was saved for analysis by gel 
electrophoresis. The sample was cleaned using Qiagen RNeasy spin columns. 
The cRNA (the in vitro transcription product) was quantified by measuring its 
absorbance at 260nm and the purity measured by the ratio of its absorbance at 
260nm and 280nm. A good quality sample should have a ratio of approximately 
2.0. Ethidium bromide gel electrophoresis of the IVT product was carried out to
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estimate the yield and size distribution o f  labeled products. Parallel gels o f
the clean up process.
1% of each sample was analysed by gel electrophoresis though a 1% agarose gel.
Quantification o f RNA after concentration o f IVT reactions -  used to determine 
level o f hybridisation target to be used on chip
The cRNA was generated with T7 RNA polymerase and labelled with biotin 
ribonucleotides. Ethidium bromide gel electrophoresis of the IVT product was 
carried out to estimate the yield and size distribution of labelled products.
Fig. 68 cRNA in the samples from different culture conditions showing a good 
28S:18S ratio
B 3 Fragmenting the cRNA for target preparation
This procedure produced a distribution of RNA fragment sizes from 
approximately 35 to 200 bases. The cRNA had to be a minimum concentration of 
0.6pg/pL. cRNA was fragmented with 5X Fragmentation Buffer and RNAse free 
water made up to a final volume of 40pL. The sample was incubated at 94°C for 
35 minutes, and then placed on ice. A small sample was saved for gel analysis.
unpurified and purified IVT product can help determine the loss of sample during
marker 1 2 3 4 5  6 7 8  9
Single stranded RNA- 
biotin labeled 
1, 2, 3 = Monolayer 
HepG2 cells 
4, 5, 6= 3-D HepG2 
culture day 8 
7, 8, 9= 3-D HepG2 
culture day 15
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Fig. 69 cRNA after fragmentation for target preparation from culture conditions 
B 3.1 Preparing the hybridisation target
For each target, the following reagents were added;
Component Volume Final
concentration
Fragmented cRNA 10ng 0.05pg/pl
Control Oligonucleotide B2 (3nM) 3.3|uL 50pM
20X Eukaryotic Hybridisation Controls 
(BioB, BioC, BioD, ere)
10pL 5.25pM
Herring Sperm DNA (lOmg/mL) 2pL O.lmg/mL
Acetylated BSA (50mg/mL) 2pL 0.5mg/mL
2X Hybridisation Buffer lOOpL IX
H20 Up to 200pL
Final volume
200pL
The probe array was equilibrated to room temperature before use and the 
hybridisation cocktail was heated for 5 minutes at 99°C in a heat block. 
Meanwhile, 160pl of IX Hybridisation buffer was placed in the array to wet it and 
the probe array was incubated at 45°C for 10 minutes with rotation.
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After the hybridisation cocktail was heated at 99°C for 5 minutes, the 
hybridisation control was transferred to a 45°C heat block for 5 minutes. The 
cocktail was spun at maximum speed in a centrifuge for 5 minutes to remove any 
insoluble material from the hybridisation mixture. The buffer solution was 
removed from the probe array cartridge and the purified hybridisation replaced it 
in the array. The probe array was placed in a rotisserie box in 45°C oven. The 
probes were hybridised for 16 hours.
B 3.2 Washing and staining o f arrays 
B 3.2.1 Materials
SAPE (Streptavidin Phycoerythrin) Stain Solution- 
For 1200pl solution
600pl of 2X Stain Buffer 
510pl of water
48pl of 50mg/mL acetylated BSA (final concentration of 
2pg/pL)
12pl of lmg/mL SAPE (final concentration of lOpg/mL)
Antibody solution- 
For 600pL solution
300pl of 2X Stain Buffer 
266pl of water
24pl of 50mg/ml acetylated BSA (final concentration of 
2 mg/mL)
6.0pl of lOmg/mL normal goat IgG (final concentration of 
0.1 mg/mL)
3.6pL of 0.5mg/mL biotinylated antibody (final 
concentration of 3 pg/mL)
5% (w/v) Antifoam Stock Solution
Stringent Wash Buffer 
For lOOOmL
83.3 mL of 12 X MES Stock Buffer 
5.2 mL of 5M NaCl
1.0 mL of 10% Tween 20 
910.5 mL of water 
Filtered through a 0.2pm filter
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Non-Stringent Wash Buffer 
For lOOOmL
300 mL of 20X SSPE (3M NaCl, 0.2M NaH2P04, 0.02M 
EDTA)
1.0 mL of 10% Tween 20 
698mL of water
Filtered through a 0.2pm filter. After filtering added 1.0 
mL 5% antifoam.
2 X Stain Buffer 
For 250mL
41.7mL 12XMES Stock Buffer 
92.5mL 5M NaCl 
2.5mL 10% Tween 20 
112.8mL water
Filtered through a 0.2 pm filter. After filtering, added 
0.5mL of 5% Anti-foam.
lOmg/mL Goat lgG Stock
Resuspended in 50mg in 5 mL PBS. Store at 4°C.
B 3,2.2 Method
The probe arrays were placed in a fluidics station in which the staining and 
washing took place. A microcentrifuge tube containing 600pL SAPE solution 
was placed into the sample holder. When the LCD window on the fluidics station 
indicated the microfuge tube containing the SAPE solution was replaced with a 
microfuge tube containing 600pL of antibody stain solution into the sample 
holder. When the LCD window indicated again, the microfuge tube was replaced 
again with the second 600pl SAPE solution. When the washing/staining protocol 
was complete the probe array was removed and as long as there were no large 
bubbles on the array, the probe was scanned. If they were not scanned 
immediately, they were stored at 4°C, in the dark.
B.4 Analysis
The cRNA from the culture conditions was hybridized to arrays of DNA probes 
on Affymetrix Human Gene Chips U95Av2, n=3.
For each sequence, a probe set contains Perfect Match (PM) and single base
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mismatch (MM) sequences complementary for each probe. When the intensity of 
the MM probe cell is significantly greater than the PM probe cell, the probe pair is 
termed Negative.
A probe pair is considered to Increase if the intensity difference between the PM 
and the MM probe cells in the experimental is significantly higher than in the 
baseline sample.
Affymetrix GeneChip^
A
complementary
match
■ ■
B
Fig. 70 Detection by fluorescence on Affymetrix Chip
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